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Abstract 
 
Stress is one of the most frequently self-identified seizure precipitants in patients with 
epilepsy, and psychogenic non-epileptic seizures (PNES) are by definition associated with 
psychological distress. Stress is a multifaceted phenomenon, yet few studies have 
systematically examined its different components in patients with seizures. The main aim of 
this thesis was therefore to assess the association between stress and seizures using a 
combination of stress measures, and to develop an intervention targeting stress in patients 
with seizures.  
The first study prospectively explored a range of psychological and physiological stress 
markers in patients undergoing video-telemetry. A diurnal pattern was observed in the 
physiological measures but, whereas some of the physiological measures were shown to be 
associated with each other, no close relationship was found with self-reported stress. Notably, 
none of the stress measures predicted occurrence of epileptic seizures or PNES; however, the 
occurrence of seizures was found to predict greater self-reported stress and autonomic arousal 
up to 12 hours after the seizures. A second part of the study assessed implicit attentional 
responses to stress-related stimuli and suggested patients with epilepsy show heightened 
vigilance towards threat (especially seizure threat), associated with increased autonomic 
arousal.  
A self-help stress-management intervention, developed as part of the second study, was 
evaluated in a pilot randomised controlled trial. Results from the pilot demonstrated the 
intervention was acceptable and provided preliminary evidence for its effectiveness in 
reducing self-perceived stress. Further evaluation in a larger trial may be justified, although 
future studies should include measures to reduce the high attrition rates observed in the pilot 
study.  
Ultimately, examination of the role of stress in seizure disorders continues to be an 
important area for future research. Simple interventions such as the one developed in this 
thesis could be a useful complementary treatment option for reducing the distress associated 
with seizures. 
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1. CHAPTER 1  
Introduction 
 
1.1 Epilepsy 
Epilepsy is one of the most common disabling neurological disorders, characterised 
by recurrent seizures (Haut et al., 2006). According to the International League Against 
Epilepsy (ILAE), epilepsy is defined as a disease of the brain diagnosed on the basis of any 
of the following three criteria: (1) occurrence of at least two unprovoked or reflex seizures 
more than 24 hours apart, (2) one unprovoked or reflex seizure associated with at least 60% 
probability of seizure recurrence in the next ten years, or (3) diagnosis of an epilepsy 
syndrome (Fisher et al., 2014). Epilepsy is a complex disorder with a heterogeneous 
aetiology and diverse manifestations (Berg et al., 2010). The ILAE proposed a classification 
system based along five axes that describe (1) the type of seizure (Figure 1.1), (2) focal or 
generalised seizure onset, (3) epilepsy syndromes (Figure 1.2), (4) aetiology and (5) the 
associated disability (Duncan et al., 2006). Seizures are events in the brain characterised by 
hypersynchronous and excessive electrical discharges that can be classified as generalised, 
focal or unknown (Berg et al., 2010). Generalised seizures arise within and spread across 
both hemispheres, whereas focal seizures originate in one part of the brain and may or may 
not spread. Seizures can vary from brief lapses of consciousness, muscle jerks or stiffening to 
severe convulsions, and can be accompanied by disturbances of sensation, mood or mental 
function (Duncan et al., 2006). Different types of epilepsy can be grouped into epilepsy 
syndromes according to the clinical symptoms and characteristics of the disorder (Haut et al., 
2006). Based on the underlying aetiology, epilepsies can be divided into genetic epilepsies 
caused by a genetic deficiency or structural-metabolic epilepsies caused by damage or 
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disorders of the brain including birth trauma, head injury, brain tumours, brain infection or 
alcohol abuse. In many cases, the cause remains unknown (Berg et al., 2010).  
The overall prevalence of epilepsy is high (between 4 - 15 per 1,000 population per 
year) and it is associated with a societal and economic burden (Duncan et al., 2006; Ngugi et 
al., 2010). Epilepsy affects individuals of all ages, across all geographical regions, and is 
associated with serious impacts on the individual’s self-image, self-esteem and health-related 
quality of life (HRQoL) (Baker et al., 2000; Fisher et al., 2000; Hermann & Jacoby, 2009). 
The aim of the treatment of epilepsy is a complete elimination of seizures, as well as 
the reduction of the associated disability and improvement of HRQoL (Haut et al., 2006). 
Most patients are offered long-term antiepileptic drug treatment, which stops the attacks in 60 
- 65% of patients, however, about one third of patients do not respond to medication (Duncan 
et al., 2006). Drug-resistant epilepsy can be treated by epilepsy surgery, vagal nerve 
stimulation (VNS) or other non-pharmacological therapeutic methods including special diets.  
Patients may also benefit from psychosocial and educational interventions or 
alternative medicine (Wolf et al., 2013). In the past these methods were an important part of 
treatment although lost favour as a result of a biomedical understanding becoming 
predominant in the second half of the 20th century (Pinikahana & Dono, 2009). Such 
approaches however, have recently gained renewed interest. This can be partly attributed to 
the fact that many patients using medication continue to have seizures and may therefore seek 
alternative treatment options (Wolf, 2002). Another reason may be that unless seizures are 
controlled altogether, HRQoL in epilepsy is related less to the frequency and severity of 
seizures than to psychosocial factors, such as social isolation or depression and anxiety, for 
which people with epilepsy are at higher risk (Kessler et al., 2012). 
One of the greatest concerns of people with epilepsy is the unpredictability of seizure 
events, one example of this is that people can often find it difficult to understand why their 
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seizures started (Fisher et al., 2000). Given that seizure (ictal) events can be paroxysmal in 
nature and have been described as highly distressing experiences (Fisher et al., 2000), the 
recognition and management of seizure triggers is an important area of research with scope 
for targeted intervention. It should be noted however that there is a difference between risk 
factors and triggers of epilepsy. Risk factors increase the likelihood that the disorder will 
develop and therefore explain the vulnerability of an individual to the process of 
epileptogenesis or the initial development of epilepsy (Haut et al., 2006). Triggers, on the 
other hand, are factors that increase the probability of an attack occurring in an individual 
who has already developed the disorder and are therefore related to ictogenesis or the 
development of epileptic seizures in the presence of a vulnerability to ‘spontaneous’ epileptic 
seizures (Haut et al., 2006).   
 
Figure 1.1. Classification of seizures by the ILAE Commission on Classification and 
Terminology (Berg et al., 2010) 
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Figure 1.2. Overview of epileptic syndromes proposed by the ILAE Commission on 
Classification and Terminology (Berg et al., 2010) 
	  
1.2 Psychogenic Non-epileptic Seizures (PNES) 
Psychogenic non-epileptic seizures (PNES) are characterised by episodes of 
involuntary alteration of consciousness and disturbances of motor, sensory, autonomic, 
cognitive or behavioural function that superficially resemble epileptic seizures but are not 
caused by epileptic activity in the brain (Reuber, 2009). PNES are attributed to underlying 
psychological causes and are classified as a conversion or somatic symptom disorder in the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-V) (APA, 2013) and as a 
dissociative disorder in the International Classification of Diseases (ICD-10) (WHO, 1992).  
There are multiple predisposing, precipitating and perpetuating factors associated 
with PNES, and the disorder is often related to a complex interplay of these factors (Reuber, 
2009). The predisposing factors may include dysfunctional family environment, childhood 
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sexual abuse or other traumatic experiences in early life (Salmon et al., 2003). PNES are 
often precipitated by significant adverse or traumatic life events and are commonly 
associated with other mental disorders, including anxiety, depression, personality disorders, 
post-traumatic stress disorder, or other dissociative or somatoform disorders (Bodde et al., 
2009). PNES also develop in about 10 - 30% of patients with concurrent epilepsy (Asadi-
Pooya & Emami, 2013; Martin et al., 2003; Reuber, 2009). In some patients, physical 
precipitants, such as minor brain injuries, epilepsy surgery or other neurosurgical procedures 
can be identified. A number of factors can further exacerbate the disorder, including the 
concurrent psychiatric disorders or maladaptive coping styles (Reuber, 2009). Similar to 
epilepsy, it is useful to distinguish between more general risk factors for PNES that 
predispose, precipitate and maintain the disorder, and more immediate triggers of the 
individual seizures. Such trigger factors include overwhelming sensory and emotional 
stimuli, which may play an important role in seizure management (Goldstein & Mellers, 
2006).  
Of patients newly presenting in seizure clinics with blackouts 10 - 20% have PNES 
(Angus-Leppan, 2008). The diagnosis of the disorder can be difficult, although a ‘gold-
standard’ can be achieved by the recording of typical seizures with synchronised video-
electroencephalography (video-EEG). However, video-EEG is typically only carried out in 
patients with persistent, frequent or treatment refractory seizures and in the majority of cases, 
PNES are associated with a delay in diagnosis (Reuber et al., 2002), and are often initially 
misdiagnosed as epilepsy (LaFrance et al., 2013). This means that, although the 
recommended treatment method for PNES is psychotherapy, many patients with PNES are 
inappropriately treated with anti-epileptic drugs, thus increasing the chance of iatrogenic 
harm (LaFrance et al., 2013; Reuber et al., 2005b). Seizure and social outcomes in patients 
with PNES are poor if no specific treatment is offered (Reuber et al., 2003). 
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1.3 The Concept of Stress 
The experience of ‘stress’ is a common component of everyday life. Stress is a part of 
an adaptive mechanism that mobilises the organism to respond appropriately to threatening or 
challenging stimuli (Aldwin, 2000). However, longitudinal research, such as the Whitehall II 
studies (Carroll et al., 2001), has suggested that the physiological changes associated with 
stress responses to environmental and psychosocial demands can have adverse effects on 
people’s health, particularly if they are excessive or prolonged. 
Stress is a complex phenomenon and its aspects and effects on health have been 
studied by a number of disciplines (Aldwin, 2000). As a result, there are multiple definitions 
and methods of measurement which have created considerable confusion and inconsistency 
(Cohen et al., 1995). Cohen et al. (1995) attempted to integrate the different approaches 
defining stress as ‘a process in which environmental demands tax or exceed the adaptive 
capacity of an organism, resulting in psychological and biological changes that may place 
persons at risk of disease’ (p. 3). This encompasses the three main theoretical perspectives on 
stress: (1) the environmental perspective, concerned with external environmental events that 
can be objectively considered as stressful; (2) the psychological perspective, focussed on the 
individual’s subjective appraisals of events and his or her capacity to cope with them; and (3) 
the biological perspective, studying the physiological stress responses, in particular the 
neuroendocrine and immune processes and their effects on health (Aldwin, 2000). The three 
perspectives can be unified into an integrative model (Figure 1.3) showing stress as a 
dynamic process with the environmental, psychological and biological variables mutually 
influencing each other. The three perspectives place a different emphasis on the subjective 
and objective experience of stress, and each of them is associated with different measures of 
stress. Given the interactive nature of the different aspects of the stress process, the most 
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informative approaches involve combinations of objective and subjective stress measures 
(Aldwin, 2000).  
One of the most challenging questions across all stress approaches is the question of 
the temporal characteristics of stress (Cohen et al., 1995). For instance, a distinction is 
commonly made between ‘acute’ and ‘chronic’ stress. There is, however, no clearly defined 
time period for the acute versus chronic stress and the consequences of the temporal 
characteristics of stress may be different for different health outcomes. Furthermore, evidence 
shows that individuals may even be affected by prenatal maternal stress through epigenetic 
mechanisms, for example, animal studies demonstrated that infants of mice who were 
exposed to a stressor during the gestation period showed memory deficits and increased 
depressive-like behaviour (Sierksma et al., 2013). Cohen et al. (1995) therefore recommend 
that the temporal aspects should always be considered in the context of the particular research 
question and characteristics of the outcome measure. 
Figure 1.3. Integrative model of the environmental, psychological and biological perspectives 
on stress. Model adapted from Cohen et al. (1995) 
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1.4 Stress and Seizures 
Stress, epilepsy and PNES are multifaceted conditions, which can interact in complex 
ways. Epilepsy and PNES are likely to be associated with a great degree of stress, resulting 
from the disabling effects of living with a chronic condition, as well as the experience of 
recurrent seizures, each of which can in itself be an acutely stressful event (Goldstein & 
Mellers, 2006). The relationship also goes in the other direction. Many studies have 
demonstrated that patients with epilepsy consider stress the most common trigger of their 
seizures (e.g., Fisher et al., 2000) and the mechanisms by which stress affects the 
neuroendocrine and immune systems have been proposed to influence the development and 
exacerbation of epilepsy at various stages of the disorder (Friedman et al., 2011). For 
instance, a review of animal work has shown that early life stress can contribute to the 
development of epilepsy and create an increased vulnerability to seizures through alteration 
of the brain structure, electrophysiology, neurotransmitter and neuroendocrine function (Koe 
et al., 2009). The neuroendocrine and immune stress responses could also exacerbate the 
neural damage following an aetiological event, such as traumatic brain injury or an isolated 
or provoked seizure, which could further contribute to the process of epileptogenesis 
(Friedman et al., 2011). Finally, by affecting neuronal excitability, stress could also 
exacerbate the frequency and severity of spontaneous seizures (Friedman et al., 2011).  
The effects of stress on PNES are even more notable, as PNES are by definition 
related to psychological stress factors and the seizures are considered to be behavioural or 
dissociative responses to emotional, physiological or social distress (Bowman, 2006; Reuber 
& Mayor, 2012). The development of PNES has been associated with adverse life events 
(Binzer et al., 2004). Stress and psychophysiological arousal have further been suggested as 
factors capable of triggering individual seizures (Goldstein & Mellers, 2006). Stress may 
therefore be both a risk factor for the development of epilepsy and PNES, as well as a trigger 
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affecting the occurrence and severity of seizures in individuals with existing seizure 
disorders.  
1.5 Aims 
The overall aims of this PhD project are to explore the relationships between stress 
and epileptic and psychogenic non-epileptic seizures and to develop and pilot-test a self-help 
stress management intervention for patients with seizures. In this thesis, I present two studies 
that were designed to achieve these aims. The project has a number of specific objectives, as 
outlined below: 
1.5.1 Primary Aims  
1.) To provide a narrative literature review of the relationship between stress and 
epileptic and psychogenic non-epileptic seizures in adults with established seizure 
disorders 
2.) To describe diurnal patterns of psychological and physiological measures of stress in 
patients with epilepsy and patients with PNES, and explore their relationships to each 
other and to seizure occurrence  
3.) To investigate implicit attentional responses to stress-related stimuli in patients with 
epilepsy and patients with PNES, compared to healthy volunteers, and to explore their 
associations to physiological stress measures  
4.) To develop a self-help stress management intervention for patients with seizures and 
assess its feasibility and acceptability in a pilot study of a randomised controlled trial 
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1.5.2 Secondary Aims  
5.) To explore moderating factors of the implicit attentional responses  
6.) To test whether the implicit cognitive and/or physiological stress responses can be 
altered by a self-affirmation intervention 
7.) To conduct a preliminary evaluation of the self-help stress management intervention 
in reducing stress, seizure frequency, anxiety and depression, and improving quality 
of life in patients with epilepsy and patients with PNES, and provide estimates of 
effect sizes to facilitate sample size calculations for future RCTs  
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2. CHAPTER 2  
The Role of Stress as a Trigger for Epileptic and Psychogenic 
Non-Epileptic Seizures: A Narrative Review of Evidence from 
Human and Animal Studies and Psychological Interventions 
 
Several previous reviews have focused on the role of early life stress and stress in 
adulthood in epileptogenesis, and the development of PNES. This narrative review 
concentrates on the relationship between stress in adulthood and seizures in people with 
established seizure disorders. Taking into an account the different perspectives on stress, both 
subjective and objective evidence for the relationship between stress and seizures will be 
reviewed, using human studies of perceived psychological stress and stressful life events, as 
well as physiological findings from animal and human studies of epilepsy and PNES. 
Additional evidence from psychological interventions will also be presented and the potential 
for development of new interventions will be discussed. 
2.1 Psychological Stress, Coping and Seizures 
Psychological models of stress emphasise the role of the subjective interpretation of a 
stimulus or an event. According to the dominant model of stress developed by (Lazarus & 
Folkman, 1984), the stress process consists of four stages: stimulus presentation, primary 
appraisal, secondary appraisal and the stress reaction. If the stimulus is appraised as 
threatening (primary appraisal), and the individual’s coping resources are appraised as 
insufficient (secondary appraisal), the individual responds with a stress reaction. This 
involves negative emotional responses (feeling tense, nervous, irritable or upset), as well as 
other behavioural reactions, such as changed sleeping or dietary habits (Lazarus, 1993). 
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Encountering a stressful situation requires emotional, cognitive and behavioural efforts, 
generally referred to as ‘coping’. According to Lazarus and Folkman, there are two broad 
types of coping, (1) emotion-focused coping, typically directed at regulating the distressing 
emotions and changing the way the individual attends to and interprets the experience, and 
(2) problem-focused coping, which involves efforts to take actions to change or improve the 
situation (Lazarus & Folkman, 1984). The evidence for whether people’s perceptions, coping 
and reactions to stress may have an effect on the occurrence of seizures is discussed below. 
2.1.1 Psychological Stress and Epileptic Seizures 
2.1.1.1 Self-report studies 
There is overwhelming evidence from patient self-reports suggesting that stress is 
most commonly perceived as a trigger of seizures.  Hayden et al. surveyed over 500 patients 
with epilepsy and found that the aspect people found most worrying about their condition 
was the unpredictability and lack of control over their seizures. When asked about the 
predictability of their seizures, 59% of patients believed that stress was related to seizure 
frequency and 41.2% further independently identified stress as the main factor that increases 
the likelihood of a seizure (1992). The trend of reporting stress as the main seizure precipitant 
was later confirmed across large numbers of patients of different nationalities and with 
various epilepsy syndromes (Hart & Shorvon, 1995; Nakken et al., 2005). 
One study pointed out a potential issue common to all of the above studies. Apart 
from stress, factors including lack of sleep and tiredness are also often reported as seizure 
precipitants (Frucht et al., 2000). Frucht et al. (2000) found that stress, which was identified 
as the main precipitant by 30% of the 400 participants, was significantly positively correlated 
with fatigue and sleep deprivation, forming a cluster of precipitants that may interact to 
produce the effect on seizures. However, a later study by Haut and colleagues demonstrated 
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that stress is frequently reported independently of other factors. In their study, 64% of the 89 
patients who participated in the study believed that stress was related to at least some of their 
seizures and this belief was not significantly associated with sleep deprivation (Haut et al., 
2003).  
Further supporting evidence comes from interview studies. A semi-structured 
interview study found that out of 100 participants, the majority stated stress or feeling 
anxious, worried and tense as the main precipitating factors, both in response to open (53%) 
and closed questions (66%) (Spector et al., 2000). Another interview study asked young 
patients and their carers about seizure precipitation and found that stress (described as feeling 
worried, upset, angry, anxious or excited) was the most frequently reported precipitant by 
both groups (Cull et al., 1996). Moreover, although there was a rather poor agreement 
between the patients and carers on all other questions, there was a high correspondence for 
stress as a precipitant.  
Another study, which showed that most patients also reported stress as a trigger 
(55.9%), also highlighted a problem with the retrospective nature of patient self-reports that 
undermines the reliability and the potential predictive value of the findings (Pinikahana & 
Dono, 2009). While 86.9% of patients reported they were aware of experiencing initial 
symptoms and seizure triggers, only 63.6% stated they were able to tell that they were going 
to have a seizure. This suggests that patients may only recognise or assume what the 
precipitating event was after the seizure. 
A major limitation of the self-report studies is the lack of a clear definition and a 
standardised, validated assessment of the self-perceived ‘stress’ or its temporal characteristics 
in relation to seizures. Furthermore, the retrospective nature and cross-sectional design of 
most of the studies do not allow any conclusions about the actual temporal or causal link 
between stress and seizure occurrence.  
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One of the few studies with a longitudinal design that used a validated stress scale 
showed that stress, measured by the Perceived Stress Scale (PSS) (Cohen et al., 1983), 
anxiety and depression were all significant predictors of self-reported seizure frequency 
(Thapar et al., 2009). This provides support for the idea that stress can trigger seizures, but 
also draws attention to the role of comorbid psychiatric disorders in the relationship between 
stress and seizures. Another study also found that reporting stress as a seizure precipitant was 
significantly related to scores on an anxiety scale (Sperling et al., 2008). Depression and 
anxiety are common comorbidities of epilepsy and there is a complex, bidirectional 
relationship among the disorders (Kanner, 2009). While epilepsy increases the risk for 
depression and anxiety, the history of a psychiatric disorder has been found to double the risk 
for developing epilepsy (Hitiris et al., 2007). There could be a common mechanism 
underlying the psychiatric disorders, stress and epilepsy that may be involved in triggering 
seizures. Whether there are physiological links between self-perceived stress and epileptic 
seizures or not, this perception could have important implications for seizure management 
and people’s quality of life. 
2.1.1.2 Prospective diary studies 
Although there is compelling evidence from the self-report research, prospective 
studies of stress and seizures yielded more controversial findings. Analysis of patients’ diary 
data showed that higher levels of stress and anxiety were associated with a higher risk of 
having a seizure the next day (Haut et al., 2007). Furthermore, higher levels of stress and 
anxiety were also related to a greater likelihood of a positive seizure prediction. This study 
does, however, have several limitations. Firstly, stress and anxiety were not defined or 
assessed by a standardised scale and the measures were only taken once a day, which may not 
be representative of the levels over the whole day. Secondly, the paper diaries used in the 
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study are rather unreliable as they allow for retrospective recording and bias in responding 
(Litt & Krieger, 2007). 
Haut et al. later conducted a similar study using a more reliable method of recording 
through electronic diaries that enabled time tracking to prevent retrospective filling (Haut et 
al., 2012). Patients were asked to make recordings twice a day and stress was measured both 
by a self-rating scale and the PSS. In addition, the study also investigated mood and 
premonitory symptoms, or so-called prodromal states. Epileptic prodromes comprise states 
and sensations that precede seizures for a prolonged period of time and include disturbances 
in behaviour, mood or sensation (Mormann & Lehnertz, 2013). Haut et al.’s (2012) study 
found that the perceived stress levels were not associated with an increased risk of seizures in 
the following 12 hours, a finding that directly contradicts the results of the earlier study by 
the same author (Haut et al., 2007). Increased seizure risk was, however, significantly 
associated with lower mood and higher number of identified premonitory symptoms (Haut et 
al., 2012).  
It seems plausible that there is a relationship between the premonitory symptoms, 
mood and stress. Haut et al. (2007) found a correlation between stress and positive self-
prediction of seizures which could suggest that patients either based their predictions on the 
awareness of stress being a potential trigger or they may have misinterpreted the premonitory 
sensations related to a forthcoming seizure as feeling ‘stressed’, a hypothesis that is 
supported by the study of Haut et al. (2012). When stress and the prodromal states were 
assessed separately, prodromes were shown to have a better predictive potential than stress 
levels indicated by the self-report and the PSS scales. The relationship between prodromal 
states, stress and other precipitants is nevertheless complex (Haut et al., 2012), and there is a 
degree of overlap. Furthermore, the diary studies are limited by possible inaccuracy of 
	   22 
seizure reporting. The evidence from these few prospective studies therefore remains 
inconclusive. 
2.1.1.3 Stressful life events 
A small body of evidence comes from studies on the impact of environmental 
stressors on seizure occurrence. There is evidence that external stressors can trigger seizures 
in people with no previous seizure history (Moshe et al., 2008). The observation that stressors 
can have epileptogenic effects suggests that they could also affect the frequency of seizures 
in individuals with existing epilepsy.  
Neufeld et al. investigated frequency of seizures during the Persian Gulf War in 1991 
(Neufeld et al., 1994). Out of 100 Israelis living in the area, 82 reported experiencing stress 
during the war period but only 8 reported an increased frequency of seizures. The authors 
conclude that there may be a weak relationship between stressful events and seizures. 
Another study examined effects of the experience of an earthquake in Seattle in 2001 and 
reported that experiencing the earthquake precipitated a seizure within 24 h after the event in 
11.5% of patients (Watson et al., 2002). The subjective perceptions of the event as stressful 
were, however, not assessed. Both studies are limited considerably by its design based on 
retrospective self-report. 
In a prospective study, analysis of diaries from 46 patients showed stressful events to 
be significantly associated with increased seizure frequency in five participants, but the 
events were also significantly associated with decreased seizure frequency in two patients 
(Neugebauer et al., 1994).  More compelling evidence for the association was obtained in a 
controlled study on the effects of a flood evacuation in the Netherlands in 1995 (Swinkels et 
al., 1998). Swinkels et al. (1998) compared the frequency of seizures from medical records or 
seizure diaries of a group of 30 evacuees and 30 control patients. The two groups differed 
significantly in the degree of change of seizure frequency from pre-evacuation period to the 
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period during evacuation and shortly after, with eight evacuees as opposed to only one 
control patient showing an increase in seizure frequency. In a follow-up questionnaire, 70% 
of the evacuees stated that they experienced triggering factors during the evacuation and the 
majority (91.9%) reported stress being one of them. However, of the evacuees with a change 
in seizure frequency, only three reported experiencing stress as a trigger. 
Although the results show a rather weak relationship, external stress does seem to 
play a role in seizure frequency - at least in a certain proportion of individuals. There are 
likely to be important differences in people’s subjective appraisal of experiences, which may 
influence their perception of how stressful a particular event is (for instance, early life and 
previous illness experiences or mitigating factors during exposure to the acute stressor). 
There is initial evidence suggesting that people with temporal lobe epilepsy who report 
experiencing emotional seizure triggers show attention bias toward threat, as demonstrated in 
an emotional Stroop test and a dot detection paradigm (Lanteaume et al., 2009). The issue is 
complicated by the fact that stressful experiences may be associated with other potentially 
seizure-precipitating factors (such as sleep withdrawal). Unfortunately, such possible 
confounding factors were not prospectively assessed in any of the studies.  
2.1.2 Psychological Stress and Psychogenic Non-epileptic Seizures 
2.1.2.1 Stressful life events, stress appraisal and coping 
While a number of studies focussed on the role of childhood trauma in PNES, fewer 
studies have looked at the role of other stressful life events and stress in adulthood, and the 
effects of stress on the occurrence of seizures (Tojek et al., 2000). 
Self-report studies of life events suggest that patients with PNES experience more 
stressful life events than healthy individuals (Frances et al., 1999; Testa et al., 2012) and 
those with epilepsy (Tojek et al., 2000). In a study that compared the two seizure disorders, 
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patients with PNES reported higher frequency of stressful life events and rated the events as 
more stressful than patients with epilepsy (Tojek et al., 2000). Patients with PNES were also 
found to be subjectively more distressed by negative life events than patients with epilepsy in 
a study by Testa et al., (2012), although both groups of patients reported an equal number of 
stressful events.  
Frances et al. (1999) suggested that both patients with epilepsy and PNES experience 
life as more stressful than healthy individuals. However, while the experience of patients with 
epilepsy may be based on realistic perceptions and concerns related to the unpredictable and 
disabling nature of their condition and the associated constraints, patients with PNES may 
have more unrealistic perceptions of situations as threatening and underestimate their coping 
resources or use maladaptive coping techniques. This may be a consequence of their difficult 
or traumatic experiences and dysfunctional family environment (Frances et al., 1999). 
Patients with PNES have indeed been shown to use avoidant coping strategies (Goldstein & 
Mellers, 2006; Frances et al., 1999), engage in ruminative thinking about their stressful life 
experiences (Tojek et al., 2000) and use less proactive coping and planning (Testa et al., 
2012). In fact, the seizures in patients with PNES can be considered a manifestation of the 
avoidant coping behaviour and a means to escape or avoid emotional distress. Goldstein & 
Mellers (2006) explored whether PNES are triggered by stress or anxiety and found that 
patients with PNES self-reported a higher number of somatic symptoms of anxiety and 
autonomic arousal during seizures than patients with epilepsy. The study was nevertheless 
based on patients’ retrospective self-reports and does not provide a direct evidence for the 
link between stress and PNES. 
2.1.2.2 Implicit stress responses 
In addition to the self-report studies, Bakvis et al. conducted a series of studies 
looking at implicit or automatic stress responses. Compared to healthy controls and patients 
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with epilepsy, patients with PNES showed greater vigilance to socially threatening stimuli, 
demonstrated by a positive attentional bias towards angry faces presented subliminally in an 
emotional Stroop test (Bakvis et al., 2009a; Bakvis et al., 2009b). Patients with PNES also 
showed greater automatic avoidance tendencies in a social approach-avoidance task than 
healthy individuals (Bakvis et al., 2011). Interestingly, these implicit responses were absent 
in acute stress conditions induced by the Trier Social Stress Test (Bakvis et al., 2009a; Bakvis 
et al., 2009b; Bakvis et al., 2011). The finding of greater attentional biases at baseline 
corresponds with the findings by Roberts et al. In their study, patients with PNES, as well as 
seizure-free individuals with a high number of post-traumatic symptoms (PTS), reported 
more emotionally intense responses to neutral and pleasant affective pictures than a group of 
seizure-free individuals with low PTS symptoms but all groups had similar responses to 
negative affective pictures (Roberts et al., 2012). Roberts et al. (2012) suggest that patients 
with PNES may exhibit greater vigilance in ‘safe’ baseline conditions due to their adverse 
experiences from the past that conditioned them to be vigilant to potential threats in the 
environment.  
The psychological stress mechanism in patients with PNES, therefore, seems to be 
characterised by greater appraisal of situations as threatening together with implicit 
hypervigilance to threat and maladaptive, avoidant coping responses to stressors. This may 
make this group of patients more vulnerable to stress and its negative effects. However, it 
remains unclear what role (if any) these stress-related responses play in precipitating 
individual seizures, as no studies have investigated the direct temporal relationship between 
stress and non-epileptic seizures. 
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2.2 Physiological Stress and Seizures 
The biological stress response is mediated by the neuroendocrine system that initiates 
activation and subsequent restoration of the organism’s functions, in order to adapt to a given 
stressor (Aldwin, 2000). The two main components involved are the hypothalamic-pituitary-
adrenocortical (HPA) axis and the sympathetic-adrenomedullary (SAM) system (Figure 2.1) 
(Cohen et al., 1995).   
2.2.1 The HPA Axis 
The activity of the HPA axis is characterised by a three-stage hormonal response (see 
Figure 2.1). During the first ‘alarm stage’, the hypothalamus increases secretion of 
corticotropin-releasing hormone (CRH) through a specialised set of neurons in the 
paraventricular nucleus (PVN), causing the anterior pituitary gland to release 
adrenocorticotropic hormone (ACTH), which activates the adrenal cortex to produce 
corticosteroid hormones (cortisol in humans, corticosterone in animals) (Cohen et al., 1995). 
After this rapid increase in hormonal secretion, the corticosteroid hormones help to adapt to 
the stressor and restore the state of the organism during the ‘resistance stage’. If exposed to a 
severe or chronic stressor, the HPA adaptive capacity is impaired and the organism reaches 
‘exhaustion stage’ in which it is no longer able to respond to stressors (Cohen et al., 1995). 
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Figure 2.1. The physiological response to stress by the HPA axis and the SAM system and the 
positive and negative feedback loops. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.2 HPA Axis Stress Mediators in Epilepsy 
As the HPA stress mediators affect excitatory and inhibitory processes in brain areas 
that are commonly involved in epilepsy, such as the limbic structures (see Figure 2.1), they 
have been suggested to have the capacity both to facilitate and suppress seizure activity 
(Myslobodsky, 1993). A few reviews (Joels, 2009; Lai & Trimble, 1997) have summarised 
the effects of the different HPA hormones. CRH has been found to increase excitability in the 
hippocampus by, for example, increasing the frequency of spontaneous excitatory 
postsynaptic currents and the number of action potentials per burst (Hollrigel et al., 1998). 
CRH can also facilitate inhibition of the hippocampus through suppression of the activity of 
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N-methyl-D-asparate (NMDA) (Sheng et al., 2008). Similarly, corticosteroid hormones can 
also enhance excitatory and inhibitory transmission. Corticosterone has been found to 
increase the amplitude of calcium currents in cells of the CA1 hippocampal area, allowing for 
greater Calcium influx and thus increased excitation of the CA1 cells (Chameau et al., 2007). 
It has also been shown to decrease the neuronal firing rate mediated by serotonin receptors 
(Beck et al., 1996). The effects of ACTH, on the other hand, seem predominantly 
anticonvulsant (Croiset & Dewied, 1992). The following paragraphs will focus especially on 
experimental studies of those hormones that could play a role in the exacerbation of seizures. 
2.2.2.1 Animal models of epilepsy 
The effects of the HPA stress hormones on seizures have not been studied 
experimentally in humans and most evidence therefore comes from animal studies. In order 
to gain a better understanding of the findings, it is important to distinguish between the 
different animal models of epilepsy and what they represent. Models of epilepsy can be 
divided into ‘acute’ and ‘chronic’ models (Loescher, 2002). In acute models, a seizure is 
induced in a healthy animal by electrical or chemical stimulation and these models therefore 
provide insights into the process of epileptogenesis.  
In chronic models of epilepsy, animals are made epileptic by chemical or electrical 
induction of status epilepticus (SE) which is a state of a persistent seizure after which 
recurrent seizures usually occur, or by kindling, which involves initial stimulation by 
electrical or chemical doses that are not acutely ictogenic but eventually induce seizures after 
repeated stimulation and may lead to development of spontaneous seizures in the fully-
kindled state. Alternatively, mutant animals with inborn epilepsy are used (Loescher, 2002). 
The chronic models represent fully developed epilepsy and enable investigation of the 
process of ictogenesis. In stress research, the exogenous administration of a stress mediator 
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(e.g., corticosterone) or endogenous sources of stress mediators via exposure to a naturalistic 
stressor (e.g., water immersion) are used in both types of models (Joels, 2009). 
Most animal studies of stress and epilepsy focus on the potential of acute and chronic 
exposure to stress or stress hormones to trigger epilepsy in non-epileptic animals. The main 
findings have been summarised by recent reviews (Joels, 2009) and as the focus of this 
review is on the process of ictogenesis, the studies of epileptogenetic effects of stress will not 
be further discussed here. 
2.2.2.2 Ictogenesis in genetic models 
One study investigated the effects of exogenous corticosterone administration in a 
genetic rat model of absence epilepsy, characterised by non-convulsive seizures manifesting 
as bursts of spike-wave discharges (SWD) detectable by EEG (Schridde & van Luijtelaar, 
2004). The study found a 327% increase in the SWD following corticosterone administration.  
A study of the effects of a natural stressor on the model of absence epilepsy presented 
a conflicting finding (Tolmacheva & van Luijtelaar, 2007). Rats exposed to an acute stress in 
the form of a foot shock showed no change in the SWD following a single shock. However, 
there was an aggravated increase in SWD over three days of repeated stressor exposure. This 
suggests possible effects of repeated but not acute stressor on the occurrence of seizures. 
However, Tolmacheva et al. later demonstrated that there may be an effect of acute 
stress which follows a gradual, time-dependent pattern (Tolmacheva et al., 2012). In their 
study of foot shock in the model of absence epilepsy, the SWD were initially suppressed by 
the stressor but there was a significant increase within an hour after the exposure. A second 
experiment confirmed the findings by Tolmacheva & van Luijtelaar (2007) and showed that 
rats exposed to the foot shock stress on three consecutive days, showed an aggravation of the 
SWDs, with the SWDs also increasing in anticipation of the foot shock on day 3.  
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The effects of acute stress were further supported by a study that tested the effects of 
three different types of stressors using the EL mouse, a genetic model of focal epilepsy 
(Forcelli et al., 2007). While mice exposed to tail suspension handling exhibited a significant 
increase in epileptiform EEG activity, no such increase was found for foot shock or a social 
intrusion stressor. Similar results were obtained by a study that investigated the effects of 
various environmental factors on seizure susceptibility (Todorova et al., 1999). The study 
found that handling of mice involving tail suspension induced seizures and further increased 
seizure susceptibility after one week.  
2.2.2.3 Ictogenesis in post-status epilepticus models 
There is also limited evidence from the post-status epilepticus model of epilepsy. A 
recent study examined the effects of repeated corticosterone administration in epileptic mice 
that had previously been chemically induced to go into SE and had subsequently developed 
spontaneous seizures (Castro et al., 2012). The corticosterone administration significantly 
increased the frequency and duration of epileptiform EEG activity, compared to control 
treatment. However, corticosterone had no effects on the frequency of overt seizures. 
Nevertheless, the study supports the findings of the previous studies, suggesting that repeated 
stress exposure may increase seizure vulnerability. 
Unfortunately, there is a lack of studies replicating these findings. Another study of 
the post-SE model found elevated levels of endogenous corticosterone in rats with epilepsy 
induced by the SE that was not related to the occurrence of spontaneous seizures but was 
correlated with the presence and severity of behaviour interpreted as depressive (Mazarati et 
al., 2008). This corresponds with the findings from human clinical studies and suggests a 
possible mediation of depression and other psychiatric disorders.  
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2.2.3 HPA Axis Stress Mediators in PNES 
The role of HPA axis stress mediators has not been investigated directly in relation to 
the occurrence of PNES. Nevertheless, there is evidence suggesting the involvement of the 
HPA axis in the pathology of PNES. Patients with PNES, and especially those with a history 
of sexual abuse, have been found to have higher levels of cortisol at baseline than healthy 
individuals (Bakvis et al., 2010). Cortisol levels of patients with PNES were also elevated 
throughout the avoidance task in the study of automatic avoidance (Bakvis et al., 2011). 
Furthermore, the levels of baseline cortisol in patients with PNES were also positively 
correlated to the attentional bias to threatening social stimuli (Bakvis et al., 2009a). The 
cortisol response to the stressful task in the study by Bakvis et al. (2009b) was, however, not 
significantly different from that of healthy subjects. These findings seem to support the data 
from studies of psychological stress, suggesting that patients with PNES may experience a 
state of cognitive hypervigilance and physiological hyperarousal at baseline. Such elevated 
cortisol levels at baseline coupled with blunted cortisol response to an acute stressor, which 
was found in patients with PNES, were also found in patients anxiety and panic disorders 
(Petrowski et al., 2013) and may reflect an impairment of the adaptive capacity of the HPA 
axis (or the so-called ‘exhaustion stage’), resulting from chronic stress exposure.  
2.2.4 The SAM System 
While most research on stress and epilepsy focuses on the HPA axis mechanisms 
(Joels, 2009), less attention has been paid to the role of the SAM system. The SAM system 
responds to stress via the two branches of the autonomic nervous system (ANS), the 
sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS) that 
regulate the homeostatic function of the organism by a mutually antagonistic influence on 
internal organs (Porges, 1992). Exposure to a stressful stimulus activates the hypothalamus 
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and the pituitary gland to release hormones that cause the adrenal medulla to secrete 
adrenaline (ADR) and noradrenaline (NA) (see Figure 2.1). These hormones activate the SNS 
causing arousal and mobilising the organism to prepare for appropriate action (Aldwin, 
2000). This is manifested by an increased heart rate, blood pressure or sweating (Cohen et al., 
1995). Porges (1992) argued that the PNS may play an even more important role in the stress 
reaction. While the SNS is activated in response to external demands, PNS activation, 
mediated mainly by the tenth cranial nerve, the vagus nerve, is responsible for the on going 
regulatory and feedback processes. In response to stress, the PNS activation (tone) is 
decreased and the homeostasis of the organism is disrupted. This can even occur in the 
absence of SNS activation (Porges, 1992).  
2.2.4.1 Patterns of SAM system activity in epilepsy 
Seizure (ictal) activity often affects parts of the brain involved in activation of the 
ANS, such as the limbic system or medulla (Nouri, 2011). As a result, ictal activity can be 
associated with changes in the SNS and PNS tone that can be detected from the pattern of 
heart rate monitored by electrocardiogram (ECG) (Nouri, 2011). Since changes of the SNS 
and PNS tone are part of the body’s reaction to a potential stressor, it can be hypothesised 
that identifying the pattern characteristic of the stress response, i.e., an increased SNS and 
suppressed PNS tone, during the pre-ictal period, could serve as an evidence for the role of 
stress in seizure precipitation.  
This was indeed found in a study that assessed the PNS and SNS input to the heart by 
inspecting parameters of the heart rate variability (HRV) calculated from ECG recordings of 
six patients with epilepsy (Jeppesen et al., 2010). The results showed suppressed PNS activity 
10 s before the seizure onset. Similarly, a rapid reduction of the PNS tone was found within 
30 s before seizure onset (Novak et al., 1999).  
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Additionally, a recent study identified significantly reduced HRV during the 
interictal, resting period, in a group of patients with epilepsy, indicating an overall reduced 
PNS tone (Ponnusamy et al., 2011). Significantly reduced PNS and increased SNS tone were 
also found during seizures in patients with epilepsy, but not in patients with PNES 
(Ponnusamy et al., 2012). 
2.2.4.2 Patterns of SAM system activity in PNES 
Similar to the limited evidence on the role of HPA axis in PNES, there are no studies 
exploring the direct links between autonomic stress responses and the occurrence of non-
epileptic seizures. There is evidence for reduced HRV in patients with PNES at baseline in 
the study of automatic avoidance (Bakvis et al., 2010) and HRV was also significantly lower 
in patients with PNES compared to healthy controls in the study by Bakvis et al. (2009a). In 
addition, the study by Ponnusamy et al. (2011) showed reduced resting HRV in both patients 
with epilepsy and PNES.  
According to Porges (1992), such a chronically reduced PNS activation found both in 
patients with epilepsy and PNES could be a manifestation of an impaired ability of the PNS 
to respond to external stressors and thus greater stress vulnerability. Indeed, decreased HRV 
has been associated with a range of psychiatric disorders, including post-traumatic stress 
disorder (Cohen et al., 1999). 
2.3 Psychological Interventions 
2.3.1 Non-Pharmacological Interventions for Epilepsy 
Better understanding, recognition and control of seizure triggers might not only 
reduce the unpredictability of seizure events, but could also help prevent or even eliminate 
seizure occurrence (Pinikahana & Dono, 2009). Wolf (2002) proposed a distinction of 
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interventions into: (1) non-specific seizure prevention, based on identification of factors that 
facilitate seizure occurrence and development of strategies to combat or prevent them, 
including a hygienic lifestyle and improvement of coping strategies, (2) specific seizure 
prevention, used for reflex epilepsy where seizures are consistently triggered by a specific 
stimulus and can therefore, be prevented by avoidance or other specific techniques targeting 
the particular trigger, and (3) specific and non-specific seizure arrest. The seizure arrest 
interventions are based on the recognition of initial warning signs and auras which are the 
altered sensations immediately preceding seizures, considered part of the actual seizure 
(Mormann & Lehnertz, 2013), and subsequent interruption of the progressing seizure (Wolf, 
2002). 
As the seizure arrest techniques involve stopping of a seizure that has already been 
triggered, they are not directly relevant to the question of stress and seizure precipitation. 
Similarly, the specific seizure prevention methods only pertain to reflex epilepsy, which is a 
very rare type of epilepsy. These techniques have recently been discussed elsewhere (Wolf et 
al., 2013) and will therefore not be considered here. Instead, the focus will be on reviewing 
the non-specific seizure prevention methods, based on the assumption that interventions 
targeting stress as a seizure precipitant that show an improvement in seizure control or 
reduction could serve as an additional evidence for the role of stress in triggering seizures. 
2.3.1.1 Educational and self-management interventions 
One of the successful educational programmes is the MOSES (Modular Service 
Package Epilepsy) programme, comprising of nine modules designed to improve knowledge 
and coping with epilepsy (May & Pfafflin, 2002). A controlled study showed that patients 
who participated in the course significantly improved their knowledge and coping skills, and 
reported greater reduction in seizure frequency, measured by a seizure frequency scale, 
compared to a control group. Although the programme did not directly target stress, one of its 
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modules focused on the psychological aspects of epilepsy and patients subsequently 
improved coping with emotions.  
Schmid-Schonbein developed and tested a psychological treatment method based on 
seizure-control, consisting of identification of seizure-facilitating factors and development of 
counter-measures and coping strategies under the guidance of a therapist (Schmid-Schonbein, 
1998). Their study of 16 patients found that psychological stress was identified as the main 
precipitant in 11 patients. After 3 – 30 months of the therapy, 68% of patients self-reported 
reduction in seizure frequency. 
An intervention that recognised and directly targeted stress as a potential seizure 
precipitant is the on-line self-management programme WebEase (Epilepsy Awareness, 
Support, and Education) (Dilorio et al., 2011). This interactive programme contains three 
modules that address medication, stress and sleep management. A recent study showed a 
trend toward significance for perceived stress in a group of people with epilepsy who 
completed all or some of the on-line modules (Dilorio et al., 2011). Unfortunately, the study 
did not assess the effects on seizure frequency.  
2.3.1.2 Andrews/Reiter method 
The Andrews/Reiter method is a behavioural technique combining aspects of both the 
seizure prevention and seizure arrest treatment methods. It consists of techniques aimed at 
interrupting auras, as well as learning to identify and cope with seizure-provoking situations, 
in particular emotional stress (Elsas et al., 2011). Michaelis et al. analysed medical diary 
records of 60 patients who underwent a three-day Andrews/Reiter therapist-guided 
intervention followed by daily practice of relaxation, breathing, journaling of emotional 
stressors and other seizure triggers, and practicing strategies to cope with them (Michaelis et 
al., 2012). Stress was identified as the most common seizure precipitant by 40% of patients 
and there was more than 50% reduction of seizure frequency in 50% of the patients from 
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baseline to the last months of the treatment.  The retrospective, self-report design of the 
study, as well as the fact that the exact length of the therapy was not specified are, however, 
major limitations of the study. 
2.3.1.3 Yoga and biofeedback 
Practicing behavioural techniques based on biofeedback and relaxation has also been 
suggested as a therapeutic method for epilepsy. These techniques enable patients to become 
aware of and subsequently deliberately control autonomic physiological processes that may 
be involved in triggering and propagation of seizures (Wolf, 2002).   
A theory linking the mechanisms of yoga, stress and seizures has recently been 
proposed (Streeter et al., 2012). Streeter et al. (2012) pointed out that yoga, a traditional 
Indian technique comprising of breathing exercises, postures and meditation, could influence 
both the SAM and the HPA mechanisms involved in stress and thus provide for potential 
stress and seizure reduction. Breathing, which is one of the main ANS functions involving 
the SNS and PNS pathways, is deliberately controlled during yoga and could therefore 
influence the ANS activity. It has indeed been demonstrated that yoga can increase the HRV 
and the PNS tone (Khattab et al., 2007), as well as to reduce levels of cortisol (Kamei et al., 
2000). 
Evidence from studies of yoga in epilepsy seems to support this hypothesis. A 
controlled study compared a group of patients treated by yoga with two control groups, one 
performing exercises mimicking yoga, and the other being followed-up without any treatment 
or exercise (Panjwani et al., 1996). The study found that 4 of the 10 participants in the yoga 
group became seizure-free, compared to none in the two control groups, and 9 of the patients 
in yoga group achieved more than a 50% reduction of seizures, compared to one in the 
control conditions. Similarly, a study of the effects of yoga and acceptance commitment 
therapy (ACT) found that yoga significantly reduced seizure frequency, with 50% of patients 
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becoming seizure-free (Lundgren et al., 2008). However, similar results were found also for 
ACT, suggesting that the effects may not have been specific to yoga, but rather based on a 
treatment mechanism common to both types of therapy. 
One of the biofeedback methods targeting the ANS pathways through biofeedback 
from measurement of the galvanic skin response (GSR) may also be of interest. GSR reflects 
the SNS influence on sweat glands, indicating emotional and attentional arousal (Nagai, 
2011). Learning to deliberately alter the GSR (and thus the SNS tone) can reduce cortical 
potentials that contribute to the regulation of cortical excitability, in particular, the excitation 
associated with initial orienting response to stimuli (Nagai, 2011). This mechanism could 
affect both the ANS-mediated stress response and seizures. Indeed, Nagai et al. found that 
GSR biofeedback training resulted in more than 50% seizure reduction in 6 out of 10 patients 
with epilepsy (Nagai et al., 2004). The GSR biofeedback has also been found effective as an 
intervention for highly stressed individuals (Khanna et al., 2007). As the GSR biofeedback is 
a relatively new method, its mechanisms still remain to be further clarified.  
It is conceivable that the effectiveness of vagus nerve stimulation (VNS) therapy is 
also, at least in part, mediated by alterations of ANS activation, although the exact 
mechanism of VNS is not yet fully understood. The treatment involves implantation of a 
stimulator into the chest cavity, which generates electrical signals that are carried by 
electrodes to stimulate the vagus nerve (Schachter & Saper, 1998). VNS has not only been 
shown to be effective for refractory epilepsy, but has also been used to treat depression 
(Bonaz et al., 2013). Animal and human studies suggest that VNS is associated with 
alterations in the activity of the structures of the central autonomic system, which are also 
involved in the stress response (Henry, 2002). 
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2.3.2 Psychological Interventions for PNES 
Although psychological treatment is accepted as the treatment of choice for PNES 
(Reuber et al., 2005), there is only limited evidence for the effectiveness of different 
psychological treatment approaches, and even less so in the relation to stress and seizures. 
There is currently no standardised treatment protocol for PNES and various types of therapy 
have been used, including cognitive behavioural therapy (CBT), group and family therapies, 
eye movement desensitisation and reprocessing (EMDR), neurofeedback or hypnosis; 
however, there is a lack of randomised controlled trials (RCT) assessing their outcomes 
(Martlew et al., 2007).  
 In an uncontrolled study of an in-patient treatment programme based on cognitive 
behavioural techniques, which included strategies for stress management and improvement of 
coping skills, 81% of 16 patients who took part in the study have been shown to achieve over 
50% seizure reduction and there was an improvement in coping skills and psychiatric 
symptoms (Kuyk et al., 2008). Two methodologically stronger studies showed support for the 
effectiveness of CBT. LaFrance et al. developed a CBT programme for PNES, based on 
modifying cognitive distortions and identifying seizure triggers and demonstrated seizure 
cessation in 11 out of 17 patients in a small pilot RCT (LaFrance et al., 2009). The therapy 
included examination of external stressors and internal seizure triggers and development of 
relaxation skills. The CBT approach has also been shown to be effective for seizure reduction 
and health service use in a larger pilot RCT (Goldstein et al., 2010). 
There is also some evidence for beneficial effects of therapies with psychodynamic 
focus. An uncontrolled study of long-term effects of a brief augmented psychodynamic 
interpersonal therapy, which covers identification of stressors, stress reduction techniques 
and improvement of coping behaviours, found seizure cessation in 25.5% of the 47 patients 
and further 40% of patients achieved over 50% seizure reduction. There was also a 
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considerable reduction in health care utilisation (Mayor et al., 2010). Another uncontrolled 
pilot study assessed a group therapy with a psychodynamic focus emphasising the 
development of coping strategies including exploration of seizure precipitants (Barry et al., 
2008). This study found improvement on all the outcome measures, including seizure 
frequency, severity of somatic symptoms and depression (Barry et al., 2008).  
These studies are, however, methodologically weak and no research assessing stress 
reduction as an outcome measure have been conducted to date. There is a clear need for more 
RCTs in the future (Martlew et al., 2007). 
2.4 Self-Affirmation as an Intervention for Stress and Seizures 
2.4.1 Self-Affirmation Theory 
Self-affirmation is a psychological mechanism that may be relevant to the 
management of the damaging effects of stress. According to self-affirmation theory, the 
individual’s self-system comprises different domains that are important to them (e.g., roles, 
goals, values or belief systems). One function of this self-system is to maintain an overall 
positive self-image and sense of ‘self-integrity’ or perception of oneself as adaptively and 
morally adequate (Steele, 1988). When an important part of the self-system is threatened, 
people are motivated to respond in ways that restore their sense of self-integrity. These 
responses can often be defensive and maladaptive; for example, smokers may ignore or 
denigrate threatening health messages, instead of using the information to attempt to quit 
(Sherman & Cohen, 2006). Self-affirmation is a mechanism that can reduce the defensive 
responses to threat. It is an alternative way of restoring global self-integrity through 
affirmation of important aspects of the self-system other than the one under threat, for 
example, reflecting upon an important personal value or characteristic (Steele, 1988).  
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Self-affirmation has been found to be effective in a range of cognitive and social 
domains and there is a growing evidence for its beneficial effects on health (Harris & Epton, 
2009; Sherman & Cohen, 2006). Self-affirmed individuals have been found to be more 
accepting of threatening health information (Armitage et al., 2008) and to express more 
intention to change their risky health behaviours (Harris & Napper, 2005). 
2.4.2 Self-affirmation and Stress Management 
Importantly, self-affirmation has been shown to buffer psychological and 
physiological responses to stress. Experimental studies have shown that self-affirmed 
participants had significantly lower cortisol levels in response to a laboratory stress task than 
a group of controls (Creswell et al., 2005) and self-affirmation has also been found to 
attenuate the epinephrine (adrenaline) response to an academic stressor (Sherman et al., 
2009). Self-affirmation also buffered psychological responses to stress by reducing 
ruminative thinking that can further exacerbate the effects of stress (Sherman et al., 2009). 
Self-affirmation therefore seems to be a promising technique that could have the potential to 
improve the effectiveness of stress management interventions. Indeed, it has been found that 
patients with end-stage renal disease who were given a self-affirming intervention involving 
writing about their most important value reported significantly reduced perceptions of stress 
(Estevez, 2002).  
2.5 Questions Arising From the Literature Review  
The reviewed studies have many limitations and raise issues that will require further 
clarification. The current evidence suggests that stress may exacerbate the epileptiform 
activity (or its effects) in the brain, and play a role in triggering overt spontaneous seizures at 
least in a certain proportion of individuals with epilepsy. However, factors including the 
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subjective perceptions of stress, and individual differences in psychological and physiological 
vulnerability, and resilience to stress in people with epilepsy deserve further investigation.  
Stress appraisal and the cognitive, physiological and coping stress responses also 
seem to play an important role in PNES. It is conceivable that the experience of stress could 
precipitate PNES, however, no studies have examined the relationship directly.  It may be the 
case that repeated stress exposure increases the risk of future stress to precipitate both 
epileptic and non-epileptic seizures, which are, in turn, associated with a degree of stress and 
further exacerbate the stress vulnerability. This bidirectional relationship clearly needs to be 
explored further.  
Many of the discussed studies were limited by cross-sectional, retrospective design 
and reliance on self-reports. Importantly, the experience of ‘stress’ is complex and multi-
faceted, however, very few studies have taken an integrative approach and measured both the 
psychological and the physiological aspects of stress, and the conclusions that can be drawn 
from such studies are therefore somewhat incomplete.  
The review of evidence from non-pharmacological interventions showed that 
psychological treatment focused on helping patients to identify seizure-provoking factors, 
including stress, and to develop strategies better to cope with them was demonstrated to 
reduce seizures in some individuals. None of these interventions have, however, specifically 
targeted stress or directly assessed whether the reduced seizure frequency was achieved 
through stress reduction. The results of the intervention studies therefore suggest a potential 
for development and empirical evaluation of new non-pharmacological treatment methods 
targeting stress as a seizure-facilitating factor. Such treatment approaches could incorporate 
and assess the self-affirmation technique, which has been shown to reduce both psychological 
and physiological responses to stress. 
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This thesis therefore sets out further to explore the different components of the stress 
process, their interactions and their relationships to epileptic and non-epileptic seizure 
occurrence, using a prospective design and integrating a range of psychological (self-report 
and implicit) as well as physiological measures of stress. As there is a potential for 
development of new psychotherapeutic interventions and a lack of randomised controlled 
trials assessing the outcomes of psychological treatment for seizure disorders, the PhD 
project also includes the development and pilot evaluation of a new self-help intervention 
specifically targeting stress in patients with seizures. 
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3. CHAPTER 3  
Study 1a: Exploring the Links between Stress and Epileptic or 
Psychogenic Non-epileptic Seizures 
 
3.1 Study Introduction 
The literature discussed in the literature review (Chapter 2) suggests that many 
patients with epilepsy believe their seizures are more likely to happen when they are feeling 
stressed (Nakken et al., 2005). Psychogenic non-epileptic seizures (PNES) are by definition 
caused by psychological distress and have been interpreted as behavioural responses to 
overwhelming psychophysiological arousal (Goldstein & Mellers, 2006). However, there is a 
lack of prospective studies investigating the link between stress and seizure occurrence 
directly and the temporal relationship between stress and seizures therefore remains unclear. 
It is conceivable that repeated or chronic stress exposure creates a greater predisposition for 
further stress experiences to trigger both epileptic seizures and PNES. Such a predisposition 
could also be affected by the stress associated with seizures themselves.  
A number of the studies discussed were limited by their retrospective, self-report 
design and the few available prospective studies provide rather inconclusive evidence. 
Furthermore, ‘stress’ is complex and multifaceted phenomenon comprised of a range of 
autonomic, endocrine, immune, cognitive, affective and behavioural processes, yet very few 
studies have measured the different aspects of stress in combination.    
This study therefore explored the patterns of physiological stress measures (HRV 
parameters extracted from video-electroencephalographic/electrocardiographic (video-
EEG/ECG) recordings and levels of salivary cortisol) and self-reported measures of 
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perceived stress across the day and the interrelationships between these measures. The study 
also prospectively assessed the association between stress and seizures, using both objective 
measures of physiological stress responses and a self-report measure of subjective 
psychological stress.  
3.2 Study Aims 
1. To describe the patterns of the daily self-reported and physiological (cortisol, HRV) 
measures of stress in patients with epilepsy and patients with PNES. 
2. To explore the associations between daily self-report and physiological (HRV, 
cortisol) measures of stress.  
3. To explore the relationship of the daily self-report, HRV and cortisol stress measures 
to seizure occurrence (number and timing of seizures during video-EEG/ECG).  
3.3 Methodology 
3.3.1 Participants and Design 
The study is a prospective assessment of the daily levels of physiological and 
psychological stress and their relationship to seizure occurrence in patients undergoing in-
patient video-EEG/ECG monitoring. Adult patients with refractory (epileptic or non-
epileptic) seizures admitted for diagnostic or pre-surgery video-EEG/ECG monitoring in the 
video telemetry unit at the Royal Hallamshire Hospital in Sheffield were recruited into the 
study. The diagnosis (epilepsy or PNES) was confirmed by the analysis of the video-EEG 
recording of at least one typical seizure by a trained Neurophysiologist. Where no typical 
seizure was recorded during the video-EEG assessment, a clinical diagnosis was established 
based on the expert opinion of the patient’s Consultant Neurologist and a second opinion 
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from a Consultant specialised in epilepsy. Patients whose diagnosis of epilepsy or PNES 
remained uncertain after completion of video-EEG monitoring were excluded from further 
analyses. 
The formal inclusion criteria for the study were as follows: 
1. Clinically firm diagnosis of epilepsy (and no additional PNES) or PNES (and no 
additional epilepsy) supported by two experts in the diagnosis and treatment of 
patients with seizures. 
2. Over the age of 16 years 
3. Able to complete the self-report questionnaires without help 
4. Able to give informed consent 
The formal exclusion criteria for the study were as follows: 
1. Patients with possible or definite mixed seizure disorders (epileptic seizures and 
PNES) 
2. People who were unable to give informed consent 
3. People who were unable to complete the self-report questionnaires unaided 
4. People whose diagnosis remained uncertain 
3.3.2 Outcome Measures 
3.3.2.1 Baseline measures 
3.3.2.1.1 Self-report questionnaires 
The validated self-report questionnaires compiled for this study were piloted in the 
neurology outpatient clinic (N = 5) at the Royal Hallamshire Hospital.     
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3.3.2.1.1.1 Demographic questionnaire 
  The demographic questionnaire was developed as part of the project to collect 
information about age, gender, employment status and level of education. Participants who 
were in full-time education, employed or self-employed were classed as ‘economically 
active’, patients who were unemployed, retired or on disability benefits were classed as 
‘economically inactive’. See Appendix 1 for the full questionnaire. 
3.3.2.1.1.2 Perceived Stress Scale – 4 Items (Cohen et al., 1983) 
The PSS-4 is a short version of the original PSS-14 developed to measure the degree 
to which situations in people’s lives are perceived as stressful (see Appendix 2). The scale is 
a global measure of non-specific stress over the course of the past month (e.g., “In the last 
month, how often have you felt difficulties were piling up so high that you could not 
overcome them?”), rated on a 5-point scale (“Never”, “Almost never”, “Sometimes”, “Fairly 
often”, “Very often”). Reliability coefficients range between 0.84 and 0.86 for the original 
PSS-14 and between 0.72 and 0.79 for the reduced 4-item version (Karam et al., 2012). The 
validity of the PSS-14 is supported by significant correlations (p < .001) with the number and 
impact of stressful life-events. The PSS-4 has been used and validated as a measure of 
perceived stress in patients with epilepsy (Haut et al., 2012; Thapar et al., 2009). The scale 
had good internal consistency reliability in the present sample (4 items; alpha = 0.79).  
3.3.2.1.1.3 Liverpool Seizure Severity Scale – Revised (Scott-Lennox et al., 2001) 
The LSSS-3 is a newly-revised version of the LSSS-2 (Baker et al., 1998). The LSSS-
3 is a 12-item inventory designed to quantify the severity of patient’s seizures (see Appendix 
3). The items are rated on 4 to 6-point scales (e.g., “After my most severe seizures: I always 
feel sleepy”,  “I usually feel sleepy”, “I sometimes feel sleepy”, “I never feel sleepy”). It 
provides a single-unit weighted scale that measures the severity of the most severe seizures 
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the patient has experienced during the past 4 weeks. Reliability of the LSSS-3 has been 
demonstrated (alpha > 0.71) and validity of the scale is supported by correspondence with 
physician-rated seizure severity (Scott-Lennox et al., 2001). The internal consistency 
reliability of the LSSS-3 in the sample was good (12 items; alpha = 0.85). 
3.3.2.1.1.4 Quality of Life in Newly Diagnosed Epilepsy - 6 Dimensions (Mulhern et 
al., 2012) 
The NEWQOL-6D was used as an epilepsy-specific measure of the health-related 
quality of life (HRQoL) (see Appendix 4). The NEWQOL-6D assesses the HRQoL on six 
dimensions, including worry about attacks, depression, memory, concentration, control, and 
stigma. Each dimension consists of one item with four response levels (e.g., the control 
dimension item: “How much control do you feel you have over things that happen to you?”; 
response levels: “I have complete control”, “I have some control”, “I have little control”, “I 
have no control”). The scoring is based on obtaining a unique health state by combining one 
level from each of the six dimensions (e.g., state 111111 indicates no problems on any of the 
six dimensions, while state 444444 indicates serious problems on all six dimensions). A 
single utility value between 0 (poor health) and 1 (perfect health) can then be derived for 
each health state based on a formula developed by the authors (Mulhern et al., 2012). The 
original NEWQOL has acceptable internal consistency reliability (0.58 – 0.97), as well as 
test-retest reliability (0.76 – 0.91). The measure was also found to have high concurrent 
validity (0.60 – 0.90) (Abetz et al., 2000). 
3.3.2.1.1.5 Life-Orientation Test – Revised (Scheier et al., 1994) 
The Life Orientation Test Revised (LOT-R) is a 10-item scale designed to assess 
generalized optimism (e.g., “In uncertain times, I usually expect the best”) (see Appendix 5). 
The items are rated on a 5-point bipolar scale (“Strongly disagree”, “Disagree”, “Neutral”, 
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“Agree”, “Strongly agree”). Only six items of the questionnaire are scored, four items are 
filler items. Internal consistency of the scale has been found adequate (alpha = 0.69 – 0.78), 
as has test-retest reliability (Hirsch et al., 2010; Scheier et al., 1994). Criterion validity of the 
scale has been supported by significant negative correlation with hopelessness (r = 0.62) and 
depression (r = 0.60) (Hirsch et al., 2010) and significant positive correlation with life 
satisfaction (r = 0.45) (Glaesmer et al., 2012). The LOT-R has been used in a number of 
behavioural, affective and health-related studies (for a review, see Scheier et al., 2010). The 
internal consistency reliability in the sample was good (6 items; alpha = 0.83). 
3.3.2.1.1.6 Spontaneous Self-Affirmation Measure (Harris et al., In preparation) 
 The SSAM is an instrument under on-going development that has been designed to 
measure the natural tendency to self-affirm. A short, 15-item, version of the measure was 
used in the current study (see Appendix 6). This measure consists of two scales, a measure 
assessing the tendency to engage in positive self-thought (the Habit Index of Positive 
Thinking; HIPT) and the tendency to self-affirm in the face of threat (the Spontaneous Self-
Affirmation Measure; SSAM). The SSAM consists of 10 items (e.g., “When I feel threatened 
or anxious by people or events I find myself thinking about my values”) rated on a 7-point 
bipolar scale with labelled end-points (“Disagree completely”, “Agree completely”). 
Preliminary evidence showed adequate reliability and validity of the measure and further 
validation of the measure was part of this study. Internal consistency reliability of the HIPT 
(5 items; alpha = 0.97) and the SSAM (9 items; alpha = 0.91) in our sample was excellent. 
3.3.2.1.1.7 Single-Item Self-Esteem Scale (Robins et al., 2001) 
The SISE is a single-item measure of global self-esteem, scored on a 5-point Likert 
scale (see Appendix 6). The mean test-retest reliability of the scale was 0.78 (Robins et al., 
2001). Construct validity has been demonstrated by a number of studies, showing significant 
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correlations with the Rosenberg Self-esteem Scale, r = 0.72 – 0.76, as well as the Texas 
Social Behaviour Inventory, r = 0.58 (Robins et al., 2001).  
3.3.2.1.1.8 Brief Resilient Coping Scale (Sinclair & Wallston, 2004) 
The BRCS is a 4-item measure designed to assess resilient coping, or tendencies to 
cope with stressful situations in an adaptive manner (e.g., “I believe I can grow in positive 
ways by dealing with difficult situations”), rated on 5-point bipolar scales with labelled end-
points (“Not true of me at all”, “Very true of me”) (see Appendix 7). The BRSC has been 
found to have adequate internal consistency reliability (alpha = 0.64 – 0.76) and test-retest 
reliability (r = 0.71) and has demonstrated sensitivity to changes associated with cognitive-
behavioural interventions (Sinclair & Wallston, 2004). The internal consistency reliability in 
this study was good (4 items; alpha = 0.79).  
3.3.2.1.1.9 Neurological Disorders Depression Inventory for Epilepsy (Gilliam et al., 
2006) 
The NDDI-E is a 6-item inventory developed to detect depression in patients with 
epilepsy (see Appendix 8). The six items represent common symptoms of depression 
experienced in the past two weeks that can be differentiated from adverse effects of anti-
epileptic drugs (e.g., “Everything is a struggle”) (Gilliam et al., 2006). Each item is rated on a 
4-point scale (“Always or often”, “Sometimes”, “Rarely”, “Never”). The inventory was 
found to have internal consistency reliability of 0.85 and test-retest reliability between 0.78 
(Gilliam et al., 2006) and 0.82 (Margrove et al., 2011). A score of more than 15 on the 
NDDI-E had 90% specificity, 81% sensitivity and a predictive value of 0.62 for a diagnosis 
of major depression (Gilliam et al., 2006). The inventory had good internal consistency 
reliability in this sample (6 items; alpha = 0.80). 
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3.3.2.1.1.10 Generalised Anxiety Disorder 7-item Scale (Spitzer et al., 2006) 
The GAD-7 assesses anxiety symptoms experienced over the course of the past two 
weeks (e.g., “Feeling anxious, nervous or on edge”) (see Appendix 9). The items are rated on 
4-point scales indicating the frequency of experiencing each symptom (“Not at all”, “Several 
days”, “Over half the days”, “Nearly every day”). Internal consistency reliability of GAD-7 
was found to range between 0.86 - 0.91 in both the general population and patients with 
psychopathology (Dear et al., 2011; Lowe et al., 2008). The scale was found to have test-
retest reliability of 0.82 (Delgadillo et al., 2012). The GAD-7 has been validated by 
significant positive correlations with a number of anxiety measures, including the Hamilton 
Anxiety Scale (r = 0.85) and Beck Anxiety Inventory (r = 0.72) (Spitzer et al., 2006). The 
GAD-7 has previously been used as a screening tool in epilepsy (Rakesh et al., 2012). The 
internal consistency reliability in this sample was excellent (7 items; alpha = 0.91). 
3.3.2.2 Daily measures 
3.3.2.2.1 Self-report measures 
3.3.2.2.1.1 Smith Stress Symptoms Inventory (Piiparinen & Smith, 2003) 
The SSSI is a 35-item measure of commonly reported stress symptoms (e.g., “I have a 
nervous stomach”) (see Appendix 10). The inventory comprises 6 sub-scales encompassing 
different symptom categories, including worry/negative emotion, attentional deficits, striated 
muscle tension, autonomic arousal/anxiety, depression, and interpersonal conflict/anger. A 
total score can be calculated from all 35 items to indicate overall level of stress 
symptomatology. Each item is rated on a 4-point scale (“Doesn’t fit me at all”, “Fits me a 
little”, “Fits me moderately well”, “Fits me very well”). A version of the scale assessing 
current stress symptoms (“right now at the present moment”) was used in this study. Internal 
consistency reliability of the scale ranges from 0.76 to 0.89 (Piiparinen & Smith, 2004). 
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Validity of the scale has also been demonstrated (Piiparinen & Smith, 2004). For further 
confirmation of validity of the scale, a single-item 7-point scale assessing how stressed the 
subject feels at the present moment was used in addition to the SSSI. There was a strong 
positive correlation between the 7-point scale and the total SSSI score in this sample (r = .83, 
p < .001) and the consistency reliability of the SSSI was excellent (35 items; alpha = 0.97). 
3.3.2.2.2 Heart rate variability 
Heart-rate variability reflects the dynamic influences of the parasympathetic (or 
vagal) and sympathetic nervous system tone on the heart. There are many different measures 
of the short- and long-term HRV that can be obtained from the ECG recordings. The main 
distinction of the HRV metrics is between the time- and frequency-domain parameters. The 
time-domain parameters include direct statistical or geometric measures of the beat-to-beat or 
inter-beat intervals (NN intervals), whereas the frequency-domain parameters are based on 
power spectral density analysis (Allen et al., 2007). In addition, non-linear HRV metrics can 
also be calculated using a method developed by Toichi (Toichi et al., 1997). This method is 
based on constructing a Lorenz plot, in which the fluctuation of the beat-to-beat intervals of 
the ECG recording is transformed into points distributed on a two-dimensional plane, with 
two axes – a transverse axis (T), which is vertical to the plane, and a longitudinal axis (L), 
which is parallel to the plane. According to this method, a measure of the parasympathetic 
nervous system (PNS) activity, called the cardiovagal index (CVI), is calculated from the 
Lorenz plot as log10 (T x L). A measure of the sympathetic nervous system (SNS) tone, called 
the cardiosympathetic index (CSI), is calculated from the Lorenz plot as L/T. 
The HRV measures of overall variability and those capturing the PNS activity tend to 
be highly correlated with each other and negatively related to parameters reflecting the SNS 
activity (Allen et al., 2007). Nevertheless, despite the close relationship between the 
measures, no single parameter has been identified as the optimal measure and it is therefore 
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recommended to use a combination of measures to get a sense of the patterns of variability, 
as each measure has its advantages and disadvantages (Task Force Of The European Society 
Of Cardiology And The North & Society Of Pacing And, 1996).  
For the analysis of HRV, three- to ten-minute samples of resting ECG free of muscle 
artefact or ectopic beats were selected. The HRV parameters calculated from the ECG 
recordings and used in the analyses are presented in Table 3.1.  
Table 3.1. The types of heart-rate variability measures used in the study 
 
 
3.3.2.2.3 Salivary cortisol 
Salivary cortisol is one of the most informative markers of the stress response. It can 
be easily and non-invasively collected using commercially available saliva collection device 
Salivette. Measures of salivary cortisol are commonly used in stress research (Bakvis et al., 
2009b; Creswell et al., 2005) and salivary cortisol has been shown accurately to reflect the 
levels of cortisol in the blood (Kirschbaum & Hellhammer, 1994), with validated liquid 
chromatography and tandem mass spectrometry (LC-MS/MS) providing the highest level of 
precision in measurement (Perogamvros et al., 2009).  
Cortisol levels can be used both as an indicator of acute stress reactivity as well as to 
measure exposure to long-term stress. Elevated cortisol levels were found to reliably reflect 
increased stress reactivity (Steward & Seeman, 2000). Cortisol secretion is characterised by a 
distinct diurnal pattern regulated by the brain’s pacemaker of the HPA axis, located in the 
suprachiasmatic nucleus (SCN) of the hypothalamus (Debono et al., 2009). A number of 
ANS tone measured by the 
HRV metric 
Type of HRV metric 
Time-domain metrics Non-linear metrics 
Combined PNS and SNS tone  SDNN Standard deviation of all NN 
intervals 
  
PNS (vagal) tone RMSSD Square root of the mean of the 
sum of squares of differences 
between adjacent NN intervals 
CVI Cardiovagal index 
SNS tone   CSI Cardiosympathetic index 
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physiological and psychological processes in humans are mediated by circadian rhythms 
regulated by the cells of the SCN but these circadian rhythms are most robustly established 
for melatonin, the core body temperature and cortisol production (Hofstra & de Weerd, 
2009). The circulating levels of cortisol are typically highest within 1 hour of awakening and 
decline throughout the day to reach the lowest point at around the sleep onset, after which 
they being to increase again between 2.00 – 4.00am (Debono et al., 2009). Chronic stress 
exposure associated with chronically elevated cortisol levels leads to a diminution of the 
natural diurnal fluctuation of cortisol levels (Herbert, 2013; Ockenfels et al., 1995). Disrupted 
circadian rhythm of cortisol has also been found in conditions such as depression or chronic 
fatigue, leading to increased cardiovascular risk (Debono et al., 2009; Herbert, 2013). 
In this study, saliva was sampled as one of the physiological stress measures each 
morning at approximately 9am and each evening at 10pm. Cortisol levels were assessed 
separately in the morning and evening, and the diurnal pattern was also explored by 
examining cortisol deltas, calculated as the difference between the morning and evening 
cortisol levels. Lower cortisol delta reflects smaller difference between the morning and 
evening cortisol and therefore indicates a diminished diurnal cortisol change. Factors that 
influence levels of cortisol, including smoking, food intake or consumption of drinks with 
low pH were controlled for. The samples were analysed using the LC-MS/MS method 
described by Perogamvros et al (2009), which is based on converting the saliva molecules 
into a charged (ionised) state and subsequently analysing the ions of interest (cortisol) on the 
basis of their mass-to-charge ratio (Perogamvros et al., 2009; Pitt, 2009). 
In addition, the daily cortisol measures collected as part of the study were compared 
to a normative sample provided by collaborators at the Department of Human Metabolism, 
University of Sheffield.  
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3.3.2.2.4 Seizure occurrence and seizure severity 
3.3.2.2.4.1 Seizure occurrence 
Occurrence of seizures was monitored throughout the video-ECG/EEG monitoring 
period. Seizures are routinely recorded by the patient and the EEG Technicians overseeing 
the patients’ care on the ward. Additionally, I asked patients about the number and timing of 
any seizures experienced each day during a daily interview. The number, timing and type of 
seizures experienced were later reviewed and confirmed by inspection of the video-
ECG/EEG. 
3.3.2.2.4.2 National Hospital Seizure Severity Scale (O'Donoghue et al., 1994)  
The NHS3 is a scale that contains seven seizure-related factors and yields a score of 1 
– 27. The scale is administered by a health professional during an interview with a patient 
and a witness of the seizures to assess the severity of the most common seizure types in a 
given time frame. The scale has demonstrated test-retest reliability of 0.90 and its validity has 
been confirmed by compatibility of the scale measures with seizure severity perceived by 
patients (O'Donoghue et al., 1994). A modified version of the scale that can be applied to 
individual seizures was used to assess the severity of each seizure that occurred during the 
video-ECG/EEG monitoring (example item: “Has the patient had a generalised convulsion 
during this seizure”) (Appendix11). Under supervision from a Senior Clinical 
Neurophysiologist, I completed the scale for each seizure based on a review of the video-
ECG/EEG recording and a video-ECG/EEG monitoring report routinely produced for each 
patient by the EEG Technicians and a Consultant Clinical Neurophysiologist.  
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3.3.3 Procedure 
3.3.3.1 Recruitment 
Potential participants were identified from a list of patients scheduled for admission to 
the inpatient video-telemetry ward at the Royal Hallamshire Hospital for vEEG/ECG 
monitoring. All potential participants were sent an invitation letter with an enclosed 
information sheet about the study one week before admission. Patients are routinely admitted 
to the video-telemetry ward for two- to five-day diagnostic or pre-surgery monitoring, 
commencing on Monday morning or on Wednesday afternoon and ending on Wednesday 
mid-day or on Friday afternoon. On the day of their admission to the video-telemetry ward 
(either Monday morning or Wednesday afternoon), I approached potential participants and 
gave them an opportunity to ask questions about the study. Individuals who expressed 
interest in participating in the study were screened using the inclusion and exclusion criteria 
detailed above and asked to provide a written informed consent. 
3.3.3.2 Baseline assessment 
Patients who consented to take part in the study were asked a set of questions related 
to their medical and seizure history in a brief interview. This included questions about any 
diagnosis of diabetes, renal failure, cardiac disorders, or neurological disorders with 
neuropathy, chronic smoking or alcohol use, current medication use (including anti-epileptic 
drugs and any other medication), duration of their seizure disorder, a brief description of their 
typical seizures, presence of any seizure triggers and the date and time of their last seizure (if 
remembered).  
Participants were then asked to complete a set of baseline self-report questionnaires 
(see Figure 3.1). The baseline questionnaires included the demographic questionnaire, 
Perceived Stress Scale – 4 Item (PSS-4) (Cohen et al., 1983), Liverpool Seizure Severity 
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Scale – Revised (LSSS-3) (Scott-Lennox et al., 2001), questionnaires assessing psychological 
resilience including the Quality of Life in Newly Diagnosed Epilepsy – 6 Dimensions 
(NEWQOL-6D; Mulhern et al., 2012), Life-Orientation Test – Revised (LOT-R; Scheier et 
al., 1994), Spontaneous Self-Affirmation Measure (SSAM; Harris et al., in preparation), 
Single-Item Self-Esteem measure (SISE; Robins et al., 2001) and Brief Resilient Coping 
Scale (BRCS; Sinclair & Wallston, 2004), plus questionnaires assessing psychopathology, 
including the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E; Gilliam et 
al., 2006), and the Generalised Anxiety Disorder 7-item Scale (GAD-7; Spitzer et al., 2006).  
3.3.3.3 Daily data collection 
After completion of the baseline questionnaires, the stress data collection procedure 
for each day was explained to the participants. They were asked to follow the same procedure 
every evening at 10pm and every morning at 9am. They were asked first to complete the 
daily Smith Stress Symptom Inventory. Having completed the questionnaire, participants 
were instructed to lie down in a supine position and rest without moving for ten minutes, 
trying to breathe normally, in order to obtain a resting ECG recording for the extraction of 
HRV parameters, free of movement artefact and with a constant respiration rate. After they 
have rested for 10 minutes, participants were asked to provide a sample of their saliva using a 
Salivette saliva collection tube and to note down the exact time of the saliva collection. I 
demonstrated how to use the Salivette tube and further instructed the participants to avoid 
smoking, eating, and drinking anything but water for one hour before taking the saliva 
sample (i.e., between 9 – 10pm in the evening and between 8 – 9am in the morning).  
Participants were provided with two envelopes, one labelled ‘Evening’, which 
contained the materials for data collection in the evening of the same day, and one labelled 
‘Morning’, which contained materials for the following morning. Each envelope included a 
detailed instruction sheet explaining the data collection procedure for each day, the daily 
	   57 
stress questionnaire (the SSSI), and the Salivette saliva collection tube (Figure 3.2). 
Participants were also given an additional brief summary sheet to keep by their bedside, 
highlighting and reminding them of the main steps to take each evening and each morning. 
All participants were further provided with an alarm clock set for 10pm to remind them to 
complete the evening measures and they were asked to re-set it for 9am after they have 
completed the evening procedure. In addition to the daily stress measure collection, 
participants were asked to keep a record of any seizures they may experience in a diary 
routinely provided to them as part of the vEEG/ECG monitoring.  
After the initial visit on the day of the admission, I visited the participants in the ward 
every morning just after 9am to check they had completed the morning measures and to 
collect the completed evening and morning questionnaires and saliva tubes. Participants were 
provided with a new set of materials for the evening and the following morning and their 
alarm clock was re-set for 10pm to remind them to complete the evening measures. As part of 
each morning’s visit, I also asked the participants whether they experienced any seizures 
since the last visit and if so, to provide the time and a brief description of the type and 
duration of each seizure. On the morning of the final day of the vEEG/ECG monitoring, after 
the relevant study materials were collected, participants were thanked for their help and their 
participation in the study was completed.  
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Figure 3.1. Flow-chart representing the data collection procedure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DAY 1 – DAY 3 or 5:  
Patient completes the SSSI 
questionnaire, rests for 10 minutes 
while resting ECG is being recorded 
and provides a saliva cortisol sample 
every morning and every evening. 
Patient also completes a seizure 
diary throughout the study.  
An invitation to take part in the 
study sent to all patients scheduled 
for video-EEG/ECG monitoring one 
week before admission. Participant 
information sheet provided. 
DAY 1:  
Patient arrives in the telemetry unit 
at the Royal Hallamshire Hospital 
and revisits the information sheet 
with the researcher. Informed 
consent taken. 
DAY 1:  
Patient completes a brief interview 
with the researcher and completes 
the baseline questionnaires, 
including the demographic 
questionnaire, the PSS-4, LSSS-3, 
NEWQoL-6D, LOT-R, SSAM, 
SISE, BRCS, NDDI-E, and GAD-7.  
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Figure 3.2. Data collection set   
 
 
 
 
 
 
 
3.3.4 Data Preparation 
3.3.4.1 Review of video-EEG/ECG recordings 
After the patient’s discharge from the video-telemetry ward, their video-EEG/ECG 
recordings were reviewed using the XLTEK EEG software, in order to check the timing of 
the morning and evening data collection and whether the participants followed the procedure 
as instructed, as well as to confirm the timing and severity of seizures that occurred during 
the video-telemetry monitoring, and to extract the resting ECG recordings. Where the video 
recording revealed that the participant failed to complete the questionnaires or take the saliva 
sample on the given day or did so more than two hours before or after the specified time, the 
data were excluded from the analysis. Saliva samples were also excluded if the recordings 
showed that the participant consumed food or drinks less than 30 minutes before taking the 
saliva sample.  
3.3.4.2 Heart rate variability data 
Three to ten-minute resting evening and morning ECG recordings were selected. The 
selected samples were visually inspected to ensure the recordings were free of muscle artefact 
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and ectopic beats. The ECG samples recorded by the XLTEK EEG system were exported as 
text files, the sampling rate used to record the ECG was identified (256, 512, or 1024 Hz), 
and the files were subsequently manually converted into corresponding time-data series 
(Ponnusamy et al., 2011; Ponnusamy et al., 2012). The HRV parameters were calculated 
from the data series using the Matlab based Kubios HRV software (Tarvainen et al., 2014) 
for Mac (version 2.2, 2014) (Figure 3.3). 
Figure 3.3. Kubios HRV software user interface. The software uses a QRS detection 
algorithm to compute time-domain, frequency-domain and non-linear HRV parameters from 
the ECG data 
 
 
 
 
 
 
 
 
 
3.3.4.3 Seizure occurrence and severity data 
The number and timing of seizures were reviewed using the XLTEK EEG software 
and the patients’ video-ECG/EEG monitoring report. Each seizure was scored for severity 
using the modified NHS3 scale. The review of seizure timings as well as the scoring of 
seizure severity was conducted under the supervision of a Clinical Neurophysiologist.   
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3.3.4.4 Saliva samples 
The collected salivary samples were stored in a cold room at 4°C during the week the 
participant spent in the video-telemetry ward and subsequently centrifuged at the end of each 
week at 1000 x g for 2 minutes (Kirschbaum & Hellhammer, 1994) (Figure 3.4). The 
obtained clear salivary supernatant was pipetted from the Salivette tubes (Figure 3.5a) into 
2ml cryovial tubes (Figure 3.5b). The samples were then frozen and stored at - 20°C until 
they were sent for the LC-MS/MS analyses at the Department of Clinical Biochemistry, 
University Hospital of South Manchester. 
Figure 3.4. Centrifuge used for saliva sample preparation     
Figure 3.5.  
(a) Salivette saliva collection device    (b) Saliva samples stored in cryovial tubes 
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3.3.4.5 Questionnaire data 
All questionnaire data were scored and missing data handled following the 
instructions in the relevant questionnaire manuals. Where no formal instruction was available 
on how to treat missing data and where no more than 10% of scores were missing, the 
missing scores were replaced by the mean of completed items for the given scale or sub-
scale. Questionnaires with more than 10% of scores missing were excluded from the 
analyses.  
3.3.5 Statistical Analyses 
The baseline data were analysed using the Statistical Package for the Social Sciences 
(SPSS; version 22 for Mac; SPSS Inc., Chicago, IL, U.S.A.). The daily stress and seizure data 
have a multi-level structure and some of the questions related to the daily data were therefore 
explored by multi-level regression analyses using the HLM 7.01 software (Student Edition) 
for hierarchical linear modelling (Raudenbush, 2011). Before analysis, all measures were 
checked for normality using the Shapiro-Wilk test. Measures that were non-normally 
distributed were normalised using natural log-transformation.  
The results of the analyses are organised into four sections. First, the baseline 
demographic, clinical and psychological characteristics of the patients are summarised and 
examined using Chi-square and independent-samples t-test analyses. 
The second section contains a description of the key daily self-report and 
physiological stress measures as well as the seizures recorded during the video-EEG/ECG 
monitoring (Aim 1). Each of the stress measures was compared using a series of two-way 
analyses of variance (ANOVA). Cortisol deltas were calculated and compared between the 
two patient groups using an independent-samples t-test. In addition, the cortisol data were 
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compared to the normative dataset provided by collaborators from the University of 
Sheffield. 
In the third section, the associations between the daily self-reported and physiological 
stress measures were explored using Pearson’s product-moment correlation analyses (Aim 2).  
In the final section, the relationships between the daily stress measures and the seizure 
occurrence were explored using the multi-level modelling approach (Aim 3).  
3.4 Results 
3.4.1 Description of Baseline Demographic and Clinical Characteristics 
A total of 55 patients were recruited for the study. Of these, 22 patients received a 
definitive diagnosis of epilepsy (13 females, 59.1%). A diagnosis of epilepsy based on a 
video-EEG recording of a typical seizure was available for 15 patients; in the remaining 
seven patients the diagnosis was based on expert clinical assessment by two epilepsy 
specialists. A definitive diagnosis of PNES was established for 23 patients (eight females, 
34.8%). Seventeen patients received a diagnosis of PNES confirmed by video-EEG; the 
diagnosis for the remaining six patients was based on expert clinical consensus. A further five 
patients were diagnosed as having a mixed disorder (all females, 100%), with three of those 
being confirmed by video-EEG and two based on expert clinical assessment. For five patients 
the diagnosis remained uncertain (four females, 80%). Patients with mixed disorder and those 
with an uncertain diagnosis were excluded from the analyses. This resulted in a final sample 
of 45 patients.  
The demographic and clinical characteristics of the 45 patients as well as their 
baseline psychological questionnaire measures are summarised in Table 3.2. Of the 22 
epilepsy patients, eight patients (36.4%) were surgery candidates; the remaining 14 epilepsy 
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patients had been admitted for diagnostic video-telemetry. As seen in Table 3.2, the majority 
of the epilepsy patients had focal epilepsy.  
Baseline differences between patients with epilepsy and patients with PNES were 
established by comparing the groups on the demographic, clinical and psychological 
measures. Chi-square analyses revealed there were no significant differences between the 
groups in gender distribution, X2(1, N = 45) = 2.67, p = .102, economic activity,  X2(1, N = 
44) = 3.38, p = .066, or medication use, X2(1, N = 45) = 0.31, p = .577.  
An independent samples t-test showed there was a significant difference in the 
duration of the seizure disorder. Patients with epilepsy reported a longer history of seizures 
than patients with PNES, t(38) = 2.09, p = .043. There were no other significant differences 
on clinical, demographic or self-report measures between patients with epilepsy and those 
with PNES (see Table 3.2 for further demographic and clinical information).  
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Table 3.2. Baseline demographic, psychological, and clinical characteristics 
Note. SD = standard deviation; PSS-4 = Perceived Stress Scale; GAD-7 = Generalised Anxiety Disorders 7-item Scale, 
NDDI-E = Neurological Disorders Depression Inventory for Epilepsy; SSAM = Spontaneous Self-Affirmation Measure; 
HIPT = Habit Index of Positive Thinking; BRCS = Brief Resilient Coping Scale; LOT-R = Life Orientation Test-Revised; 
SISE = Single-Item Self-Esteem Scale; NEWQOL-6D = Quality of Life in Newly Diagnosed Epilepsy – 6 Dimensions; AED 
= anti-epileptic drugs. 
 
 
 
3.4.2 Description of Diurnal Variability of Daily Stress Measures (Aim 1) 
Of the 45 patients included in the analyses, 30 patients (66.7%) experienced seizures 
during the video-EEG/ECG monitoring. A total of 83 seizures were recorded (Table 3.3). A 
Mann-Whitney U Test was performed to examine differences between patients with epilepsy 
and patients with PNES in the number of seizures they experienced and the seizure severity. 
Characteristic Epilepsy (N = 22) PNES (N = 23) P-value 
Mean (SD) Mean (SD)  
Gender (N female (%))  13 (59.1%) 8 (34.8%) .102 
Age  39.00 (16.05) 43.74 (11.97) .266 
Education (years) 14.55 (2.70) 13.28 (2.32) .125 
Economically active (N (%)) 12 (54.5%) 6 (26.1%) .066 
PSS-4 7.14 (3.04) 7.13 (3.09) .995 
GAD-7 8.68 (5.72) 10.81 (5.90) .226 
NDDI-E 14.36 (3.03) 15.48 (3.73) .279 
SSAM 4.17 (1.38) 4.57 (1.51) .380 
HIPT 3.79 (1.56) 3.82 (1.80) .952 
BRCS 12.64 (3.63) 11.52 (3.75) .317 
LOT-R 11.86 (4.47) 12.70 (5.15) .562 
SISE 3.23 (1.34) 3.00 (1.31) .573 
NEWQOL-6D 0.77 (0.10) 0.71 (0.13) .104 
Seizure duration (years) 14.75 (14.60) 7.15 (7.05) .043 
Seizure frequency (seizures/month) 15.19 (24.16) 18.10 (37.27) .766 
Seizure severity (measured by LSSS-3) 48.09 (21.07) 50.40 (21.38) .740 
Medication use total (N (%)) 21 (95.5%) 21 (91.3%) .577 
     AED Monotherapy 5 (22.7%) 9 (39.1%) - 
     AED Polytherapy 16 (72.7%) 4 (17.4%) - 
     Anti-anxiety/Anti-depressants/Beta-blockers 7 (31.8%) 11 (47.8%) - 
     Any other medication 8 (36.4%) 15 (65.2%) - 
Epilepsy type (N (%))    
     Idiopathic generalised epilepsy 1 (4.6%) n/a - 
     Focal epilepsy 14 (63.6%) n/a - 
     Unclassifiable epilepsy 7  (31.8%) n/a - 
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The test showed there were no significant differences between the two groups in the number 
of seizures experienced during the monitoring, U = 210.00, p = .315. Unfortunately, seizure 
severity ratings were not available for all of the seizures recorded, as some seizures were too 
brief to be rated and some were not visible on the camera. The severity ratings were only 
available for 27 out of the 34 epileptic seizures and for 21 out of the 49 PNES. Comparison 
of seizure severity ratings from all epileptic and non-epileptic seizures for which the seizure 
severity ratings were available showed that, overall, the non-epileptic seizures were rated as 
more severe than the epileptic seizures, U = 173.50, p = .021.  
Table 3.3. Summary of length of hospital stay and seizure occurrence in the two patient 
groups 
 Epilepsy  (N = 22) PNES (N = 23) P-value 
Days spent in hospital (Mean (SD)) 4.18 (1.01) 3.61 (0.94) .056 
Number of seizures recorded 34 49 .315 
Occurrence of seizures during vEEG/ECG    
    Patients with no seizures (N (%)) 9 (40.9%) 6 (26.1%) - 
    Patients with one seizure (N (%)) 5 (22.7%) 5 (21.7%) - 
    Patients with multiple seizures (N (%)) 8 (36.4%) 12 (52.2%) - 
    Severity of all seizures recorded (Median (IQR))* 4.00 (5.00) 7.00 (4.00) .021 
Note. N = sample size; SD = standard deviation.; IQR = inter-quartile range. *The seizure severity ratings are based on 
seizures for which scores were available (epileptic seizures N = 27; PNES N = 21).  
 
The initial summary and description of the daily stress measures was only performed 
at the person level using aggregated measures from each patient. The measures were 
aggregated using each person’s mean morning and mean evening self-reported stress, means 
of the equivalent morning and evening HRV measures and means of their morning and 
evening cortisol values. Table 3.4 summarises the mean morning and mean evening stress 
measures and cortisol deltas. The evening and morning HRV and cortisol measures were 
non-normally distributed and the values were therefore log-transformed before analysis. A 
descriptive summary of the log-transformed values on which the analyses are based is 
presented in Table 3.5. Differences in the stress measures were explored for each measure 
separately using a series of two-way ANOVAs for mixed designs with diagnostic group 
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(epilepsy vs. PNES) as between-participants independent variable and time of day (morning 
vs. evening) as within-participants independent variable. 
 
Table 3.4. Mean morning and mean evening stress measures in the two patient groups 
Note. M = mean; SD = standard deviation; Variation in sample sizes indicates missing data for certain variables. 
 
Table 3.5. Mean morning and mean evening HRV and cortisol measures in the two patient 
groups after log-transformation 
Note. M = mean; SD = standard deviation; Variation in sample sizes indicates missing data for certain variables 
 
3.4.2.1 Self-reported stress 
The ANOVA showed there were no significant main effects of time, group, or time 
by group interactions for self-reported stress (p’s > .05), suggesting that the mean levels of 
self-reported stress were comparable in the mornings and in the evenings in both patients 
with epilepsy and patients with PNES.  
 
 
Stress Measure Epilepsy PNES 
 N Morning M (SD) 
Evening 
M (SD) N 
Morning 
M (SD) 
Evening 
M (SD) 
Self-reported stress 21 1.57 (0.50) 1.64 (0.50) 22 1.88 (0.83) 1.88 (0.77) 
HRV parameters 20   21   
   SDNN  37.78 (19.78) 39.12 (20.73)  31.07 (23.84) 36.39 (25.25) 
   RMSSD  38.34 (23.17) 45.30 (31.22)  27.52 (27.51) 39.17 (34.23) 
   CVI  2.96 (0.44) 2.98 (0.47)  2.65 (0.57) 2.86 (0.54) 
   CSI  1.83 (0.51) 1.68 (0.60)  2.38 (0.60) 1.87 (0.59) 
Cortisol levels 
(nmol/L) 22 5.10 (1.99) 1.19 (0.68) 22 4.65 (2.16) 0.98 (0.42) 
Cortisol delta 
(nmol/L) 21 3.54 (2.80) 18 3.81 (2.22) 
Stress Measure Epilepsy PNES 
 N Morning M (SD) 
Evening 
M (SD) N 
Morning 
M (SD) 
Evening 
M (SD) 
HRV parameters 20   21   
   LogSDNN  1.52 (0.21) 1.52 (0.22)  1.40 (0.27) 1.47 (0.25) 
   LogRMSSD  1.51 (0.24) 1.54 (0.28)  1.30 (0.32) 1.46 (0.31) 
   LogCVI  0.47 (0.06) 0.47 (0.07)  0.41 (0.10) 0.48 (0.08) 
   LogCSI  0.24 (0.12) 0.20 (0.15)  0.36 (0.12) 0.25 (0.13) 
LogCortisol  22 0.64 (0.18) 0.02 (0.17) 22 0.60 (0.22) -0.04 (0.12) 
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3.4.2.2 Heart-rate variability 
The ANOVA revealed there was a significant main effect of time of day on RMSSD, 
F(1, 35) = 6.46, p = .019. Figure 3.6 shows that RMSSD was higher in the evening than in 
the morning in both patient groups.  
The analysis also revealed a significant main effect of time of day on CSI, F(1, 35) = 
11.45, p = .002. Overall, CSI was higher in the morning than in the evening. There was also a 
significant main effect of patient group, F(1, 35) = 5.31, p = .027. As shown in Figure 3.7, 
CSI was higher in patients with PNES than in patients with epilepsy.  
There were no significant main effects or interactions for SDNN or CVI (p’s > .05), 
suggesting there was no difference between morning and evening SDNN or CVI and no 
difference between the two patient groups in these measures.      
Figure 3.6.	  Morning and evening log-transformed RMSSD in the two patient groups 
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Figure 3.7. Morning and evening log-transformed CSI in the two patient groups 
 
 
 
 
 
 
 
 
 
3.4.2.3 Salivary cortisol 
Examination of the morning and evening cortisol showed there was a significant main 
effect of time of day on the levels of cortisol, F(1, 40) = 317.79, p < .001. As can be seen in 
Figure 3.8, cortisol levels were higher in the morning than in the evening in both patient 
groups. There were no significant main effects of patient group and no significant 
interactions (p’s > .05).  
An independent-samples t-test was further performed to examine the differences 
between patients with epilepsy and patients with PNES in their mean cortisol delta values. No 
significant difference was found between the two patient groups, t(37) = -0.33, p = .740, 
suggesting the diurnal cortisol changes were similar in patients with epilepsy and patients 
with PNES.  
In addition, the cortisol data were compared to normative salivary cortisol data from 
14 healthy volunteers (all male; age M = 32.86, SD = 11.24) collected at the same time points 
(at 9am and 10pm), using two-way ANOVAs for the morning and evening measures, and 
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one-way ANOVA for the cortisol deltas. The analyses showed no significant differences 
between the three groups in the morning or evening cortisol levels or the cortisol deltas (ps > 
.05). For a summary of the normative cortisol values see Appendix 12. 
 
Figure 3.8. Morning and evening log-transformed cortisol levels in the two patient groups 
 
 
 
 
 
 
 
 
 
 
 
 
3.4.3 Associations among Daily Stress Measures (Aim 2) 
Correlations between the morning measures and between the evening measures were 
explored both at the time-point level using all available data points from all patients and at 
the person level using the aggregate (mean) values for each patient.  
3.4.3.1 Time-point level correlations 
The correlation matrix in Table 3.6 shows the correlation coefficients between the 
morning measures using all available data points for self-reported stress, salivary cortisol and 
the heart-rate variability parameters. There were no significant correlations between self-
reported stress and any of the physiological measures, including cortisol and HRV (p’s > 
.05).  
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However, there was a significant negative correlation between salivary cortisol and 
SDNN (p = .012), as well as between salivary cortisol and RMSSD (p = .027). This suggests 
that higher morning cortisol levels were associated with lower overall heart-rate variability 
(as indicated by the SDNN) and lower vagal tone (as indicated by the RMSSD). It is also 
worth noting that all the morning HRV parameters were significantly correlated with each 
other (see Table 3.6). 
Table 3.6. Correlations between the morning stress measures in both patient groups 
combined  
Note. *Correlation is significant at .05 level. ** Correlation is significant at .01 level.  
 
The correlations between the evening measures are shown in Table 3.7. No significant 
correlations were found between self-reported stress and cortisol or between self-reported 
stress and any of the HRV measures (p’s > .05). There were also no significant correlations 
between cortisol and the HRV parameters (p’s > .05). Similarly to the morning measures, the 
evening HRV parameters were significantly correlated with each other (see Table 3.7). 
Correlations between the morning and evening measures were also examined 
separately in patients with epilepsy and patients with PNES. The correlation patterns were 
similar in the two groups, with the only significant correlations being among the HRV 
parameters in both patient groups. For the correlation matrices, see Appendix 13.  
 
 
 1 2 3 4 5 6 
1 Self-reported stress (N = 113)       
2 LogCortisol (N = 110) .002      
3 LogSDNN (N = 80) -.053 -.288*     
4 LogRMSSD (N = 80) -.079 -.253* .941**    
5 LogCVI (N = 80) -.053 -.225 .975** .964**   
6 LogCSI (N = 80) .102 .068 -.352** -.646** -.469**  
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 Table 3.7. Correlations between the evening stress measures in both patient groups 
combined  
 
Note. *Correlation is significant at .05 level. ** Correlation is significant at .01 level.  
 
3.4.3.2  Person level correlations 
The between-subject correlations among the patients’ mean morning and mean 
evening measures in both patient groups combined are presented in Tables 3.8 and 3.9. 
Pearson’s product-moment correlation analyses showed that there were no significant 
correlations between the mean morning self-reported stress and salivary cortisol or between 
self-reported stress and the HRV parameters (p’s > .05). There were, however, significant 
correlations between the morning HRV parameters (see Table 3.8). 
Table 3.8. Between-subject correlations among the mean morning measures 
 1 2 3 4 5 6 
1 Self-reported stress (N = 43)       
2 LogCortisol (N = 42) .063      
3 LogSDNN (N = 38) -.030 -.272     
4 LogRMSSD (N = 38) -.077 -.260 .948**    
5 LogCVI (N = 38) -.040 -.233 .979** .964**   
6 LogCSI (N = 38) .161 .106 -.338* -.620** -.438**  
Note. N = number of patients.  *Correlation is significant at .05 level. ** Correlation is significant at .01 level 
 
Similarly, no significant correlations were found between the mean evening measures 
of self-reported stress and any of the physiological stress measures or between cortisol and 
any of the HRV parameters. The evening HRV parameters were significantly related to each 
other (Table 3.9).  
 1 2 3 4 5 6 
1 Self-reported stress (N = 103)        
2 LogCortisol (N = 106) .061      
3 LogSDNN (N = 94) -.053 .058     
4 LogRMSSD (N = 94) -.047 .057 .943**    
5 LogCVI (N = 94) -.045 .067 .980** .969**   
6 LogCSI (N = 94) .018 -.016 -.434** -.706** -.538**  
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Examination of the between-subject correlations among the mean morning and mean 
evening measures in the two patient groups separately revealed a similar pattern of 
correlations, with the only significant relationships found among the HRV parameters. 
Table 3.9. Between-subject correlations among the mean evening measures 
 1 2 3 4 5 6 
1 Self-reported stress (N = 42)       
2 LogCortisol (N = 44) -.053      
3 LogSDNN (N = 40) .014 -.042     
4 LogRMSSD (N = 40) .017 -.065 .951**    
5 LogCVI (N = 40) .031 -.041 .986** .974**   
6 LogCSI (N = 40) -.014 .100 -.489** -.733** -.581**  
Note. N = number of patients.  *Correlation is significant at .05 level. ** Correlation is significant at .01 level 
 
3.4.4 Relationships between Stress and Seizure Occurrence (Aim 3) 
The data have a multi-level structure with time-points (Level 1) nested within patients 
(Level 2), therefore a series of multi-level regression analyses with maximum likelihood 
estimation was used to explore the relationships. The relationships were examined in two 
different ways. Firstly, a series of multi-level models was tested to investigate whether any of 
the daily stress measures predicted the occurrence of seizures in the next 12 hours. Secondly, 
another series of models was tested to examine whether the occurrence of seizures in the past 
12 hours predicted the levels of self-reported stress, cortisol or HRV at each time point.   
3.4.4.1 Do any of the daily stress measures predict seizure occurrence? 
To answer this question, a series of multi-level regression models was constructed 
with the number of seizures occurring in the next 12 hours as the outcome in the models. The 
daily self-reported stress, cortisol and HRV measures as well as time of day (coded as 
morning = 0, evening = 1) and the number of seizures occurring in the past 12 hours were 
used as Level 1 predictors in the models. Patient group (coded as PNES = 0, epilepsy = 1) 
and the mean self-reported stress, cortisol and HRV measures for each person were used as 
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Level 2 predictors. All missing data were removed before analysis using the HLM software, 
which resulted in a final sample of N = 153 at Level 1 and N = 39 at Level 2.  
To test for significant predictors of seizure occurrence, each stress measure was 
examined separately by comparing four models: (1) a null model predicting seizures in the 
next 12 hours with an intercept only; (2) a daily stress model, adding a fixed effect of daily 
self-reported stress/cortisol/HRV at Level 1; (3) a model with added fixed effects of time of 
day and seizures in the past 12 hours at Level 1 and the diagnostic group at Level 2; and (4) a 
full model, adding the mean self-reported stress/cortisol/HRV at Level 2 to test for patient-
level effects.  
3.4.4.1.1 Self-reported stress predicting seizure occurrence 
The model parameters and the significance level of each predictor in each model are 
shown in Table 3.10. For comparison purposes, a null model without any predictors was 
created (Table 3.10). The intra-class correlation (ICC) was calculated from the null model by 
dividing the Level 2 variance by the sum of the total variance (Level 1 + Level 2). The ICC 
for the number of seizures in the next 12 hours was 0.154, suggesting that 15.4% of variance 
in this outcome was between Level 2 units, i.e., at the patient level. 
Model fit for each model was assessed with likelihood ratio tests based on the deviance 
statistic (deviance is calculated by the HLM software as -2 x log likelihood). For a model 
with a better fit, the likelihood ratio test should show a significant reduction in deviance.  
To test the daily stress model (Model 1), daily self-reported stress (as measured by the 
SSSI) alone was added as a fixed parameter to the null model. As seen in Table 3.10, self-
reported stress was not a significant predictor of seizure occurrence and the likelihood ratio 
test showed that adding this parameter did not provide significant improvement in deviance 
compared to the null model, X2 (1) = 0.01, p = .904. 
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To check for any effects of the time of day, whether or not seizures occurred in the 12 
hours before each stress measurement, and diagnostic group (i.e., whether the occurrence of 
seizures was different in patients with epilepsy or those with PNES), these parameters were 
added to the daily stress model (Model 2). As can be seen in Table 3.10, none of these 
additional parameters were significant predictors of seizures. The likelihood ratio test showed 
that this model did not provide a significant reduction in deviance compared with the null 
model, X2 (4) = 1.26, p = .867, or compared with Model 1, X2 (3) = 1.25, p = .741.  
Finally, to check for the patient-level effects of self-reported stress, the aggregate 
(mean) self-reported stress was added as a Level 2 predictor (Model 3). As can be seen in 
Table 3.10, the aggregate self-reported stress was not a significant predictor of seizures and 
did not affect the significance of any of the other model parameters. The likelihood ratio test 
showed that adding the aggregate self-reported stress at Level 2 did not provide a significant 
reduction in deviance compared with the null model, X2 (5) = 2.17, p = .825, or compared 
with Model 2, X2 (1) = 0.91, p = .340.  
 
Table 3.10. Summary of multi-level regression models for self-reported stress (SSSI) as a 
predictor of seizure occurrence, with time-points (Level 1: N = 153) nested within patients 
(Level 2: N = 39) with random intercept and fixed slopes for all predictors 
Note. B = coefficient; SE = standard error; SSSI = Smith Stress Symptom Inventory as a measure of self-reported stress. 
 
 
 
 Null Model Model 1 Model 2 Model 3 
Parameter B SE B SE p B SE p B SE p 
Level 1 predictors            
    Intercept 0.22 0.05 0.20 0.16 .206 0.27 0.17 .131 0.33 0.19 .087 
    SSSI - - 0.01 0.09 .902 0.02 0.09 .867 0.26 0.26 .329 
    Time of day - - - - - -0.01 0.08 .865 -0.02 0.08 .759 
    Seizures in past 12 hrs - - - - - -0.03 0.05 .556 -0.05 0.06 .401 
Level 2 predictors            
    Diagnostic group  - - - - - -0.11 0.11 .318 -0.12 0.11 .286 
    Aggregate SSSI - - - - - - - - -0.27 0.28 .338 
Deviance 230.00 229.99 228.74 227.83 
Parameters 3 4 7 8 
	   76 
3.4.4.1.2 Salivary cortisol predicting seizure occurrence 
The parameters for the cortisol models are displayed in Table 3.11. To test the model 
with daily salivary cortisol alone (Model 1), daily cortisol values were added as a Level 1 
fixed parameter to the null model. As can be seen in Table 3.11, salivary cortisol was not a 
significant predictor of seizure occurrence and the likelihood ratio test showed that adding 
this parameter did not provide significant reduction in deviance compared to the null model, 
X2 (1) = 0.10, p = .748. 
Next, time of day, seizures occurring in the 12 hours before each stress measurement 
and the diagnostic group were added to the daily cortisol model (Model 2). The likelihood 
ratio test showed that this model did not provide a significant reduction in deviance compared 
with the null model, X2 (4) = 1.31, p = .859, or compared with Model 1, X2 (3) = 1.21, p = 
.751. 
Finally, to check for the patient-level effects of cortisol, the aggregate cortisol was added 
as a Level 2 predictor (Model 3). Aggregate cortisol was not a significant predictor of 
seizures (Table 3.11). The likelihood ratio test showed that adding this parameter did not 
provide a significant improvement in deviance compared with the null model, X2 (5) = 3.45, p 
= .631, or compared with Model 2, X2 (1) = 2.14, p = .144.  
Table 3.11. Summary of multi-level regression models for salivary cortisol as a predictor of 
seizure occurrence, with time-points (Level 1: N = 153) nested within patients (Level 2: N = 
39) with random intercept and fixed slopes for all predictors 
 Null Model Model 1 Model 2 Model 3 
Parameter B SE B SE p B SE p B SE p 
Level 1 predictors            
    Intercept 0.22 0.05 0.21 0.06 .001 0.26 0.15 .091 0.37 0.17 .033 
    Cortisol - - 0.03 0.10 .748 0.05 0.20 .785 0.17 0.21 .416 
    Time of day - - - - - 0.02 0.15 .883 0.09 0.16 .572 
    Seizures in past 12 hrs - - - - - -0.03 0.05 .549 -0.03 0.05 .581 
Level 2 predictors            
    Diagnostic group - - - - - -0.11 0.11 .316 -0.08 0.11 .452 
    Aggregate cortisol - - - - - - - - -0.63 0.43 .151 
Deviance 230.00 229.90 228.69 226.55 
Parameters 3 4 7 8 
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3.4.4.1.3 Heart-rate variability parameters predicting seizure occurrence 
Because the HRV parameters were all correlated among each other, in order to avoid 
the issue of multicollinearity as well as to avoid having too many variables in the model, the 
models were constructed separately for the four HRV parameters. The model parameters and 
their significance levels are summarised in Tables 3.12 – 3.15.  
 As shown in Table 3.12, the daily SDNN alone (Model 1) was not a significant 
predictor of seizures. The likelihood ratio test showed that adding this parameter did not 
significantly improve the model, compared to the null model, X2 (1) < .001, p = .993. Adding 
the time of day, seizures in past 12 hours and diagnostic group to the model (Model 2) did not 
provide a significant reduction in deviance either, compared to the null model, X2 (4) = 1.25, 
p = .870, or compared to Model 1, X2 (3) = 1.25, p = .741. Adding the aggregate SDNN at 
Level 2 (Model 3) to examine the patient-level effects of SDNN showed that aggregate 
SDNN was not a significant predictor (see Table 3.12) and adding this parameter to the 
model did not significantly reduce the deviance, compared to the null model, X2 (5) = 3.30, p 
= .654, or compared to Model 2, X2 (1) = 2.05, p = .152.  
Table 3.12. Summary of multi-level regression models for SDNN as a predictor of seizure 
occurrence, with time-points (Level 1: N = 153) nested within patients (Level 2: N = 39) with 
random intercept and fixed slopes for all predictors 
  
 Null Model Model 1 Model 2 Model 3 
Parameter B SE B SE p B SE p B SE p 
Level 1 predictors            
    Intercept 0.22 0.05 0.22 0.28 .435 0.26 0.29 .366 -0.08 0.38 .834 
    SDNN - - -0.001 0.17 .992 0.02 0.19 .912 -0.30 0.29 .306 
    Time of day - - - - - -0.01 0.08 .864 -0.001 0.08 .988 
    Seizures in past 12 hrs - - - - - -0.03 0.05 .571 -0.05 0.06 .339 
Level 2 predictors            
    Diagnostic group - - - - - -0.11 0.11 .316 -0.14 0.11 .218 
    Aggregate SDNN - - - - - - - - 0.56 0.39 .155 
Deviance 230.00 230.00 228.75 226.70 
Parameters 3 4 7 8 
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Similarly, the daily RMSSD was not a significant predictor of seizures (Model 1) and 
adding this parameter to the null model did not significantly reduce the deviance, X2 (1) = 
0.34, p = .560 (Table 3.13). Adding the time of day, seizures in past 12 hours and diagnostic 
group (Model 2) did not provide significant reduction in variance, compared to the null 
model, X2 (4) = 1.90, p = .755, or compared to Model 1, X2 (3) = 1.56, p = .669. The 
aggregate RMSSD was not a significant predictor (Model 3) and did not provide significant 
reduction in deviance either, compared to the null model, X2 (5) = 4.10, p = .536, or 
compared to Model 2, X2 (1) = 2.20, p = .138.  
 Table 3.13. Summary of multi-level regression models for RMSSD as a predictor of seizure 
occurrence, with time-points (Level 1: N = 153) nested within patients (Level 2: N = 39) with 
random intercept and fixed slopes for all predictors 
  
Examination of the models for the CVI showed that the daily CVI alone (Model 1) 
was not a significant predictor of seizures (see Table 3.14) and adding this parameter did not 
provide a significant reduction in deviance compared to the null model, X2 (1) = 0.07, p = 
.797. Adding the time of day, seizures in the past 12 hours and diagnostic group (Model 2) 
did not significantly reduce the deviance compared to the null model, X2 (4) = 1.44, p = .836, 
or compared to Model 1, X2 (3) = 1.38, p = .710. Adding the aggregate CVI at Level 2 
(Model 3) showed the aggregate CVI was not a significant predictor and did not provide 
 Null Model Model 1 Model 2 Model 3 
Parameter B SE B SE p B SE p B SE p 
Level 1 predictors            
    Intercept 0.22 0.05 0.09 0.22 .680 0.12 0.23 .594 -0.16 0.30 .581 
    RMSSD - - 0.09 0.15 .559 0.13 0.16 .415 -0.13 0.23 .567 
    Time of day - - - - - -0.03 0.08 .762 -0.003 0.08 .967 
    Seizures in past 12 hrs - - - - - -0.03 0.05 .602 -0.05 0.05 .359 
Level 2 predictors            
    Diagnostic group - - - - - -0.13 0.11 .259 -0.16 0.11 .157 
    Aggregate RMSSD - - - - - - - - 0.47 0.31 .141 
Deviance 230.00 229.66 228.10 225.90 
Parameters 3 4 7 8 
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significant reduction of deviance (Table 3.14), compared to the null model, X2 (5) = 3.63, p = 
.604, or compared to Model 2, X2 (1) = 2.18, p = .140.  
 
Table 3.14. Summary of multi-level regression models for CVI as a predictor of seizure 
occurrence, with time-points (Level 1: N = 153) nested within patients (Level 2: N = 39) with 
random intercept and fixed slopes for all predictors 
 
 
  As shown in Table 3.15, the daily CSI alone was not a significant predictor of 
seizures (Model 1) and adding this parameter to the null model did not provide a significant 
reduction in deviance, X2 (1) = 2.50, p = .114. However, when the effects of time of day, 
seizures in the past 12 hours and diagnostic group were added to the model (Model 2), the 
daily CSI became a significant predictor of seizures in the next 12 hours (see Table 3.15), 
although this model did not provide a significant reduction in deviance, compared to the null 
model, X2 (4) = 5.10, p = .277, or compared to Model 1, X2 (3) = 2.60, p = .457. To examine 
the patient-level effects of CSI, the aggregate CSI was added at Level 2 (Model 3). As shown 
in Table 3.15, when aggregate CSI was added, the daily CSI lost its significance again, 
suggesting that the variance in seizures occurring in the next 12 hours was not explained by 
daily CSI when the patients’ aggregate CSI was accounted for. The aggregate CSI itself was 
not a significant predictor of seizures and adding this parameter to the model did not provide 
 Null Model Model 1 Model 2 Model 3 
Parameter B SE B SE p B SE p B SE p 
Level 1 predictors            
    Intercept 0.22 0.05 0.16 0.25 .534 0.18 0.25 .473 -0.15 0.34 .669 
    CVI - - 0.14 0.55 .797 0.26 0.57 .647 -0.67 0.84 .427 
    Time of day - - - - - -0.02 0.08 .824 -0.002 0.08 .978 
    Seizures in past 12 hrs - - - - - -0.03 0.05 586 -0.05 0.05 .355 
Level 2 predictors            
    Diagnostic group - - - - - -0.12 0.11 .288 -0.16 0.11 .177 
    Aggregate CVI - - - - - - - - 1.71 1.14 .143 
Deviance 230.00 229.93 228.55 226.37 
Parameters 3 4 7 8 
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significant reduction in deviance compared to the null model, X2 (5) = 7.36, p = .195, or 
compared to Model 2, X2 (1) = 2.26, p = .132.1 
 
Table 3.15. Summary of multi-level regression models for CSI as a predictor of seizure 
occurrence, with time-points (Level 1: N = 153) nested within patients (Level 2: N = 39) with 
random intercept and fixed slopes for all predictors 
 
 
3.4.4.2 Does seizure occurrence predict daily stress levels? 
Another set of multi-level models was constructed to explore the question of whether 
seizure occurrence can predict any of the daily stress measures. Four multi-level regression 
models were compared for each stress measure as an outcome: (1) a null model predicting the 
self-reported stress/cortisol/HRV with an intercept only, (2) a model with the number of 
seizures in the past 12 hours as a Level 1 predictor, (3) a model adding the fixed effects of 
time of day (coded as morning = 0, evening = 1) at Level 1 and diagnostic group (coded as 
PNES = 0, epilepsy = 1) at Level 2, and (4) a model in which the sum of seizures for each 
patient (i.e., the total number of seizures the patient experienced during the video-EEG 
recording) was added as a Level 2 predictor to check for patient-level effects of seizure 
occurrence.  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  Additionally, to check whether the Level 1 parameters for all the models reported in section 3.4.4.1 varied 
differently between patients, the Level 1 slopes were made to vary at random at Level 2. Making the slopes 
random did not significantly reduce the deviation (p > .05), suggesting the parameters did not vary differently 
between patients and there were not likely to be any cross-level interactions.	  
 Null Model Model 1 Model 2 Model 3 
Parameter B SE B SE p B SE p B SE p 
Level 1 predictors            
    Intercept 0.22 0.05 0.34 0.09 <.001 0.50 0.14 <.001 0.64 0.16 <.001 
    CSI - - -0.47 0.29 .110 -0.63 0.31 .047 -0.19 0.42 .635 
    Time of day - - - - - -0.06 0.08 .502 -0.03 0.08 .694 
    Seizures in past 12 hrs - - - - - -0.03 0.05 .552 -0.04 0.05 .425 
Level 2 predictors            
    Diagnostic group - - - - - -0.15 0.11 .165 -0.19 0.11 .089 
    Aggregate CSI - - - - - - - - -0.93 0.62 .139 
Deviance 230.00 227.51 224.91 222.64 
Parameters 3 4 7 8 
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3.4.4.2.1 Seizure occurrence predicting self-reported stress   
The summary of the model parameters is provided in Table 3.16. The intra-class 
correlation for self-reported stress calculated from the null model was 0.924, suggesting that 
92.4% of variance in self-reported stress was between the Level 2 units (i.e., at the patient 
level).  
The number of seizures occurring in the past 12 hours (Model 1) was a significant 
predictor of daily self-reported stress. One unit increase in the number of seizures occurring 
in the past 12 hours was associated with a 0.06 increase in the self-reported stress score. The 
likelihood ratio test showed that this model provided a significant reduction in deviance 
compared to the null model, X2 (1) = 7.34, p = .007. Estimation of the modelled variance was 
derived using the formula proposed by Raudenbush and Bryk (Raudenbush & Bryk, 2002). 
The model accounted for an estimated 7% of the within-participants variance in daily self-
reported stress. Seizures remained a significant predictor when the fixed effects of time of 
day and diagnostic group were introduced in the model (Model 2). Adding these parameters 
did not significantly reduce the deviance compared to Model 1, X2 (2) = 2.25, p = .325. 
Finally, the sum of seizures was added as a Level 2 predictor (Model 3). This parameter was 
not a significant predictor of self-reported stress and the model did not provide a significant 
improvement in deviance compared to Model 2, X2 (1) = 1.83, p = .176. 
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Table 3.16. Summary of multi-level regression models for number of seizures predicting self-
reported stress, with time-points (Level 1: N = 153) nested within patients (Level 2: N = 39) 
with random intercept and fixed slopes for all predictors 
 
3.4.4.2.2 Seizure occurrence predicting salivary cortisol levels 
The model parameters are presented in Table 3.17. The ICC for salivary cortisol 
calculated from the null model was 0.0002, suggesting that only 0.02% of the variance in 
cortisol was at the patient level. As shown in Table 3.17, the number of seizures in the past 
12 hours alone (Model 1) was not a significant predictor of salivary cortisol levels and this 
model did not provide a significant improvement compared to the null model, X2 (1) = 0.29, p 
= .592. Next, the time of day and the diagnostic group were added to the model (Model 2). 
Time of day was found to be a significant predictor of salivary cortisol. In line with the 
findings reported in section 3.4.2, cortisol levels in the morning (coded 0) were higher than 
the levels in the evening. The model provided a significant reduction in deviance compared to 
Model 1, X2 (2) = 187.53, p < .001, accounting for an estimated 74.5% of the within-
participants variance in salivary cortisol. Introducing the sum of seizures at Level 2 (Model 
3) did not provide further significant improvement in deviance compared to Model 2, X2 (1) = 
0.39, p = .530. 
 
 
 Null Model Model 1 Model 2 Model 3 
Parameter B SE B SE p B SE p B SE p 
Level 1 predictors of SSSI          
    Intercept 1.70 0.10 1.68 0.10 <.001 1.69 0.14 <.001 1.81 0.15 <.001 
    Seizures in past 12 hrs - - 0.06 0.02 .007 0.06 0.02 .011 0.06 0.02 .007 
    Time of day - - - - - 0.04 0.03 .146 0.04 0.03 .150 
Level 2 predictors of SSSI            
    Diagnostic group - - - - - -0.07 0.19 .717 -0.10 0.19 .608 
    Sum of seizures - - - - - - - - -0.06 0.04 .179 
Deviance 31.32 23.98 21.74 19.90 
Parameters 3 4 6 7 
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Table 3.17. Summary of multi-level regression models for number of seizures predicting 
salivary cortisol, with time-points (Level 1: N = 153) nested within patients (Level 2: N = 39) 
with random intercept and fixed slopes for all predictors 
 
3.4.4.2.3 Seizure occurrence predicting HRV parameters 
The intra-class correlations for the HRV parameters calculated from the null models 
are summarised in Table 3.18. The models for the four HRV parameters are summarised in 
Tables 3.19 – 3.22. 
Examination of the models for SDNN showed that the number of seizures in the past 
12 hours alone (Model 1) was a significant predictor of SDNN (Table 3.19) and this model 
provided a significant improvement in deviance compared to the null model, X2 (1) = 4.19, p 
= .041, accounting for an estimated 4.9% of the within-participant variance in daily SDNN. 
One unit increase in the number of seizures in the past 12 hours was associated with a 0.04 
per cent reduction in SDNN. Seizures remained a significant predictor when the effects of 
time of day and diagnostic group were added to the model (Model 2) and this model was not 
a significant improvement compared to Model 1, X2 (2) = 0.68, p = .409. Similarly, the 
number of seizures in the past 12 hours remained a significant Level 1 predictor when the 
sum of seizures was introduced at Level 2 (Model 3) and this model did not provide a 
significance reduction in deviance, X2 (1) = 2.74, p = .100. 
 
 
 Null Model Model 1 Model 2 Model 3 
Parameter B SE B SE p B SE p B SE p 
Level 1 predictors of cort          
    Intercept 0.29 0.03 0.29 0.03 <.001 0.62 0.04 <.001 0.59 0.04 <.001 
    Seizures in past 12 hrs - - -0.02 0.04 .593 0.02 0.02 .419 0.01 0.03 .699 
    Time of day - - - - - -0.65 0.03 <.001 -0.65 .0.03 <.001 
Level 2 predictors of cort            
    Diagnostic group - - - - - 0.01 0.05 .873 0.01 0.04 .861 
    Sum of seizures - - - - - - - - 0.01 0.01 .528 
Deviance 146.10 145.81 -41.72 -42.11 
Parameters 3 4 6 7 
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Table 3.18. Intra-class correlation estimates for the HRV parameters 
 
 
 
 
 
 
Table 3.19. Summary of multi-level regression models for number of seizures predicting 
SDNN, with time-points (Level 1: N = 153) nested within patients (Level 2: N = 39) with 
random intercept and fixed slopes for all predictors 
 
As shown in Table 3.20, seizures in the past 12 hours were not a significant predictor 
of RMSSD (Model 1) and this model did not provide a significant reduction in deviance 
compared to the null model, X2 (1) = 2.06, p = .151. Introducing the effects of time of day 
and diagnostic group in the model (Model 2) showed that the time of day was a significant 
predictor of RMSSD. In line with the results reported in section 3.4.2, RMSSD was likely to 
be lower in the morning (coded as 0) than in the evening. This model provided a significant 
reduction in deviance compared to Model 1, X2 (2) = 10.79, p = .005. Interestingly, when the 
sum of seizures was added at Level 2 (Model 3), the number of seizures in the past 12 hours 
at Level 1 became a significant predictor of RMSSD. The model suggested that when the 
patient’s total number of seizures was controlled for, one unit increase in the number of 
seizures in the past 12 hours was associated with a 0.06 per cent decrease in daily RMSSD. 
The overall sum of seizures was a significant Level 2 predictor, suggesting that in patients 
HRV Parameter Intra-Class Correlation (ICC) 
SDNN 0.630 (63.0%) 
RMSSD 0.611 (61.1%) 
CVI 0.605 (60.5%) 
CSI 0.478 (47.8%) 
 Null Model Model 1 Model 2 Model 3 
Parameter B SE B SE p B SE p B SE p 
Level 1 predictors of 
SDNN          
    Intercept 1.67 0.04 1.48 0.04 <.001 1.43 0.05 <.001 1.38 0.06 <.001 
    Seizures in past 12 hrs - - -0.04 0.02 .039 -0.04 0.02 .025 -0.05 0.02 .010 
    Time of day - - - - - 0.05 0.03 .072 0.05 0.03 .066 
Level 2 predictors of 
SDNN            
    Diagnostic group - - - - - 0.06 0.07 .410 0.07 0.07 .318 
    Sum of seizures - - - - - - - - 0.03 0.02 .102 
Deviance -66.67 -70.87 -74.86 -77.60 
Parameters 3 4 6 7 
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who experienced more seizures during the video-EEG monitoring period, the RMSSD levels 
were higher. The time of day also remained a significant predictor, as shown in Table 3.20. 
This model provided a significant improvement in deviance compared to Model 2, X2 (1) = 
4.65, p = .031, accounting for an estimated 10.3% of the within-participants variance in 
RMSSD.  
 
Table 3.20. Summary of multi-level regression models for number of seizures predicting 
RMSSD, with time-points (Level 1: N = 153) nested within patients (Level 2: N = 39) with 
random intercept and fixed slopes for all predictors 
 
The model parameters for CVI are summarised in Table 3.21. The number of seizures 
in the past 12 hours alone was not a significant predictor of CVI (Model 1) and adding this 
parameter did not provide a significant improvement in deviance compared to the null model, 
X2 (1) = 2.39, p = .121. Adding the effects of time of day and diagnostic group to the model 
(Model 2) showed that time of day was a significant predictor of CVI, suggesting that CVI in 
the morning (coded 0) was likely to be lower than in the evening. This model provided a 
significant reduction in deviance compared to Model 2, X2 (2) = 6.92, p = .032, accounting 
for an estimated 7.3% of the within-participants variance in CVI. The time of day remained a 
significant predictor when the sum of seizures was added at Level 2 (Model 3). Furthermore, 
when the sum of seizures was included in the model, the number of seizures in the past 12 
hours became a significant predictor of CVI at Level 1, suggesting that when the patients’ 
 Null Model Model 1 Model 2 Model 3 
Parameter B SE B SE p B SE p B SE p 
Level 1 predictors of 
RMSSD          
    Intercept 1.44 0.04 1.45 0.04 <.001 1.35 0.06 <.001 1.28 0.07 <.001 
    Seizures in past 12 hrs - - -0.04 0.02 .148 -0.04 0.02 .076 -0.06 0.03 .022 
    Time of day - - - - - 0.10 0.03 .003 0.10 0.03 .002 
Level 2 predictors of 
RMSSD            
    Diagnostic group - - - - - 0.11 0.09 .218 0.12 0.08 .135 
    Sum of seizures - - - - - - - - 0.04 0.02 .034 
Deviance 4.98 2.92 -7.87 -12.52 
Parameters 3 4 6 7 
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overall number of seizures was held constant, a one unit increase in the number of seizures in 
the past 12 hours was associated with 0.02 per cent reduction in CVI. However, adding these 
parameters did not provide a significant reduction in deviance compared to Model 2, X2 (1) = 
3.54, p = .060. 
 
Table 3.21. Summary of multi-level regression models for number of seizures predicting CVI, 
with time-points (Level 1: N = 153) nested within patients (Level 2: N = 39) with random 
intercept and fixed slopes for all predictors 
 
Examination of the models for CSI showed that the number of seizures in the past 12 
hours alone was not a significant predictor of CSI (Model 1) and this model did not provide a 
significant improvement in deviance compared to the null model, X2 (1) = 0.31, p = .575.  
Introducing the effects of time of day and diagnostic group (Model 2) showed that 
time of day was a significant predictor of CSI. As shown in Table 3.22, the model suggests 
that CSI in the morning (coded as 0) was likely to be higher than in the evening, which is 
consistent with the findings reported in section 3.4.2. This model provided a significant 
improvement in deviance compared to Model 1, X2 (2) = 17.70, p < .001. Finally, the sum of 
seizures was added at Level 2 (Model 3). The sum of seizures was a significant predictor of 
CSI, suggesting that one unit increase in the overall number of seizures a patient experienced 
was associated with 0.02 per cent reduction of CSI. When this parameter was included in the 
model, the diagnostic group also became a significant predictor of CSI, suggesting that when 
 Null Model Model 1 Model 2 Model 3 
Parameter B SE B SE p B SE p B SE p 
Level 1 predictors of CVI          
    Intercept 0.45 0.01 0.45 0.01 <.001 0.42 0.02 <.001 0.41 0.02 <.001 
    Seizures in past 12 hrs - - -0.01 0.01 .118 -0.01 0.01 .078 -0.02 0.01 .027 
    Time of day - - - - - 0.02 0.01 .022 0.02 0.01 .020 
Level 2 predictors of CVI            
    Diagnostic group - - - - - 0.03 0.03 .212 0.03 0.02 .144 
    Sum of seizures - - - - - - - - 0.01 0.01 .064 
Deviance -389.74 -392.13 -399.05 -402.60 
Parameters 3 4 6 7 
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the overall number of seizures was held constant, patients with PNES (coded as 0) had higher 
CSI than patients with epilepsy (see Table 3.22). The time of day also remained a significant 
predictor of CSI. This model provided a further significant reduction in deviance, X2 (1) = 
5.43, p = 0.020, and accounted for an estimated 10.4% of the within-participants variance in 
CSI. 2 
 
Table 3.22 Summary of multi-level regression models for number of seizures predicting CSI, 
with time-points (Level 1: N = 153) nested within patients (Level 2: N = 39) with random 
intercept and fixed slopes for all predictors 
 
 
 
3.5 Discussion 
The main objective of this exploratory study was prospectively to capture a range of 
psychological and physiological stress measures in patients with epilepsy and those with 
PNES, to describe the daily patterns of these measures, their associations with each other, and 
their relationships with seizure occurrence.  
The first aim of this chapter was to provide a description of diurnal variability in the 
different daily stress measures. The summary of the morning and evening data from both 
patient groups revealed that levels of self-reported stress were comparable in the mornings 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	  In addition, all models reported in section 3.4.4.2 were also run with random slopes at Level 2. Making the 
slopes random to check for random effects did not significantly reduce the deviation (p > .05), suggesting there 
were no cross-level interactions.	  
 Null Model Model 1 Model 2 Model 3 
Parameter B SE B SE p B SE p B SE p 
Level 1 predictors of CSI          
    Intercept 0.26 0.02 0.26 0.02 <.001 0.33 0.03 <.001 0.36 0.03 <.001 
    Seizures in past 12 hrs - - -0.01 0.01 .575 -0.004 0.01 .776 0.01 0.01 .566 
    Time of day - - - - - -0.07 0.02 <.001 -0.07 0.02 <.001 
Level 2 predictors of CSI            
    Diagnostic group - - - - - -0.07 0.04 .083 -0.07 0.03 .041 
    Sum of seizures - - - - - - - - -0.02 0.01 .021 
Deviance -184.36 -184.67 -202.37 -207.05 
Parameters 3 4 6 7 
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and in the evenings in both patient groups. In contrast, the physiological stress measures 
showed a circadian pattern.  
The HRV parameter reflecting the parasympathetic nervous system tone (RMSSD) 
was lower in the morning and higher in the evening, whereas the parameter reflecting 
sympathetic nervous system tone (CSI) showed an opposite pattern, with values being higher 
in the morning and lower in the evening. The sympathetic metric was also higher overall in 
patients with PNES than in patients with epilepsy. This is in contrast to the findings of 
Ponnusamy et al. (2011) who found no differences in resting parasympathetic or sympathetic 
HRV parameters between patients with epilepsy and patients with PNES. In terms of the 
circadian patterns of HRV, a day-night pattern has been reported in healthy individuals, with 
a peak of the vagal tone at night, decrease towards a sympathetic dominance in the morning 
and a plateau throughout the day (Bonnemeier et al., 2003). Most studies of the cardiac and 
autonomic changes in epilepsy examined heart-rate variability in relation to the risk of 
sudden unexpected death in epilepsy (SUDEP). Several studies reported HRV alterations in 
patients with epilepsy, with reduced vagal tone both ictally and interictally, compared to 
healthy controls, particularly in refractory epilepsy (Brotherstone & McLellan, 2012; 
Jeppesen et al., 2010; Lotufo et al., 2012; Nei, 2009; Ponnusamy et al., 2012; Pradhan et al., 
2011). However, not many researchers have examined the diurnal patterns of HRV in patients 
with epilepsy and the evidence is even more limited for patients with PNES. One study found 
suppressed circadian HRV characterised by attenuation of the normal night time increase of 
HRV in patients with temporal lobe epilepsy, compared to healthy controls (Ronkainen et al., 
2005). In contrast, the results of the present study suggest that the circadian changes in both 
patients with epilepsy and patients with PNES follow the normal day – night pattern. The 
results are consistent with the findings of a doctoral thesis on the autonomic function in 
epilepsy, which assessed 24-hour HRV in 66 patients with intractable epilepsy and found a 
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similar diurnal pattern of HRV changes, with high vagal tone (RMSSD) at night and lower 
vagal tone in the morning and throughout the day but no significant differences in the overall 
HRV (SDNN) between day and night time (Adjei, 2011). Nevertheless, both the present 
study and the study conducted by Adjei lack a control group of healthy participants, and it is 
therefore possible that whilst there are detectable differences between the morning and 
evening vagal tone in the patient sample, these differences may not be as pronounced as they 
are in healthy individuals and/or that the HRV in the patients may be reduced overall. 
Similarly to the patterns found in heart-rate variability, the results of the present study 
showed a distinct pattern in the levels of salivary cortisol, with high values in the morning 
and lower levels in the evening. This pattern is consistent with the well-established circadian 
rhythm of cortisol and it was similar in both patients with PNES and patients with epilepsy. 
No differences were found between the groups in their cortisol deltas either (morning cortisol 
minus evening cortisol). Interestingly, when the cortisol measures were compared to data 
from healthy volunteers collected at the same time points (9am and 10pm), there were no 
significant differences in the morning, evening or cortisol delta levels between patients and 
healthy individuals. This would suggest that the normal cortisol rhythm was preserved in the 
two patient groups and that they did not have significantly altered levels of morning or 
evening cortisol and did not show a blunted cortisol delta, compared to the normative data. 
This is rather surprising, considering the presence of factors that may have been expected to 
reduce diurnal cortisol fluctuation, such as the use of enzyme-inducing anti-epileptic drugs 
and psychological disturbances related to comorbid depression. Nevertheless, this finding 
seems to parallel the results of studies that found no differences in baseline cortisol levels 
between patients with epilepsy and healthy controls (Hofstra & de Weerd, 2009; Pritchard, 
1991).  
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The evidence for the diurnal levels of cortisol in patients with PNES is mixed. A few 
studies reported no difference between patients with PNES and healthy controls (Bakvis et 
al., 2009b; Tunca et al., 1996) whilst later studies by the same authors found increased 
cortisol levels in patients compared to controls (Bakvis et al., 2010; Tunca et al., 2000). One 
reason for the discrepancy between the findings of the latter study by Bakvis and colleagues 
and the results of the present study may be the time of measurement. Bakvis and colleagues 
found significant differences in cortisol levels between patients and controls at 12pm, 2pm, 
4pm, 6pm and 8pm but, similarly to the present study, the groups in the Bakvis study were 
not significantly different at 10am or at 10pm (Bakvis et al., 2010). This suggests that 
patients and healthy individuals may not differ significantly at the extreme points, i.e., in the 
morning when the cortisol levels are the highest and late in the evening when the cortisol 
levels are very low, but that there may be differences in the day curve of cortisol. The lack of 
multiple saliva collection points throughout the day that would allow for construction of 
cortisol day curves is a limitation of the current study. Another reason for the findings of the 
study by Bakvis and colleagues may be that their group of patients included a high proportion 
of individuals who experienced sexual trauma. These patients had higher cortisol levels in the 
study by Bakvis et al. than patients with PNES but no history of sexual trauma. History of 
sexual trauma was not assessed as part of the present study and it is therefore not possible to 
determine whether it may have had any influence on the patients’ cortisol levels. However, it 
is worth noting that the PNES group in the present study consisted predominantly of male 
participants, in whom the likelihood of a previous experience of sexual abuse is lower than in 
females (Bowman & Markand, 1999; Duncan & Oto, 2008). 
As part of the second aim of this chapter, the relationships between these measures 
were examined both at the person level using mean measures for each patient and at the time-
point level, using all available data points. No significant relationships were found between 
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the self-reported stress and any of the physiological measures. As would be expected from 
the patterns found in the physiological measures, there was a significant negative relationship 
between the HRV and cortisol measures in the morning. No relationships were found 
between the evening measures, which may be largely related to the very low cortisol levels in 
the evening. As found in previous studies of HRV, most of the HRV parameters were closely 
related to each other both in the morning and in the evening (Allen et al., 2007; Stalder et al., 
2011). Data on the relationship between the HPA axis and the HRV are limited. A study of a 
group of healthy psychology students showed a significant negative association between 
cortisol awakening response and resting HRV later in the day but no associations between 
awakening-induced changes in cortisol and awakening-induced changes in HRV (Stalder et 
al., 2011). A study of healthy medical students found no correlation between cortisol and 
HRV at rest but correlation was found under stressful conditions on an examination day 
(Lucini et al., 2002). Similarly, a study of healthy nurses during working shifts suggested that 
the two systems might function relatively independently during everyday situations 
characterised by low levels of stress but the cortisol and HRV response becomes closely 
correlated in highly stressful situations (Looser et al., 2010). It could be speculated that the 
correlation of morning HRV and cortisol observed in the patients in the present study is more 
similar to a correlational pattern found in healthy individuals in stressed rather than non-
stressed states.   
Overall, the pattern of the HRV and cortisol measures and their relationships in the 
current study suggest that the physiological stress markers in patients with seizures follow a 
diurnal pattern characterised by higher physiological arousal in the morning and lower levels 
of arousal in the evening. This pattern is not reflected in the subjectively reported levels of 
stress, which suggests some discrepancy between the more objective physiological measures 
and the subjectively self-reported measures. This discrepancy has been noted in other studies. 
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For example, in Stalder et al. (2011), cortisol, heart rate and HRV were not associated with 
self-reported measures of either perceived stress or emotional regulation. Furthermore, both 
patients with epilepsy and patients with PNES tend to have relatively high levels of 
alexithymia (i.e., difficulty in identifying, understanding and describing own emotions), 
which can cause further inaccuracies in their self-reports (Bewley et al., 2005; Myers et al., 
2013). This highlights the complexity of the experience of stress and the difficulty of its 
assessment in patients with seizures, as patients’ subjective perceptions may not always 
match or reliably reflect the underlying physiological processes. However, it is also possible 
that self-report stress measures, particularly the momentary version of the SSSI questionnaire 
used in the present study, may be better at capturing acute changes in stress levels. Despite 
the fact that the patients in the present study experienced seizures during the monitoring 
period and were undergoing various diagnostic and other medical procedures, the morning 
and evening stress measurements were mostly conducted during the interictal, resting state.  
 The third aim of this chapter was to explore the relationships between the daily 
psychological and physiological stress measures and seizure occurrence using a multi-level 
analysis approach. The results indicate that, in the current study, the occurrence of epileptic 
or psychogenic non-epileptic seizures was not predicted by any of the daily self-report, 
cortisol or heart-rate variability measures. Stress has been described as a seizure precipitant 
in patients with epilepsy by many cross-sectional and self-report studies (Ferlisi & Shorvon, 
2014; Nakken et al., 2005; Privitera et al., 2014; Sperling et al., 2008; Wassenaar et al., 
2014). However, to date, only two studies have examined the links between stress and seizure 
occurrence prospectively in adult epilepsy and their findings were mixed (Haut et al., 2012; 
Haut et al., 2007).  As discussed in the Literature Review, the first study, which used paper 
diaries completed once a day, found that stress, anxiety and sleep deprivation increased the 
likelihood of seizure occurrence in the next 24 hours (Haut et al., 2007). In contrast, the later 
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study, in which electronic diaries with morning and evening alarm prompts were used and 
which assessed a wider range of precipitating factors and premonitory symptoms, did not find 
stress to be a significant precipitant of seizures (Haut et al., 2012). Instead, mood and so-
called premonitory symptoms were associated with increased likelihood of seizure 
occurrence over the following 12-hour period. There are currently no prospective studies of 
the links between stress and seizure occurrence in patients with PNES. The present study 
extends the previous diary studies by including physiological stress markers, in addition to 
self-reported stress. Similarly to the latter study by Haut and colleagues, the present study did 
not find self-reported stress to be a significant predictor of seizures. The present study did not 
assess the premonitory seizure symptoms described in the study by Haut and colleagues, 
which were found to be significant predictors of seizure occurrence. However, the Smith 
Stress Symptom Inventory used to assess the daily stress in the present study does include a 
range of somatic and cognitive symptoms that would fit the definition of some of the 
premonitory symptoms in the study by Haut and colleagues, such as feeling irritable, feeling 
emotional, experiencing headaches or having trouble concentrating (Haut et al., 2012). 
Furthermore, the present study assessed physiological arousal using biological markers of 
both the HPA axis and the autonomic nervous system. Yet, none of these measures were 
found to be predictive of the number of seizures occurring in the subsequent 12 hours. One 
possible explanation for the discrepancy between the studies may be the different 
environments in which the diary data were collected (naturalistic home environment in the 
study by Haut et al., versus inpatient video-telemetry ward in the present study). A further 
limitation of the present study, compared to the study by Haut and colleagues, is the 
considerably smaller number of data points, as the present data were collected over a 3 – 5 
day period, whereas the participants in the Haut study kept diaries for 12 – 14 weeks.  
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  The examination of whether the occurrence of seizures can predict any of the daily 
stress measures over the following 12 hours revealed that seizures were predictive of self-
reported stress as well as some of the heart-rate variability measures. However, seizures did 
not predict the levels of salivary cortisol in either patient group. Cortisol was better predicted 
by time of day, which accounted for a large proportion of the within-participants variance. 
This is consistent with the earlier finding of a distinct diurnal pattern characterised by high 
cortisol levels in the morning and low levels in the evening.  
Occurrence of seizures was associated with higher levels of self-reported stress and 
reduced overall heart-rate variability (as measured by the SDNN parameter) in both patient 
groups. The relationship was maintained when time of day and the overall number of seizures 
were accounted for in the more complex models. Although the within-subject variance in 
self-reported stress and SDNN explained by the number of seizures in the previous 12 hours 
was relatively small (7% and 4.9% respectively), this finding seems to suggest that at least 
some of the daily variance in these stress measures was accounted for by seizure occurrence. 
This is perhaps not surprising, as both epileptic and non-epileptic seizures are distressing 
events, associated with a range of psychological and physiological changes. Patients with 
PNES were previously found to report high levels of somatic symptoms of anxiety during 
their attacks (Goldstein & Mellers, 2006) and a number of studies demonstrated ictal 
alterations of HRV during epileptic seizures (Brotherstone & McLellan, 2012; Ponnusamy et 
al., 2012). A previous study of 31 surgical candidates with epilepsy found post-ictal 
disturbance in heart-rate variability lasting for up to 5 – 6 hours after the seizure (Toth et al., 
2010).  
The relationships between seizure occurrence and the other HRV parameters were 
more complex. The multi-level analyses confirmed the earlier findings and showed that the 
parasympathetic (RMSSD, CVI) and sympathetic (CSI) parameters were significantly 
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predicted by time of day, with lower parasympathetic and higher sympathetic nervous system 
tone in the morning and higher PNS and lower SNS tone in the evening. There was a 
discrepancy in terms of the effects of time of day on the CVI parameter. While the multi-
level analyses suggested that CVI was lower in the morning and higher in the evening, the 
earlier analysis in section 3.4.2 did not detect a significant difference between the mean 
morning and the mean evening CVI. This could be explained by the fact that the multi-level 
analyses used both time-level and person-level data rather than person-level mean measures 
and as such are therefore likely to provide a more accurate estimate of the relationships.  
When the overall number of seizures the patient experienced during the monitoring 
was held constant, seizures in the past 12 hours were also a significant predictor of RMSSD. 
Occurrence of seizures in the previous 12-hour period was associated with reduced RMSSD, 
indicating a decrease in the parasympathetic (vagal) tone after seizures. However, the overall 
number of seizures was also a significant predictor of RMSSD but in the opposite direction. 
The results seem to suggest that patients who experienced more seizures overall had higher 
RMSSD. Similarly, the overall number of seizures was a significant predictor of CSI, with 
patients who experienced more seizures overall having lower CSI, i.e., lower sympathetic 
nervous system tone.  The reasons for this seemingly contradictory finding are not entirely 
clear. When the overall number of seizures was held constant, the diagnostic group was also a 
significant predictor of CSI, suggesting that CSI was higher in patients with PNES than in 
patients with epilepsy, which is consistent with the earlier analysis.  
Taken together, the findings about the relationship between stress and seizure 
occurrence in this exploratory study seem to suggest that, whereas the experience of seizures 
may be associated with increased perceived stress and autonomic arousal observable for up to 
12 hours after the seizure, neither the subjectively perceived stress nor the physiological 
stress markers are reliable predictors of seizure occurrence. This is not consistent with the 
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findings of the large number of studies in which patients reported stress as the main seizure 
precipitant. Considering the lack of correlation between the physiological and self-reported 
stress measures in the present study, it could be speculated that patients may be unable to 
reliably assess their subjective stress symptoms or that their subjective experience does not 
necessarily match their physiological stress responses. Either way, it is conceivable that when 
thinking about their seizures, which are experiences that are associated with increased 
subjective and physiological stress, patients may misattribute seizures to stress as a trigger in 
retrospective self-reports. Similarly, it is also possible that their post-seizure appraisal of pre-
seizure events may characterise these events as more stressful in retrospect than they were 
experienced at the time. Recent perspectives on patients’ self-reports indeed suggest that 
retrospective self-report questionnaires tap into the ‘remembering’ self, which is linked to 
default and long-term memory networks and is functionally and neuroanatomically different 
from the conscious, ‘experiencing’ self, which is more connected to the salience network and 
bodily sensations (Conner & Barrett, 2012). While patients’ subjective memories, perceptions 
and beliefs about their seizures and seizure precipitants are important, the results of the 
present study suggest that they may not be a reliable seizure prediction tool. However, it is 
important to remember that this is a single exploratory study with a number of limitations 
(discussed below), and more data will be needed to establish the relationships with more 
certainty.  
3.5.1 Limitations  
The study has a number of limitations. The main limitations are related to its 
exploratory nature and its correlational design, which does not provide evidence about causal 
links among the variables. Due to the exploratory nature of the study, a number of tests have 
been performed without making adjustments for multiple testing, which may have increased 
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the risk of Type 1 error. Furthermore, although the sample size is comparable to that of 
similar previous studies, there were a relatively limited number of data-points available for 
analysis, particularly for patients admitted for only 3 days and those with a lot of missing 
data. The findings of this study therefore need to be interpreted with caution and taken as 
preliminary bases for future well-powered studies rather than conclusive evidence.  
Another limitation is the environment in which the study took place. The levels of 
acute stress are likely to be somewhat different in the hospital setting than in patients’ home 
environment. It is possible that some individuals may experience the hospital environment as 
well as the daily diagnostic procedures as generally stressful. On the other hand, being away 
from the context of common everyday demands and hassles and stressful or dysfunctional 
family relationships and interactions may reduce stress for some patients.  
This is related to another limitation of the study, namely the fact that it only 
accounted for a limited range of factors that may affect the stress that patients experience and 
its effect on seizures. There is a range of other factors that could be considered in future 
studies, including stressful or traumatic experiences in early life and other major life events 
throughout adulthood, significant interpersonal relationships or even the influence of genetic 
factors. Although there were no major differences between the two patient groups on their 
baseline measures, the groups were nevertheless heterogeneous, with different patients taking 
different medication and experiencing different seizure types. There were patients who did 
not experience any seizures during the video-EEG monitoring and there were patients in the 
PNES group whose seizures did not involve loss of consciousness, which means that 
although two expert clinical opinions were obtained to establish the diagnosis, some patients 
may still have been misdiagnosed. Given the heterogeneity of these patients and the 
complexity of the relationship between stress and seizures, it is possible that there may be a 
sub-group of patients who may be more vulnerable to stress and/or its effects on seizures than 
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others. One mechanism that could underlie this vulnerability is the cognitive bias to stress-
related stimuli, explored and discussed in Chapter 4. However, the relatively small sample 
size in this study and the limited number of seizures experienced during the monitoring did 
not allow for performance of sufficiently powered sub-group analyses.  
Another limitation is the possible effect of antiepileptic medication. The patients in 
this study were taking different anti-epileptic (and other) drugs and some subjects had their 
medication temporarily withdrawn or reduced during the stay in the telemetry unit, which 
may have affected their psychological and physiological state.	   Hepatic enzyme-inducing 
medications (such as some of the most commonly used antiepileptic drugs) may have 
significant effects on salivary cortisol levels (Hofstra & de Weerd, 2009). Antiepileptic drugs 
may also affect HRV measures (Hofstra & de Weerd, 2009; Sevcencu & Struijk, 2010). 
However, there is currently no available literature to provide comprehensive guidance on 
possible exclusion criteria for particular AEDs. The fact that the cortisol levels did not differ 
significantly between patients or from the normative data from healthy individuals seems to 
suggest that the medication did not cause any significant alterations in cortisol levels in 
patients. However, this cannot be determined with certainty. 
A further issue is related to the temporal dynamics and relationships between the 
variables. As mentioned previously, the daily assessment was performed twice. As a result, 
the time period between the stress assessments and seizure occurrence was variable, with 
some seizures occurring within a few hours of the morning/evening stress measurement but 
others occurring nearly 12 hours later. It also meant that it was not possible to explore 
cortisol day curves or assess these measures at fixed times before and after seizures. 
Furthermore, certain events during the course of the day that may have caused increased or 
acute stress to patients may have been missed. Therefore, the lack of a relationship between 
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stress and subsequent seizure occurrence may be explained by the fact that the time-window 
of 12 hours was too large.  
3.5.2 Future Research 
The results of this exploratory study highlight the complexity of the experience of 
stress and the relationship of its different components to each other and to seizures. Further 
examination of these relationships is therefore warranted. For example, future studies could 
include a control group of healthy participants, in order to compare the diurnal patterns of 
physiological stress measures between patients with seizures and healthy individuals.  
The present study could be replicated with a larger sample of patients and with more 
data collection points throughout the day and before and after seizures. It would also be 
interesting to examine the effects of seizure severity on the levels of stress, which is 
something that was not feasible as part of the present study, due to the significant proportion 
of missing seizure severity data.  
A sufficiently powered study with a larger sample could also perform sub-group 
analyses to explore factors that may make certain sub-groups of patients particularly 
vulnerable to the effects of stress or the effects of stress on their seizures, such as past 
experience of trauma or a range of individual vulnerability or resilience factors. A recent 
study of childhood epilepsy (N = 64), which used both retrospective reports and diaries found 
a positive relationship between acute stress and seizures in 62% of the children (van Campen 
et al., 2015). The study further found that children with such stress-related seizures showed 
blunted cortisol response to an acute stressor, compared to children without stress-
precipitated seizures or healthy controls, although the groups did not differ in their 
sympathetic stress response or in their baseline cortisol levels. Immediate responses to acute 
stressors were not assessed in the present study. Therefore, a design similar to that of the van 
	   100 
Campen study could be replicated in adult epilepsy and the effects of acute versus more 
chronic stress on seizures could be further explored by prospective longitudinal studies with 
more frequent assessment points. Based on the finding of a diurnal pattern of both cortisol 
and HRV reported in this chapter, future cortisol and HRV-based studies in patients with 
seizures will need to take into consideration the time of when the study was conducted,   
3.5.3 Implications and Conclusions 
To conclude, this exploratory study assessed a combination of physiological and 
psychological stress measures and prospectively assessed their relationships to each other as 
well as to seizure occurrence. Despite the limitations of the study, the present findings 
contribute to previous studies of the diurnal patterns of physiological stress measures in 
patients with seizures, particularly in those with PNES, where these measures have not 
previously been assessed prospectively. The study also expands on the findings of previous 
diary studies of the relationships between stress and seizures by including physiological 
measures of stress. The results of the present study indicate that there may be a discrepancy 
between patients’ physiological responses and their subjective perceptions, and that whereas 
the experience of seizures seems to be associated with increased self-reported stress and 
physiological arousal, the effects of the physiological and self-reported stress on seizure 
occurrence are less clear.  
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4. CHAPTER 4  
Study 1b: Exploring Implicit Attentional Responses to Stress-
Related Stimuli Using the Emotional Stroop Test 
 
4.1 Study Introduction 
A large body of psychological research has focused on studying implicit cognition as 
a way of assessing and understanding processes that are not accessible to introspection and 
therefore not easily captured by self-report (Wiers et al., 2007). Implicit cognition comprises 
processes involving attention, memory, learning, or social cognition that are automatic, 
outside of conscious awareness, and are believed to have important effects on behaviour and 
physiological responses (Dimaro et al., 2014; Egloff et al., 2002; Wiers et al., 2007). It has 
been demonstrated that biased implicit attitudes can influence decision making, for example 
in the context of shortlisting members of ethnic minorities for academic positions (Beattie et 
al., 2013). As another example, in a study of healthy participants undertaking a speech stress 
test, an implicit attention task predicted heart rate and blood pressure reactivity to the speech 
test (Egloff et al., 2002). These implicit processes have also been suggested to be more 
reliable predictors of psychological and behavioural outcomes than explicit measures and 
self-reports (Beattie et al., 2013; Cox et al., 2002; Dimaro et al., 2014; Nock et al., 2010). For 
example, Nock et al. (2010) found that implicit associations between the self and 
death/suicide in individuals attending a psychiatric emergency department were a 
significantly better predictor of the patients making a suicide attempt than known risk factors 
such as depression or the clinicians’ and patients’ predictions. Implicit cognitive processes 
may also play an important role in the aetiology and maintenance of psychopathology (Wiers 
et al., 2007; Williams et al., 1996). 
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One common paradigm used to study implicit attention is the Stroop test. The Stroop 
test is a measure of attentional bias and response automaticity (Stroop, 1935). It demonstrates 
that more automatic responses can cause interference in situations where the individual is 
required to attend selectively to a less automatic task. In the traditional colour word Stroop 
test, the task is to name the colour of the ink in which a word is written, ignoring the meaning 
of the word itself, which creates a conflict between the more automatic tendency to read the 
word and the colour naming. The conflict, or the so-called Stroop effect, is reflected in 
slower response times. The emotional version of the Stroop test is based on the notion that 
people with affective disorders have a greater sensitivity to stimuli and information related to 
their concern. This sensitivity causes them to automatically selectively attend to negative 
emotional stimuli, which is associated with further exacerbation and maintenance of the 
disorders (Williams et al., 1996). Such attentional bias has indeed been demonstrated in 
individuals with post-traumatic stress disorder (PTSD), anxiety, panic or depression, who 
consistently show slower response times to emotional words related to their psychopathology 
than to emotionally neutral words in an emotional Stroop test (Buckley et al., 2002; 
Mitterschiffthaler et al., 2008). There is also some evidence suggesting an attentional bias 
towards threat may exist in patients with epilepsy (Lanteaume et al., 2009; Zeitlin et al., 
1995) and patients with PNES (Bakvis et al., 2009a).  
In the current study, the emotional Stroop test was used to assess attentional bias to 
different types of stress-related stimuli in patients with epileptic seizures and patients with 
PNES, compared to healthy individuals, as such bias could play an important role in the 
patients’ stress responsiveness and vulnerability and could be a target for psychological 
interventions. To explore how such attentional biases may relate to the underlying stress 
physiology, the associations between attentional biases and physiological stress measures 
were also explored as part of the study.  
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Additionally, to explore individual characteristics that may make patients more or less 
vulnerable to attentional hypervigilance other than the seizure disorder itself, as a secondary 
outcome, the study also examined whether the attentional biases in the two patient groups are 
moderated by overall levels of self-perceived stress and individual differences in optimism 
and resilient coping. While heightened attentiveness towards stress-related information may 
be associated with more frequent stress responses, and may increase vulnerability to 
emotional distress (Lanteaume et al., 2009), experiencing long-term stress may, in turn, be 
one of the factors contributing to the development and further exacerbation of attentional 
biases. Long-term self-perceived stress reported by the patients was therefore explored as one 
of the possible moderating factors. At the same time, personal resources that contribute to 
psychological resilience could serve as protective factors, making individuals less vulnerable 
to developing maladaptive attentional biases. Psychological resilience refers to the 
individual’s ability to adapt to and recover from significant stressors and is associated with 
personality traits such as optimism, self-efficacy and self-esteem, as well as emotional, 
cognitive and behavioural processes such as resilient coping, characterised by tendencies to 
cope with stressors in an active and adaptive manner (Sinclair & Wallston, 2004). Likewise, 
optimism, which is a personality trait characterised by holding positive beliefs and 
expectancies about the future, has been linked to less reactivity to stressful experiences and 
therefore less vulnerability to psychological problems and better subjective wellbeing and 
quality of life in both healthy populations and patients with medical and psychiatric 
conditions including coronary heart disease (Carver et al., 2010), epilepsy (Pais-Ribeiro et al., 
2007), or PNES (Griffith et al., 2008). Higher optimism is also associated with better 
adjustment to chronic neurological conditions such as multiple sclerosis (de Ridder et al., 
2000) and it has been linked to proactive, engagement coping and lower levels of avoidance 
(Carver & Connor-Smith, 2010). For example, optimism in patients undergoing coronary 
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artery bypass surgery was associated with information seeking and goal-setting for recovery 
(Scheier et al., 1989), and a number of studies of breast cancer patients reported that 
optimism was related to greater acceptance of the diagnosis, less cognitive avoidance and less 
helplessness, which in turn led to reduced distress and better quality of life (Carver et al., 
1993; Schou et al., 2005). Individual coping style also plays an important role in 
psychological resilience and there are a number of types of coping including problem- and 
emotion-focussed coping, engagement and disengagement coping, and proactive and 
avoidant coping (Carver & Connor-Smith, 2010). In this study, optimism and a resilient 
coping style were examined as possible moderating factors that could make patients more 
resilient to attentional biases.  
Finally, the effectiveness of a brief self-affirmation intervention in reducing any 
attentional biases was tested as an additional secondary outcome, in order to explore whether 
attentional biases in the patients could be altered by this psychological intervention.  
4.2 Study Aims 
4.2.1 Primary Aims  
1. To investigate implicit attentional biases towards/away from stress-related stimuli in 
patients with epilepsy and patients with PNES, compared to healthy volunteers 
2. To test associations between attentional biases and physiological stress measured by 
heart-rate variability and salivary cortisol within each of the groups 
4.2.2 Secondary Aims   
3. To examine the moderating effects of self-reported stress, optimism and resilient 
coping on attentional biases in the two patient groups 
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4. To test whether attentional biases and/or physiological stress responses can be altered 
by a brief self-affirmation intervention 
4.3 Methodology 
4.3.1 Development of the Stroop Test 
4.3.1.1 Pre-selection of emotional and neutral words 
 The selective attentional bias in the emotional Stroop test is characterised by a highly 
disorder-specific response (Becker et al., 2001). Testing responses to specific types of threat 
in patients with epilepsy and PNES could therefore provide insights into the mechanisms 
underlying their psychophysiological stress responses. Based on a review of literature, four 
categories of threat were identified: (1) seizure-related threat, (2) social threat, (3), somatic 
threat, and (4) general threat.  
In order to assess the responses directly related to the experience of having seizures, a 
category of seizure-related words was created. Due to the lack of studies specifically 
investigating the effects of seizure-relevant words, only a small set of words was available, 
from a study by Zeitlin et al. (1995), including words such as epilepsy, seizure and toxic. An 
additional set of candidate words (e.g., convulsion, blackout, fit) was identified from a 
publication of personal accounts of individuals living with seizures (Schachter, 1993).  
Given the perceived stigma associated with epilepsy (Baker et al., 2000; Hayden et 
al., 1992) and the implicit responses to socially threatening images in patients with PNES 
(Bakvis et al., 2009a), a category of socially threatening words was also included. The word 
stimuli for this category (e.g., foolish, humiliated, inferior) were taken from previous studies 
of social anxiety (Johnson-Laird & Oatley, 1989; Martin et al., 1991; Mattia et al., 1993).  
To explore the role of somatisation in PNES, a further category of illness-related or 
somatic symptom words (e.g., sick, medication, aches) was included. Word stimuli used in 
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studies of somatoform disorders (Moss-Morris & Petrie, 2003; Witthoft et al., 2009) and 
panic (McNally et al., 1990) were selected for this category, as were a set of medical words 
used in a study of epilepsy patients (Zeitlin et al., 1995). A small number of words associated 
with somatic symptoms identified by the researcher (e.g., illness, pain, pills) were also added.  
Finally, to explore the effect of generally threatening stimuli, a category of generally 
threatening words (e.g., murder, massacre, rape) that have previously been tested in patients 
with temporal lobe epilepsy (Lanteaume et al., 2009) was included in the study.  
 A list of 100 word stimuli was compiled (25 words in each of the four categories of 
threat) and the words were then matched in frequency, length and semantic category (where 
possible) with emotionally neutral counterparts. The matching was based on the CELEX 
Lexical Database (Baayen et al., 1995), using the N-Watch programme for psycholinguistic 
statistics (Davis, 2005). This resulted in a final list of 25 threat words and 25 neutral words in 
each of the four categories (200 words in total).  
4.3.1.2 Word-rating survey 
In order to test the validity of these words for patients with epilepsy and PNES, a 
survey was conducted using two on-line questionnaires, one asking participants to rate each 
word in terms of the level of threat and the other to rate them in terms of perceived relevance 
to seizures.  
4.3.1.3 Survey participants  
 Members of the on-line communities of epilepsy organisations including Epilepsy 
Action and Fable were approached. Additional participants were recruited in the outpatient 
clinic at the Royal Hallamshire Hospital in Sheffield. Patients with epilepsy and non-epileptic 
seizures were included. A total of 21 participants (eight males), aged 24 – 64 years (M = 
43.52, SD = 12.49) provided ratings of the level of threat. Seizure-relevance ratings were 
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obtained from 20 participants (eight males), aged 21 – 73 years (M = 38.95, SD = 14.60). 
Four participants who did the threat ratings also completed the seizure-relevance 
questionnaire. 
4.3.1.4 Materials and procedure 
 Two online questionnaires were constructed using Survey Gizmo questionnaire 
software. A web-link that randomly allocated participants to either the threat or the seizure-
relevance rating questionnaire was circulated via online forums of the named epilepsy 
organisations. Participants were presented with the 200 words in random order and asked to 
provide ratings of the level of threat (‘Please indicate how threatening you find each of the 
following words’) or the relevance to seizures (‘Please indicate how much you think about 
each of the following words as being related to seizures’) on a 7-point Likert scale (‘Not at 
all threatening/Extremely threatening’ or ‘Not related to seizures/Very closely related to 
seizures’). Participants recruited in the outpatient clinic completed paper versions of the 
questionnaires. 
4.3.1.5 Survey results 
 The main aim of the analyses was to determine whether the pre-selected threat words 
were indeed relevant to patients with seizures and to select the most threatening set of stimuli 
for each category. The analyses were also designed to validate the category of seizure-related 
words, as the words in this category had not been used in previous studies.  
 A series of independent-samples t-tests were performed to compare the level of threat 
of the different word categories. Overall, there was a significant difference between the threat 
words and the neutral words (p < .001) and a significant difference was also found between 
the neutral words and each of the four threat categories (Table 4.1) (p < .001). These findings 
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confirmed that the threat words were perceived as significantly more threatening than the 
neutral words by patients with epileptic or non-epileptic seizures.  
Table 4.1. Mean ratings of the level of threat for the neutral and threatening words overall 
and in each category. 
 Threat Words  
M (SD) 
Neutral Words 
M (SD) 
P- values 
Threat vs. Neutral 
Overall 2.99 (1.37) 1.32 (0.48) < .001 
    General threat words 3.47 (1.53)  < .001 
    Social threat words 2.87 (1.58)  < .001 
    Somatic threat words 2.68 (1.58)  < .001 
    Seizure threat words 2.92 (1.46)  < .001 
      Note. M = mean, SD = standard deviation. 
 Ten words from the general, social and somatic threat category with the highest threat 
ratings were identified. Almost all of these words fell within the highest quartile; four were 
among the highest-rated words in the second quartile.   
The ten words for the seizure threat category were selected on the basis of the seizure 
relatedness ratings. The majority of words rated as most closely related to seizures were the 
words from the pre-selected seizure category. Interestingly, a number of words from the 
general, social and somatic threat category were also rated as relatively closely related to 
seizures. There was a particular overlap with the somatic words, with three words from the 
original pool of somatic threat words being rated among the ten most closely related to 
seizures. These three words were moved into the seizure threat category.  
Each of the selected threat words was paired with its neutral counterpart and the 
neutral words were then checked for ratings of threat and seizure relatedness. Neutral words 
that had rather high ratings were replaced by neutral words with lower ratings, matched as 
closely as possible in frequency and length (N = 5). The final list of the 80 words that was 
used in the experiment is presented in Table 4.2.    
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Table 4.2. Threat and neutral words selected for the Stroop experiment with mean threat and 
seizure relatedness ratings 
 
      Note. M = mean, SD = standard deviation. 
General Threat Social Threat 
 Threat Rating Seizure Rating  Threat Rating Seizure Rating 
Threat M (SD) M (SD) Threat M (SD) M (SD) 
  RAPE 4.76 (2.12) 2.30 (2.18)   STRESSED 3.76 (2.30) 4.50 (1.88) 
  MASSACRE 4.57 (2.27) 2.10 (1.92)   FAILURE 3.43 (2.10) 3.35 (2.37) 
  MURDER 4.52 (2.27) 2.35 (2.18)   PANICKY 3.33 (1.88) 4.05 (2.04) 
  TERROR 4.38 (2.09) 4.00 (2.60)   HUMILIATED 3.29 (2.00) 3.40 (2.28) 
  BOMB 4.29 (2.17) 2.60 (2.19)   FEARFUL 3.24 (2.26) 3.95 (2.44) 
  RAGE 4.14 (1.77) 3.45 (2.61)   INSECURE 3.19 (1.97) 3.30 (2.36) 
  KILL 4.10 (2.41) 2.55 (2.44)   INADEQUATE 3.10 (2.36) 3.00 (2.34) 
  HOSTAGE 4.10 (2.23) 2.53 (2.27)   RIDICULE 3.05 (2.00) 2.60 (2.23) 
  HOSTILE 3.86 (2.10) 2.65 (2.01)   ISOLATED 3.00 (1.90) 3.42 (2.19) 
  ASSASSIN 3.81 (2.50) 1.85 (1.50)   FAIL 3.00 (2.00) 2.65 (2.21) 
Neutral   Neutral   
  TALE 1.38 (0.92) 1.25 (0.79)   STREAMS 1.33 (1.00) 1.45 (1.47) 
  MUSICIAN 1.24 (0.70) 1.10 (0.45)   FLOWERS  1.05 (0.22) 1.16 (0.50) 
  DETAIL 1.57 (1.47) 1.75 (1.71)   ORBITAL 1.10 (0.32) 1.00 (0.00) 
  BUTTER 1.19 (0.68) 1.10 (0.45)   LANDSCAPES 1.05 (0.22) 1.00 (0.00) 
  BOWL 1.10 (0.44) 1.25 (1.12)   LUGGAGE 1.57 (1.57) 1.30 (1.34) 
  KNEE 1.29 (0.78) 1.26 (0.65)   ADJACENT  1.62 (1.57) 1.45 (1.47) 
  SEAT 1.33 (0.91) 1.20 (0.62)   HOUSEHOLDS 1.38 (1.07) 1.25 (1.12) 
  HAIRCUT 1.33 (0.58) 1.20 (0.70)   BANANA 1.10 (0.30) 1.05 (0.22) 
  FORESTS 1.10 (0.30) 1.30 (0.92)   INTERIOR 1.24 (0.70) 1.40 (1.39) 
  SCISSORS 1.90 (1.30) 1.65 (1.53)   SMOOTH 1.10 (0.30) 1.05 (0.22) 
Somatic Threat Seizure Threat 
 Threat Rating Seizure Rating  Threat Rating Seizure Rating 
Threat M (SD) M (SD) Threat M (SD) M (SD) 
  PARALYSIS 3.95 (2.48) 3.20 (2.07)   SEIZURE 3.57 (2.58) 6.25 (1.62) 
  FAINTNESS 3.25 (2.05) 4.45 (1.82)   EPILEPSY 4.05 (2.40) 6.05 (1.76) 
  ILLNESS 3.14 (1.88) 4.05 (2.26)   BLACKOUT 3.33 (2.33) 5.60 (1.70) 
  DISEASE 3.05 (2.21) 2.15 (1.90)   HEADACHE 2.52 (2.04) 5.25 (1.97) 
  SICKNESS 3.05 (2.25) 3.40 (2.46)   CONFUSION 2.91 (2.05) 5.10 (1.80) 
  BREATHLESS 3.00 (2.03) 3.20 (2.07)   FORGETFUL 3.24 (2.27) 5.00 (2.13) 
  SHAKY  2.91 (2.05) 3.45 (2.31)   MEDICATION 2.33 (1.65) 5.00 (2.29) 
  SICK  2.91 (1.97) 3.40 (2.26)   FALL 2.86 (1.98) 4.75 (2.00) 
  PAIN  2.86 (1.98) 3.80 (2.04)   FATIGUE 3.00 (2.14) 4.75 (2.27) 
  ILL 2.81 (1.63) 4.50 (1.88)   COLLAPSE 3.38 (2.09) 4.75 (2.40) 
Neutral   Neutral   
  EQUATIONS 1.38 (1.07) 1.25 (0.91)   PEANUTS 1.14 (0.48) 1.15 (0.49) 
  BILLBOARD 1.05 (0.22) 1.10 (0.45)   PLATYPUS 1.19 (0.68) 1.10 (0.45) 
  BOTTLES 1.10 (0.30) 1.50 (1.48)   LANTERNS 1.05 (0.22) 1.05 (0.22) 
  CAPTAIN 1.05 (0.22) 1.00 (0.00)   NOTEBOOK 1.19 (0.51) 1.25 (0.79) 
  PAVEMENT 1.33 (0.97) 1.25 (0.91)   DOCUMENTS 1.48 (1.12) 1.45 (1.23) 
  PROGRAMMED 1.24 (0.77) 1.30 (0.92)   READERSHIP 1.38 (0.92) 1.15 (0.49) 
  SILKY 1.05 (0.22) 1.05 (0.22)   STATIONERY 1.33 (1.32) 1.10 (0.45) 
  PARK 1.10 (0.30) 1.00 (0.00)   CENT 1.19(0.68) 1.05 (0.22) 
  LIST 1.67 (1.56) 1.25 (0.91)   DRAWERS 1.14 (0.48) 1.10 (0.45) 
  BAG 1.05 (0.22) 1.05 (0.22)   CATEGORY 1.14 (0.36) 1.45 (1.15) 
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4.3.2 Selection of Self-Affirmation Intervention 
A literature search for existing self-affirmation manipulations suitable for use in this 
Stroop experiment yielded two possible manipulations: a kindness self-affirmation 
manipulation (Reed & Aspinwall, 1998) and a self-affirmation task based on the Values in 
Action Strengths scale (Peterson & Seligman, 2003) developed by Napper and colleagues 
(Napper et al., 2009).  
The kindness self-affirmation manipulation is a ten-item self-report questionnaire 
designed to elicit affirmative responses by asking participants about past acts of kindness 
(e.g., ‘Have you ever attended to the needs of other person?’). Based on evidence that 
kindness is a highly desirable personal value, self-affirmation is achieved through affirming 
the self as possessing this important characteristic. 
The Values in Action (VIA) self-affirmation manipulation is a 32-item self-report 
questionnaire adapted from the original 250-item Values in Action Strengths scale. The self-
affirming effects of the questionnaire are achieved through focussing participants’ minds on 
important personal values and strengths (e.g., ‘I always try to keep my word.’). The items are 
rated on a 5-point scale (very much like me / like me/ neutral / unlike me / very much unlike 
me).  
These manipulations were selected because they are simpler to use than, for example, 
the frequently used Allport-Vernon-Lindzey Scales (Vernon & Allport, 1931), which require 
either pre-screening of participants or later allocation of participants to a particular sub-scale. 
The two selected manipulations are also less demanding than essay-based self-affirmation 
manipulations, which involve writing an essay about an important value or characteristic.  
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4.3.2.1  Self-affirmation intervention selection study 
In order to make an informed decision about which one of the two manipulations was 
more suitable for the experiment and for people with seizures, the manipulations were tested 
and evaluated by members of the local Sheffield branch of the Epilepsy Action. 
4.3.2.2 Participants 
 Six individuals (four males) aged 46 – 68 years (M = 56.00, SD = 8.85) volunteered to 
take part in the selection study. Four volunteers suffered from epileptic seizures, one 
volunteer from PNES and one volunteer experienced both epileptic and non-epileptic 
seizures.  
4.3.2.3 Outcome Measures 
 The self-affirming effects of the two interventions were assessed using the scales 
developed by Napper et al. (2009). Seven items rated on bipolar scales (scored 0 – 6) were 
used to assess self-appraisal (e.g., ‘The task made me think about positive aspects of myself’), 
two items rated on unipolar scales (scored 0 – 4) assessed awareness of the self and values 
(‘The task made me aware of who I am’ and ‘The task made me aware of my values (the 
principals and standards by which I try to live my life’).  
 In addition, a brief interview was conducted with each participant, in order to find out 
about clarity of the instructions, possible problems with either of the interventions and 
recommendations regarding the suitability of the interventions for the purposes of the study.  
4.3.2.4 Procedure 
 Members of the Epilepsy Action group in Sheffield were approached by email 
distributed by the branch officer. Interested volunteers were invited for a one-hour session at 
the Royal Hallamshire Hospital. Further recruitment was undertaken in person during one of 
the monthly meetings of the Epilepsy Action Sheffield branch. 
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 Individuals who agreed to participate obtained an information sheet summarising the 
background and purposes of the study, as well as the purpose and procedure of the session. 
Participants had an opportunity to ask questions and they agreed to take part by signing a 
consent form. Participants were asked to complete a brief demographic questionnaire and the 
two self-affirmation manipulations, first the kindness then the VIA manipulation, each 
followed by the Napper et al. (2009) rating scales.  
After completing the questionnaires, each participant was briefly interviewed about 
the clarity of instructions and appropriateness of the interventions and asked for additional 
feedback and comments.  
4.3.2.5 Results 
 A series of paired-samples t-tests were performed to test for differences between the 
self-affirming effects of the two interventions. Table 4.3 shows that the kindness affirmation 
produced slightly higher ratings on self-appraisal and awareness of self and values. However, 
the difference between the two interventions was not significant in the elicited sense of self-
appraisal (t = 2.01, p = .100) or awareness of self and values (t = .67, p = .530). 
 
Table 4.3. Mean ratings for the kindness self-affirmation and the VIA self-affirmation 
manipulations 
Note. M = mean, SD = standard deviation, n.s. = not significant. 
 
 Verbal feedback from participants suggested that both self-affirmation manipulations 
were comprehensible and there were no significant problems with completing either. With 
regard to the self-affirming effects of the manipulations, participants’ responses seemed to 
 Kindness Affirmation  VIA Affirmation P-values 
 M (SD) M (SD)  
Self-Appraisal 3.69 (0.95) 3.12 (1.26) n.s. 
Awareness of Self and Values 3.17 (0.93) 3.00 (0.55) n.s. 
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correspond with results of the quantitative ratings. Three participants felt that the kindness 
manipulation was more thought provoking than the VIA manipulation and that having to 
write particular examples of past acts of kindness elicited more self-reflection. Two 
participants preferred the VIA manipulation and found it more personally relevant. One 
participant had no preference and found both self-affirmation manipulations equally 
challenging. Overall, the self-affirming effects of the two manipulations seem comparable, 
although the kindness affirmation may be slightly more effective. As the kindness 
manipulation is also shorter and has more established support in the literature (Armitage, 
2012; Armitage et al., 2008; Epton & Harris, 2008), it was eventually selected for use as the 
self-affirmation manipulation for the experiment (Appendix 14). 
4.3.3 Experimental Design 
The Stroop experiment assessed participants’ performance on the emotional Stroop 
test at two time points, before and after the self-affirmation intervention, in order to assess 
and compare their attentional biases towards/away from stress-related stimuli and to evaluate 
their responsiveness to psychological intervention.    
4.3.4 Participants 
4.3.4.1 Patients 
Patients admitted for inpatient video-EEG/ECG recruited for Study 1a were 
approached to take part in the Stroop experiment. Patients were recruited on the basis of the 
inclusion/exclusion criteria described in Chapter 3.   
4.3.4.2  Healthy volunteers 
In addition to the patient participants, healthy volunteers were recruited to undertake 
the emotional Stroop experiment as a control group. Healthy volunteers were recruited 
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through a volunteer mailing list of the University of Sheffield. All potential participants were 
sent an email invitation to the study with a link to an online screening questionnaire, which 
included detailed information about the study and questions about past history of any 
neurological or psychiatric disorders, age, and gender. This enabled matching of the control 
group with patients by age and sex and screening for past neurological and psychiatric 
history. Volunteers with no history of neurological or psychiatric disorders matched in age 
and gender to the patient participants were invited for the study appointment.  
4.3.5 Outcome Measures 
4.3.5.1 Self-report measures 
A selection of self-report measures completed by all patients at baseline was used for 
this part of the study. These questionnaires included the demographic questionnaire, 
Perceived Stress Scale – 4 Item (PSS-4) (Cohen et al., 1983), Liverpool Seizure Severity 
Scale – Revised (LSSS-3) (Scott-Lennox et al., 2001), Life-Orientation Test – Revised (LOT-
R) (Scheier et al., 1994), Spontaneous Self-Affirmation Measure (SSAM) (Harris et al., In 
preparation), Brief Resilient Coping Scale (BRCS) (Sinclair & Wallston, 2004), and 
questionnaires assessing psychopathology, including the Neurological Disorders Depression 
Inventory for Epilepsy (NDDI-E) and the Generalised Anxiety Disorder 7-item Scale (GAD-
7) (Spitzer et al., 2006). A detailed description of these measures is provided in Chapter 3.  
4.3.5.2 Attentional biases  
Implicit attentional biases were investigated by comparing the participants’ response 
times (RTs) to neutral versus threatening words. Slower response times to threatening words, 
as compared to neutral words, indicate greater attentional bias towards threatening or stress-
related stimuli and therefore suggest a cognitive hyper-vigilance towards threat that could 
increase the vulnerability to stress.  
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Mean RTs were calculated for the threatening and neutral words overall, as well as for 
the different word categories. Error trials and trials in which the RT was below or above 2 SD 
of the participant’s mean RT were removed. In order to control for variability in response 
times between individuals, a D-transformation procedure was used to standardise the scores 
on the basis of within-participant variability (Greenwald et al., 2003). A D-transformed 
Stroop Index (D-SI) was calculated as a measure of attentional bias using the following 
equation:  
D-SI = 
(mean  RT  for  threatening  words  –  mean  RT  for  neutral  words)  pooled  SD  for  threatening  and  neutral  words  
 
4.3.5.3 Heart-rate variability parameters 
Patients’ ECG was recorded using the ECG channel of the XLTEK EEG system 
(XLTEK, Ontario, Canada) as is used routinely for video-EEG/ECG monitoring. Healthy 
participants’ ECG recording was obtained using a portable R-R interval recording device 
(Firstbeat Bodyguard 2) with two chest electrodes. Heart-rate variability parameters were 
extracted from resting ECG recordings taken at four time-points, immediately before and 
immediately after each of the Stroop tests. For the analysis of HRV, 3-5 minute samples of 
resting ECG free of muscle artefact or ectopic beats were selected. The selected samples were 
visually inspected to ensure the recordings were artefact-free. Patients’ ECG samples were 
recorded by the XLTEK EEG system described in Chapter 3. The ECG samples from healthy 
participants were extracted from the Firstbeat Bodyguard device using the Firstbeat Uploader 
software, and saved in an R-R interval data series format (sampled at 1000 Hz). HRV 
parameters were extracted using the Kubios HRV software, following the procedure detailed 
in Chapter 3. 
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The following HRV parameters were used: SDNN as a time domain metric of overall 
HRV, RMSSD as a time domain parasympathetic metric, total power (TP) as a frequency 
domain metric of overall HRV, CVI as a non-linear parasympathetic metric, and CSI as a 
non-linear sympathetic metric.     
4.3.5.4 Salivary Cortisol 
In this part of the study, saliva was sampled as one of the physiological stress 
measures at two time points, just before the Time 1 Stroop test and just after the Time 2 
Stroop test. The samples were collected using the Salivette collection device (Sarstedt Ltd). 
Factors that influence levels of cortisol, including smoking, food intake or consumption of 
drinks with low pH were controlled for. The salivary samples were prepared for analysis, 
stored and analysed using the same procedure described in Chapter 3.  
4.3.6 Procedure and Data Collection Tools 
Patients completed the experiment on one of the days they spent in the in-patient 
video-telemetry ward. Most patients completed the experiment on the first or second day of 
their stay in the ward. An attempt was made to perform the experiment on days when no 
seizures had occurred prior to the Stroop test (i.e., since midnight on that day). For patients 
for whom this was not possible (N = 7), the experimenter ensured that the Stroop experiment 
was completed at least one hour after the seizure occurrence. Healthy volunteers were invited 
to the Royal Hallamshire Hospital for a 2-hour appointment, during which they underwent 
the same procedure as the patient participants with the same experimenter. 
All participants were asked to complete a set of baseline self-report questionnaires 
after consenting to participate in the study (see Chapter 3 for the questionnaire description). 
Only the questionnaires of interest to this part of the study are reported in this chapter. These 
questionnaires include the demographic questionnaire, the PSS-4, the LSSS-3, the LOT-R, 
	   117 
the SSAM, the BRCS, the NDDI-E and the GAD-7. Completion of these questionnaires took 
about 30 minutes. 
The main part of this study was completion of the emotional Stroop test. The test was 
performed at two time points: before (Time 1) and after the kindness self-affirmation 
intervention (Time 2). The experiment was carried out on a laptop computer (13-inch 
MacBook Pro, OS X 10.8.5, 2012) using software developed specifically for this experiment 
in the C++ programming language by a research fellow at the Department of Medical Physics 
and Clinical Engineering, Sheffield Teaching Hospitals NHS Foundation Trust.  
Participants sat on a bed or a chair, approximately 50 cm from the laptop screen, 
which was placed on a hospital table (patients) or a desk (healthy participants). At Time 1, 
participants were presented with a set of emotionally threatening and matched emotionally 
neutral words, and asked to indicate the colour of each word by pressing a corresponding key 
on the laptop keyboard marked with a coloured sticker (‘F’ = red, ‘G’ = blue, ‘H’ = green, ‘J’ 
= black). The experimental trials were preceded by 20 practice trials. The following 
instructions were presented on the laptop screen: “You will be presented with a set of words 
written in RED, BLUE, GREEN or BLACK colour. Your task is to indicate the colour of each 
word by pressing the corresponding key on the keyboard. Please ignore the meaning of the 
word and identify the colour as quickly as you can without making any errors. You will have 
a chance to familiarise yourself with the task in a short practice trial before the real test 
begins. Keep your eyes fixated on the black cross in the middle of the screen and respond to 
each word as fast as possible.” 
Each trial consisted of a black fixation cross display for 500ms, followed by the word 
stimulus presentation until response was given. The stimuli consisted of the four categories of 
threatening words described above: (1) general threat words, (2) social threat words, (3) 
words related to somatic symptoms and (4) words related to the experience of seizures, and a 
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matched set of neutral counterparts. There were 5 threat words and 5 matched neutral words 
in each category, adding up to 20 threatening and 20 neutral words in total. Each word was 
presented singly in the middle of the computer screen, four times, once in each of the four 
colours (red, blue, green, black), which resulted in a total of 160 trials. Presentation of the 
word stimuli was randomised for each participant.  
Afterwards, participants completed the kindness self-affirmation intervention (Reed & 
Aspinwall, 1998). After the intervention, patients were asked to perform the emotional Stroop 
test again (Time 2), using a different set of randomly presented 20 threatening and 20 neutral 
words taken from the four identified word categories. The order of presentation of the two 
word-sets used in the Time 1 and Time 2 Stroop tests was counter-balanced across 
participants. 
Participants’ resting ECG was recorded for analysis before as well as after the Time 1 
and Time 2 Stroop test. For this purpose, participants were asked to lie still in a supine 
position and breathe normally for 3 - 5 minutes.  
In addition, salivary samples were collected from participants for analysis of the 
levels of free cortisol as a marker of physiological stress. Saliva was sampled at two time 
points, just before the Time 1 Stroop test and just after the Time 2 Stroop test. The whole 
experiment took between one and two hours. 
4.3.7 Statistical Analyses 
 The data were analysed using SPSS (version 22; SPSS Inc., Chicago, IL, U.S.A.). 
Distribution of scores was assessed for normality using the Shapiro-Wilk test. The results are 
organised into five sections. In the first section, descriptive and inferential statistics including 
Chi-square and one-way ANOVA with the group (epilepsy vs. PNES vs. healthy controls) as 
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between-participants independent variable were used to describe and compare the 
demographic and clinical characteristics of the three groups.  
In the second section, the attentional biases in the first Stroop test are explored. The 
D-SI scores were normally distributed. One-sample t-tests were used to explore the 
attentional biases in each group. A two-way ANOVA for mixed designs with group as a 
between-participant independent variable (epilepsy vs. PNES vs. healthy controls) and word 
category as a within-participant independent variable (general vs. seizure vs. social vs. 
somatic threat words) was performed to examine attentional bias differences between the 
groups. Differences between the groups were further explored using Tukey’s Honestly 
Significant Difference (HSD) post-hoc tests.  
In the third section, associations between attentional biases and physiological 
measures are examined. The cortisol data and the HRV parameters were non-normally 
distributed and the distribution was therefore normalised using natural log-transformation 
prior to analysis and subsequently analysed using parametric tests. A series of one-way 
ANOVAs were used to first explore the differences in the physiological stress measures 
including salivary cortisol and HRV between the groups. The relationships between 
physiological stress measures and the attentional biases were subsequently examined using 
Pearson’s Product-Moment Correlation.  
 In the fourth section, the moderating effects of self-reported stress, optimism and 
resilient coping are explored by moderated multiple regression and tests of simple slopes, 
using the PROCESS for SPSS macro programme (Hayes, 2013).  
In the final section, the effects of the self-affirmation intervention are explored. A 
three-way ANOVA for mixed designs with group (epilepsy vs. PNES vs. healthy controls) as 
a between-participants independent variable and time (pre- versus post-intervention Stroop 
test) and word category (general vs. seizure vs. social vs. somatic threat words) as within-
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participants independent variables was conducted to examine the effects on attentional biases. 
The changes in the HRV parameters were examined using a two-way ANOVA for mixed 
designs with group (epilepsy vs. PNES vs. healthy controls) as a between-participants 
independent variable and time (before Time 1 Stroop vs. after Time 1 Stroop vs. before Time 
2 Stroop vs. after Time 2 Stroop) as a within-participants independent variable. Changes in 
salivary cortisol measured between the Time 1 Stroop test and after the Time 2 Stroop test 
were explored using a two-way ANOVA for mixed designs with group (epilepsy vs. PNES 
vs. healthy controls) as a between-participants independent variable and time (pre- vs. post-
Stroop test) as a within-participants independent variable. 
In view of the fact that this is an exploratory study, no adjustments were made for 
multiple comparisons (Goeman & Solari, 2011). Two-tailed p-values of <0.05 were 
considered statistically significant. 
4.4 Results  
4.4.1 Demographic, Clinical and Psychological Characteristics 
Of the 55 patients recruited for Part 1 of the study, 54 patients completed the Stroop 
experiment. Of these, 22 patients had a diagnosis of epilepsy (13 females, 59.1%), 22 patients 
had a diagnosis of PNES (eight females, 36.4%), and further five patients had a mixed 
seizure disorder (all females, 100%). For the remaining five patients, the diagnosis remained 
uncertain after their admission and expert review (four females, 80%). Patients with mixed 
disorder and those with an uncertain diagnosis (N = 10) were excluded from the analyses, 
which resulted in a final sample of 44 patients. In addition to the patient participants, 22 
healthy adults with no history of a neurological or a psychiatric disorder, matched in age and 
gender to the patients were recruited for the study as a control group. As one participant later 
withdrew, the final control group consisted of 21 healthy volunteers (15 females, 71.4%). 
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Table 4.4 summarises the demographic and psychological characteristics of the 
participants. Chi-square analysis showed there was no significant difference in gender 
distribution between the three groups, X2(2, N = 65) = 5.53, p = .063. A series of one-way 
ANOVAs showed there were no significant differences between the groups in age, F(2, 62) = 
0.53, p = .591) or spontaneous self-affirmation, F(2,58) = 0.67, p = .516. However, there 
were significant differences in years spent in full-time education, F(2, 62) = 15.42, p = < 
.001, levels of self-perceived stress, F(2, 62) = 7.81, p = .001, anxiety, F(2, 62) = 7.34, p = 
.001, depression, F(2, 62) = 6.11, p = .004, resilient coping, F(2, 62) = 5.11, p = .009, and 
optimism, F(2, 62) = 7.55, p = .001, between the groups. Tukey’s HSD post-hoc tests showed 
that both patients with epilepsy and patients with PNES spent fewer years in full-time 
education, had higher levels of self-perceived stress, anxiety and depression, and lower levels 
of optimism than healthy volunteers (p’s < .05). Patients with PNES but not patients with 
epilepsy had lower levels of resilient coping than healthy participants (p = .007). A 
significant difference was found between the groups in their medication use, X2(2, N = 65) = 
33.18, p < .001. As seen from Table 4.4, a significantly higher proportion of patients were on 
medication, compared to healthy participants. There were no significant differences between 
patients with epilepsy and patients with PNES in the duration of their disorder, seizure 
frequency, or seizure severity (p’s > .05). 
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Table 4.4. Demographic, psychological and clinical characteristics    
Note. SD = standard deviation. 
 
4.4.2 Attentional Biases (Aim 1) 
The attentional biases towards/away from stress-related stimuli in the three groups 
were explored using the D-SI measures in the Time 1 Stroop test (pre-intervention). Table 4.5 
summarises the mean overall score as well as the scores for the four word categories in the 
three groups. 
Table 4.5. Pre-intervention D-transformed Stroop Index (D-SI) in the patient groups and 
healthy volunteers for the different word categories  
Note. D-SI = D-transformed Stroop Index, SD = standard deviation.  
 
Characteristic Epilepsy (N = 22) PNES (N = 22) Healthy Controls (N = 21) 
Mean (SD) Mean (SD) Mean (SD) 
Gender (N female (%))  13 (59.1%) 8 (36.4%) 15 (71.4%) 
Age  39.00 (16.05) 43.68 (12.25) 40.24 (18.07) 
Education (years) 14.55 (2.70) 13.29 (2.39) 17.95 (2.98) 
PSS-4 7.14 (3.04) 7.14 (3.17) 4.14 (3.24) 
GAD-7 8.68 (5.72) 10.62 (5.97) 4.29 (4.84) 
NDDI-E 14.36 (3.03) 15.36 (3.77) 11.95 (2.96) 
SSAM 4.17 (1.38) 4.56 (1.55) 4.63 (1.17) 
BRCS 12.64 (3.63) 11.59 (3.83) 14.81 (2.40) 
LOT-R 11.86 (4.47) 12.78 (5.26) 17.24 (4.76) 
Seizure duration (years) 14.75 (14.60) 7.27 (7.22) n/a 
Seizure frequency (seizures/month) 15.19 (24.16) 20.76 (41.00) n/a 
Seizure severity (measured by LSSS-3) 48.09 (21.07) 50.44 (22.24) n/a 
Medication use total (N (%)) 21 (95.5%) 20 (90.9%) 5 (23.8%) 
     AED Monotherapy 5 (22.7%) 9 (40.9%) n/a 
     AED Polytherapy 16 (72.7%) 3 (13.6%) n/a 
     Anti-anxiety/Anti-depressants/Beta-blockers 7 (31.8%) 11 (50.0%) 0 
     Any other medication 8 (36.4%) 14 (63.6%) 5 (23.8%) 
Word Category D-SI  
(milliseconds) 
Epilepsy (N = 22) PNES (N = 22) Healthy Controls (N = 21) 
Mean (SD) Mean (SD) Mean (SD) 
Overall D-SI 87.04 (144.21) 23.96 (152.92) -30.59 (183.14) 
General Threat D-SI 65.77 (279.28) 31.15 (292.82) -70.03 (342.94) 
Seizure Threat D-SI 155.35 (304.43) 3.44 (250.13) 49.62 (249.36) 
Social Threat D-SI 16.06 (308.72) 26.56 (253.59) -75.99 (320.67) 
Somatic Threat D-SI 131.66 (332.82) 16.56 (328.92) -17.11 (285.34) 
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 The one-sample t-tests used to explore the patterns of responses in each group showed 
that in patients with epilepsy, the overall D-SI, t(21) = 2.83, p = .010, as well as the D-
transformed Stroop Index for the seizure-related threat category, were significantly different 
from zero, t(21) = 2.39, p = .026, indicating a significant positive bias towards threatening 
words. The Stroop responses in patients with PNES and in healthy controls were not 
significantly different from zero (p’s > .05). 
The two-way ANOVA used to compare the responses between the groups revealed 
that the main effect of group (epilepsy vs. PNES vs. healthy controls) was significant, F(2, 
62) = 3.28, p = .044, whereas the main effect of word category (general vs. seizure vs. social 
vs. somatic threat) was not significant, F(3, 62) = 0.98, p = .405. The interaction between 
group and word category was not significant either, F(2, 62) = 0.47, p = .828. The main 
effect of group was further investigated using Tukey’s HSD post-hoc tests. These tests 
showed that patients with epilepsy had significantly higher D-SI scores than healthy controls 
in each word category (p = .036). The differences between patients with PNES and healthy 
controls, as well as between patients with epilepsy and patients with PNES were not 
significant (p’s > .05).      
4.4.3 Associations between Attentional Biases and Physiological Stress Measures 
(Aim 2) 
4.4.3.1 Associations between attentional biases and salivary cortisol 
Before exploring the associations between the measures, differences between the three 
groups in salivary cortisol measured before the Time 1 Stroop test were assessed. The mean 
log-transformed salivary cortisol values for the three groups from samples collected before 
the Time 1 Stroop test are displayed in Table 4.6. The one-way ANOVA showed there was 
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no significant difference between the groups in cortisol, although the result approached 
significance, F(2, 51) = 2.92, p = .063.3    
Pearson’s product-moment correlation showed there were no significant correlations 
between salivary cortisol and the Stroop responses overall or in any of the word categories in 
patients with epilepsy or patients with PNES (p’s = .087 – .966; r2 < .001 – .16). However, 
significant positive correlations were found in the healthy controls between salivary cortisol 
and the overall D-SI, r(13) = .53, p = .042, r2 = .28 (28% variance explained), and between 
salivary cortisol and the social threat category D-SI, r(13) = .62, p = .014, r2 = .38 (38% 
variance explained). 
4.4.3.2 Associations between attentional biases and HRV 
The heart-rate variability parameters extracted from the resting ECG recording taken 
just before the Time 1 Stroop are displayed in Table 4.6. First, differences in the HRV 
parameters between the three groups were explored. The analysis revealed significant 
differences in SDNN, F(2, 52) = 5.57, p = .006, TP, F(2, 52) = 5.35, p = .008, RMSSD, F(2, 
52) = 3.72, p = .031, and CVI, F(2, 52) = 5.23, p = .009. No significant difference was found 
in CSI (F(2, 52) = 0.04, p = .957) between the groups. Tukey’s HSD post-hoc tests showed 
the significant differences were between patients with PNES and healthy controls. Patients 
with PNES had significantly lower overall measures of HRV than healthy controls, namely 
the SDNN (p = .005) and TP (p = .006), as well as lower measures of vagal tone, including 
RMSSD (p = .024) and CVI (p = .007), indicating increased autonomic arousal. There were 
no significant differences between patients with epilepsy and patients with PNES or between 
patients with epilepsy and healthy controls.  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3 Given the diurnal fluctuations in salivary cortisol discussed in Chapter 3 and the fact that participants 
performed the Stroop test at various times of the day and the samples were therefore collected at different times, 
the effects of the cortisol collection time were checked by adding the saliva collection time (samples collected 
before 12pm versus those collected after 12pm) into the ANOVA. The analysis yielded no significant main 
effect of collection time and no significant interaction between group and collection time (p’s > .05), suggesting 
that collection time did not significantly affect the cortisol levels in any of the groups. 
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Next, the associations between the attentional biases measured by the Time 1 Stroop 
test and the HRV parameters measured prior to the Time 1 Stroop test were examined. In 
patients with epilepsy, a significant negative correlation was found between the D-SI for 
somatic words and the total power, r(13) = - .58, p = .022, r2 = .34 (34% variance explained)  
(Figure 4.1). There was also a negative correlation between the D-SI for somatic words and 
SDNN which approached significance, r(13) = - .49, p = .064, r2 = .24 (24% variance 
explained). No other significant relationships were found between any of the Stroop 
responses and the HRV parameters in any of the groups (p’s = .072 - .947). The associated 
effect sizes were small and varied from r2 < .001 (less than 0.1% variance explained) to r2 = 
.17 (17% variance explained).  
Figure 4.1. Scatterplot representing the correlation between total power and D-transformed 
Stroop Index for the somatic threat category in patients with epilepsy 
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4.4.3.3 Associations between salivary cortisol and HRV 
There were no significant correlations between any of the HRV parameters and 
salivary cortisol in any of the three groups (p’s = .191 - .995). Effect sizes were small, 
varying from r2 < .001 (less than 0.1% variance explained) to r2 = .10 (10% variance 
explained). 
Table 4.6. Physiological stress measures in the three groups taken before Time 1 Stroop 
Note. *Log-transformed values. Variation in sample sizes indicates missing data for certain variables. 
 
4.4.4 Moderation of Attentional Biases in the Two Patient Groups (Aim 3) 
Table 4.7 shows zero-order correlations between attentional biases in the Time 1 
Stroop test in the two patient groups and the self-reported psychological measures. To test 
whether the attentional biases in the two patient groups were affected by self-reported stress, 
optimism, or resilient coping, a series of moderated multiple regression analyses were 
conducted, with patient group (patients with epilepsy vs. patients with PNES) as an 
independent variable and self-reported stress/optimism/resilient coping as moderators. The 
self-reported stress, optimism, and resilient coping scores were mean-centred prior to 
analysis.  
 
Physiological Measure Epilepsy PNES Healthy Controls 
N Mean (SD) N Mean (SD) N Mean (SD) 
Median cortisol level (nmol/L)* 20 0.55 (0.30) 19 0.38 (0.30) 15 0.35 (0.24) 
HRV parameters*       
      SDNN 15 1.51 (0.21) 20 1.36 (0.23) 20 1.61 (0.26) 
      TP 15 2.98 (0.43) 20 2.67 (0.46) 20 3.15 (0.52) 
      RMSSD 15 1.52 (0.25) 20 1.37 (0.26) 20 1.61 (0.31) 
      CVI 15 0.47 (0.06) 20 0.42 (0.08) 20 0.49 (0.08) 
      CSI 15 0.22 (0.15) 20 0.21 (0.15) 20 0.22 (0.13) 
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Table 4.7. Correlations between the Time 1 Stroop test D-SIs and the self-reported 
psychological measures in the two patient groups combined 
 1 2 3 4 5 6 7 8 9 10 11 
1 Overall D-SI            
2 General D-SI .492**           
3 Seizure D-SI .640** .113          
4 Social D-SI .419** .071 .042         
5 Somatic D-SI .419** -.135 .121 -.235        
6 PSS-4 -.072 -.043 -.096 .150 -.182       
7 GAD-7 -.235 -.079 -.361* .018 -.120 .655**      
8 NDDI-E -.192 -.075 -.390** .190 -.146 .615** .773**     
9 LOT-R .276 .090 .203 .009 .245 -.527** -.488** -.544**    
10 BRCS .142 .137 .170 -.194 .184 -.445** -.431** -.391** .461**   
11 SSAM -.125 -.215 .041 -.159 .078 -.267 -.005 -.115 .470** .378*  
Note. N = 44. *Correlation is significant at 0.05 level. **Correlation is significant at 0.01 level.    
 
4.4.4.1 Self-reported stress 
The regression models for the overall Stroop index, general, seizure, social and 
somatic threat categories were not significant (p’s > .05). There were no significant main 
effects of self-reported stress, group or their interaction (p’s > .05).  
4.4.4.2 Optimism 
The regression model for the overall Stroop index was significant, F(3, 44) = 9.05, p 
<.001. There was a significant main effect of optimism, β = 42.98, p < .001; the higher 
optimism scores the patients reported, the greater their overall attentional bias. There was 
also a significant interaction between optimism and patient group, β = -21.30, p = .006. The 
interaction was decomposed using simple slopes analysis at high (one standard deviation 
above the mean) and low (one standard deviation below the mean) levels of optimism. The 
simple slopes analysis revealed that patient group was significantly predictive of the overall 
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attentional bias for patients high in optimism, β  = -176.44, p = .005, but not those low in 
optimism, β = 29.83, p = .551. As shown in Figure 4.2, among those scoring high in 
optimism, patients with epilepsy showed greater overall attentional bias (indicated by the 
overall D-SI score) than patients with PNES. 
Figure 4.2. Interaction between patient group and optimism on the overall D-transformed 
Stroop Index scores. Simple slopes for patient groups at high and low levels of optimism 
 
 
 
 
 
 
 
 
 
 
 
The model was also significant for the seizure threat category, F(3, 44) = 3.32, p = 
.019. There was a significant main effect of optimism, β = 87.15, p = .008; the higher the 
patients scored on optimism, the greater their attentional biases toward seizure-related threat. 
There was also a significant interaction between optimism and group, β = -43.65, p = .024. 
Simple slopes analysis at high and low levels of optimism again showed that patient group 
was significantly predictive of attentional bias towards seizure-related threat in patients who 
scored high on optimism, β = -346.55, p = .013, but not those who scored low on optimism, β 
= 76.18, p = .570. The attentional bias towards seizure-related threat was greater in patients 
with epilepsy than in patients with PNES among patients high in optimism (Figure 4.3). 
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Figure 4.3. Interaction between patient group and optimism on the D-transformed Stroop 
Index scores for seizure-related threat. Simple slopes for patient groups at high and low 
levels of optimism 
 
 
 
 
 
 
 
 
 
 
 
4.4.4.3 Resilient coping 
 The models for the overall Stroop index, general, seizure and somatic threat category 
were non-significant (p’s> .05). There were no significant main effects of resilient coping or 
group, and there were no significant resilient coping by group interactions (p’s> .05). The 
overall model for social threat category was significant, F(3, 44) = 3.16, p = .035; however, 
there were no significant main effects of resilient coping or group and no significant 
interaction (p’s > .05). 
4.4.5 Effects of the Self-Affirmation Intervention (Aim 4) 
4.4.5.1 Effects on the attentional biases 
The post-intervention D-SI scores are summarised in Table 4.8. One-sample t-tests 
used to explore the post-intervention Stroop response patterns in each group showed that the 
post-intervention D-SIs did not significantly differ from zero in any of the three groups.  
-50 
0 
50 
100 
150 
200 
250 
300 
Low Optimism High Optimism 
Epilepsy 
PNES 
	   130 
The three-way ANOVA conducted to examine the effects of the self-affirmation 
intervention on the attentional biases showed there were no significant main effects of time, 
F(1, 62) = 0.25, p = .621, group, F(2, 62) = 0.92, p = .406, or word category, F(3, 62) = 0.62, 
p = .606. There were no significant interactions between time and group, F(2, 62) = 1.96, p = 
.149, word category and group, F(6, 62) = 0.73, p = .622, or between time and word category, 
F(3, 62) = 0.62, p = .606. The three-way interaction between group, time and word-category 
was not significant either, F(6, 62) = 0.54, p = .779. 
Table 4.8. Post-intervention D-SI in the patient groups and healthy volunteers for the 
different word categories 
Note. D-SI = D-transformed Stroop Index, SD = standard deviation.  
 
4.4.5.2 Changes in heart rate variability 
The HRV parameters taken at the four different time points (before and after the Time 
1 and Time 2 Stroop tests) are summarised in Table 4.9. The two-way ANOVA showed there 
was a main effect of group for SDNN, F(2, 52) = 3.73, p = .032, for CVI, F(2, 52) = 3.33, p = 
.045, and for TP, F(2, 52) = 3.85, p = .029. Further post-hoc Tukey’s HSD tests showed that 
patients with PNES had significantly lower SDNN, CVI and TP than healthy controls (p’s < 
.05) across the four time points. No significant main effect of group was found for RMSSD 
or CSI. There were no main effects of time for any of the HRV parameters and no significant 
time by group interactions (p’s > .05).   
 
 
Word Category D-SI  
(milliseconds) 
Epilepsy (N = 22) PNES (N = 22) Healthy Controls (N = 21) 
 
Mean (SD) Mean (SD) Mean (SD) 
Overall D-SI 27.17 (175.87) 51.46 (202.43) 51.17 (171.14) 
General Threat D-SI -52.66 (281.88) 92.82 (299.18) 0.48 (348.99) 
Seizure Threat D-SI 42.51 (335.54) 65.61 (290.50) 33.25 (334.49) 
Social Threat D-SI 24.82 (328.13) 35.80 (330.15) 119.57 (357.52) 
Somatic Threat D-SI 100.41 (323.86) 3.43 (306.02) 43.28 (313.93) 
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Table 4.9. Heart-rate variability parameters after Time 1 and before and after Time 2 Stroop 
Test 
Note. N Epilepsy = 11; N PNES = 16; N Control = 18. *Log-transformed values. 
4.4.5.3 Changes in salivary cortisol 
The mean difference between the sampling time of cortisol collected before the Time 
1 and after the Time 2 Stroop test in all three groups combined was 41.50 minutes. The two-
way ANOVA used to assess changes in salivary cortisol revealed that there was a significant 
main effect of time, F(1, 50) = 13.86, p <.001. Salivary cortisol was significantly higher 
before the Time 1 Stroop test (M = 0.43, SD = 0.29) than after the Time 2 Stroop test (M = 
0.35, SD = 0.27) across all the three groups (see Figure 4.4).  
Figure 4.4. Mean log-transformed salivary cortisol levels before Time 1 Stroop test (Time 1) 
and after Time 2 Stroop test (Time 2) in the three groups combined. 
 
 
 
 
 
 
 
 
 
 
 
 
 After Time 1 Stroop Test 
Mean (SD) 
Before Time 2 Stroop Test 
Mean (SD) 
After Time 2 Stroop Test 
Mean (SD) 
HRV 
parameters* 
Epilepsy PNES Control Epilepsy PNES Control Epilepsy PNES Control 
SDNN 1.52 
(0.22) 
1.42 
(0.25) 
1.60 
(0.25) 
1.55 
(0.22) 
1.42 
(0.24) 
1.59 
(0.24) 
1.55 
(0.23) 
1.39 
(0.16) 
1.52 
(0.23) 
TP 3.02 
(0.45) 
2.80 
(0.51) 
3.21 
(0.47) 
3.05 
(0.47) 
2.76 
(0.51) 
3.13 
(0.51) 
3.06 
(0.42) 
2.76 
(0.51) 
3.18 
(0.50) 
RMSSD 1.54 
(0.29) 
1.42 
(0.30) 
1.56 
(0.31) 
1.56 
(0.30) 
1.42 
(0.29) 
1.57 
(0.29) 
1.55 
(0.29) 
1.38 
(0.22) 
1.60 
(0.32) 
CVI 0.47 
(0.07) 
0.43 
(0.08) 
0.49 
(0.08) 
0.48 
(0.07) 
0.43 
(0.08) 
0.48 
(0.07) 
0.48 
(0.07) 
0.43 
(0.05) 
0.49 
(0.07) 
CSI 0.20 
(0.13) 
0.22 
(0.17) 
0.28 
(/15) 
0.20 
(0.16) 
0.21 
(0.16) 
0.25 
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There was also a significant main effect of group, F(2, 50) = 3.28, p = .046 (Figure 
4.5). Tukey’s HSD post-hoc tests revealed that across the two time points, patients with 
epilepsy had significantly higher levels of cortisol than healthy controls (p = .041). The 
interaction between time and group was not significant, F(2, 50) = 2.19, p = .122. 
 
Figure 4.5. Mean log-transformed salivary cortisol levels in patients with epilepsy, patients 
with PNES and healthy controls at the two time points combined 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.5 Discussion 
This chapter described the development and results of an emotional Stroop 
experiment designed to explore attentional biases towards/away from stress related stimuli in 
patients with epilepsy and patients with PNES, compared to healthy individuals. As part of 
the Stroop experiment, the relationships between attentional biases and physiological stress 
measures were also explored. In addition, the moderating effects of self-reported stress, 
optimism and resilient coping on attentional biases in the two patient groups were examined 
as a secondary outcome to explore factors underlying vulnerability and resilience to 
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attentional biases in these patients. The study also explored whether the attentional biases 
and/or any of the physiological stress measures could be altered by a self-affirmation 
intervention.  
The findings of the study revealed that patients with epilepsy showed a significant 
positive attentional bias towards threatening words overall as well as towards seizure-related 
threat words specifically, as indicated by a positive Stroop index, which was significantly 
different from zero. In patients with PNES, the overall Stroop index, as well as the Stroop 
indexes for the four word categories were also positive, suggesting a bias towards threatening 
rather than neutral words, although this was less marked than in patients with epilepsy and 
did not reach statistical significance. Conversely, in the healthy control group, the Stroop 
indexes were predominantly negative, suggesting a bias towards neutral rather than 
threatening words, although this bias was not statistically significant. Previous studies of 
attentional biases in patients with seizures and in healthy individuals interpret a negative 
attentional bias seen in healthy participants as a preconscious avoidance or orienting away 
from the threatening stimuli (Bakvis et al., 2009a; Bakvis et al., 2009b). Such attentional 
avoidance has been described as appropriate, as avoiding threat and harm is an adaptive 
response (van Honk et al., 2000). 
Comparison of the three groups among each other revealed that patients with epilepsy 
exhibited significantly greater bias across the different word categories than healthy 
volunteers but did not differ significantly from patients with PNES. The differences between 
patients with PNES and healthy controls were not significant. This suggests that in this study 
patients with epilepsy but not patients with PNES were highly vigilant towards threat related 
stimuli and particularly towards information related to the seizure disorder itself. This would 
fit with the findings by Jones et al. who found that seizure severity was a more significant 
contributor to anxiety symptoms in patients with epilepsy than in patients with PNES, in 
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whom attachment style and relationship quality contributed more (Jones et al., Manuscript in 
preparation). 
With regard to epilepsy, this finding seems consistent with the emotional Stroop 
literature, in which a disorder-specific Stroop response is typically found in patients with a 
range of disorders, including depression, anxiety or PTSD (Williams et al., 1996). The 
findings are also in line with those of Zeitlin et al. (1995) who found attentional biases 
towards seizure-related words in patients with epilepsy who reported a high number of 
seizure-related fears, as well as the results from the study by Lanteaume et al. (2009) who 
showed attentional biases towards threat in a sub-group of patients with temporal lobe 
epilepsy who reported experiencing emotional seizure triggers. However, the patients in the 
Lanteaume et al. (2009) study showed an attentional bias towards generally threatening 
words, whereas patients in the current study were biased towards threatening words across 
the four categories and towards seizure-related threat words in particular. Contrary to the 
Lanteaume et al. (2009) study, the sample of patients who participated in the current study 
included patients with different epilepsy types and both patients who did and those who did 
not endorse stress as a seizure trigger4. The findings from the current study therefore seem to 
suggest that the increased attentional vigilance towards threat in patients with epilepsy may 
not be limited to those with temporal lobe epilepsy or those who subjectively experience 
stress-related or emotional triggers.  Interestingly, the attentional vigilance towards seizure-
related threat found in patients with epilepsy in the present study also fits with the findings of 
a qualitative study of patients’ seizure metaphors, in which patients with epilepsy but not 
patients with PNES described their seizures as hostile, external entities of which they are a 
victim (Plug et al., 2009).   
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4 Comparison of patients with epilepsy and patients with PNES who endorsed versus those did not endorse 
stress to be a possible seizure trigger using a two-way ANOVA for independent designs yielded no significant 
differences in the Stroop responses between the groups.  
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Based on previous studies suggesting implicit attentional vigilance towards threat to 
be a maladaptive response, associated with the maintenance and exacerbation of various 
psychopathologies, the assumption of the present study was that such attentional biases in 
patients with seizures could contribute to their vulnerability towards greater and/or more 
frequent stress responses. However, it is worth considering whether the attentional vigilance 
may in fact be an expected or not necessarily a maladaptive response in patients with 
epilepsy. In their review of emotional Stroop test studies, Williams et al (1996) discuss the 
possible role of exposure to certain types of stimuli in the emotional Stroop interference. For 
example, there is a possibility that the greater attentional bias towards negative words such as 
‘gloomy’ in individuals with depression may be caused by the fact that depressed individuals 
tend to often dwell on such concepts and the Stroop interference for depressive words could 
therefore reflect mere extended exposure or practice in processing this type of information 
(Williams et al., 1996). Likewise, patients with refractory epilepsy are likely to be frequently 
exposed to information related to seizures and this could perhaps prime them to automatically 
attend to such information. However, while this could be true for the attentional vigilance 
towards the seizure-related stimuli, the fact that patients exhibited significantly greater 
attentional bias towards threatening words across all the different word categories compared 
to healthy volunteers suggests that the attentional vigilance towards threat in the epilepsy 
patients is more generalised and therefore more likely to be a maladaptive or a hyper-vigilant 
attentional response. Furthermore, Williams et al (1996) argue that the disorder-specific 
attentional bias seen in various psychological disorders is not likely to be only due to 
extended practice, as therapeutic studies show that reduction of symptoms or recovery from 
the disorder following therapy is also associated with alleviation of the attentional bias – 
something that would not be expected if the bias was caused purely by repeated exposure.     
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In terms of attentional biases in patients with PNES, although the PNES patients 
showed a somewhat different pattern of responses than the healthy volunteers, the differences 
in the responses between the groups did not reach statistical significance, unlike in the study 
conducted by Bakvis et al., who reported a significant attentional bias towards angry stimuli 
in patients with PNES, compared to healthy controls (Bakvis et al., 2009a). When 
interpreting responses to emotional stimuli, several modulating factors need to be considered, 
including characteristics of the individual, characteristics of the stimulus and characteristics 
of the environment such as task and situational demands (Okon-Singer et al., 2013). While 
the main aims of this study were to examine the effects of having a seizure disorder and the 
associated physiological and psychological characteristics of the patients on the attentional 
responses to stress-related stimuli, the effects of the stimulus properties and the testing 
environment should also be addressed. One possible explanation for the discrepancy between 
the findings of the current study and that of Bakvis et al. (2009a) may be the type of 
emotional stimuli used in the two studies. While the current study used word stimuli, Bakvis 
and colleagues used pictures of angry faces. Pictures of faces and real-life scenes may be 
more salient stimuli than words (Okon-Singer et al., 2013). Faces in particular are considered 
to be significant social and biological stimuli processed through dedicated neural circuits that 
may be different to those used to process word stimuli (Okon-Singer et al., 2013). 
Furthermore, PNES are often associated with a history of interpersonal trauma (Kaplan et al., 
2013) and the attentional bias towards angry faces in the Bakvis et al. (2009a) study was 
indeed positively related to levels of self-reported sexual trauma. It is therefore conceivable 
that the angry facial stimuli in the Bakvis et al. study elicited stronger responses than the 
word stimuli used in the present study. Alternatively, the attentional biases identified in the 
Bakvis et al. study may have been a feature of those patients who experienced sexual trauma, 
which is something that has not been specifically assessed in the PNES patients who took 
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part in the current study. Furthermore, as described in Chapter 3, the majority of the PNES 
patients in this study were male and therefore less likely to have a history of sexual abuse 
(Bowman & Markand, 1999; Duncan & Oto, 2008). Apart from the different stimuli used, the 
current study also used a different mode of stimuli presentation. While the Bakvis et al. study 
used masked stimuli, the word stimuli in the current study were unmasked, although 
participants were instructed to focus on the colour of the words rather than their meaning. It 
is therefore possible that the study by Bakvis et al. captured preconscious attentional biases 
that were not captured by the longer and unmasked presentation of the stimuli in the current 
study. 
Examination of the physiological stress measures and their relationships to the 
attentional biases revealed that there were no differences between the groups in their levels of 
salivary cortisol measured before the first Stroop test. The salivary cortisol levels were not 
related to attentional biases in either of the patient groups but there was a positive association 
between salivary cortisol and the overall Stroop index, as well as the Stroop index for the 
social category in healthy participants. This would suggest that healthy volunteers who were 
physiologically more aroused were more vigilant towards threat. Considering the higher 
levels of medication use, depression, anxiety, and possible seizure-related physiological 
changes in the two patient groups compared to the healthy individuals, it could be speculated 
that these factors may have affected the cortisol levels in the two patient groups and this 
could have obscured possible relationships between cortisol levels and attentional biases.  
Interestingly, a previous study that investigated baseline cortisol levels from samples 
taken before a masked emotional Stroop test in patients with PNES, patients with epilepsy 
and a healthy control group and their association with attentional biases towards angry faces, 
found no significant differences in cortisol levels between the groups, similarly to the results 
of the current study (Bakvis et al., 2009b). However, unlike in the present study, the study by 
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Bakvis et al. found a positive relationship between cortisol and attentional bias towards threat 
in patients with PNES (Bakvis et al., 2009b). It is important to note that patients with PNES 
in the study by Bakvis et al were all unmedicated, whereas patients in the present study were 
taking a range of different medications. The lack of a relationship between cortisol and 
attentional biases in the present study could therefore be attributed to possible medication 
effects, as mentioned above, although the finding that morning and evening cortisol levels or 
cortisol deltas in the patients in the present study did not differ from a normative sample of 
healthy individuals would argue against significant medication effects. Furthermore, a later 
study by Bakvis and colleagues found that baseline cortisol levels in patients with PNES 
were higher in those who reported sexual trauma than in those with no history of sexual 
abuse (Bakvis et al., 2010). As discussed earlier, the likelihood of sexual abuse in the PNES 
group in the present study is low, although this was not formally assessed.  
In terms of heart rate variability, patients with PNES but not patients with epilepsy 
had significantly reduced overall heart rate variability as well as lower vagal tone than 
healthy controls, indicating greater physiological stress vulnerability. This physiological 
vulnerability in the PNES group was also indicated by the findings reported in Chapter 3, as 
patients with PNES had higher sympathetic nervous system tone, reflected by higher CSI, 
than patients with epilepsy. Similar findings were reported by Bakvis et al. (2009a) who 
found reduced HRV in patients with PNES, compared to healthy controls. This finding is also 
partly in line with a previous HRV study, which showed a pathologically reduced resting 
HRV in patients with PNES, in keeping with heightened level of autonomic arousal 
(Ponnusamy et al., 2011). However, Ponnusamy et al. (2011) also found reduced HRV in 
patients with epilepsy, compared to healthy individuals, which was not replicated in the 
current study. Other studies of HRV parameters in epilepsy have found variable results. 
Although most studies show altered HRV in patients with epilepsy compared to controls 
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(Lotufo et al., 2012), there are studies that found no difference between patients with epilepsy 
and controls (Persson et al., 2007). 
Examination of the relationships between HRV and attentional biases showed a 
negative association between the total power (a measure of overall HRV) and attentional bias 
towards somatic threat words in patients with epilepsy, suggesting that patients with lower 
overall HRV show greater vigilance towards somatic threat. This finding could be explained 
in the context of the neurovisceral integration model (Thayer & Lane, 2000). According to 
this model, the neural networks involved in emotional and cognitive regulation, including the 
anterior cingulate, the insula, the ventromedial prefrontal cortices, the amygdala, or the 
paraventricular nuclei of the hypothalamus, among others, are also involved in the regulation 
of cardiac autonomic activity that can be measured by HRV (Thayer & Lane, 2000). The 
model proposes that these neural systems are responsible for making adaptive and flexible 
cognitive, emotional and autonomic responses to environmental demands. Disruption of 
regulation in these systems can lead to prolonged activation of excitatory sympathetic 
nervous system responses and defensive cognitive and behavioural mechanisms, put a strain 
on the autonomic nervous system, and lead to a range of psychopathologies (Thayer & Lane, 
2000). Indeed, while higher resting HRV was found to be related to more adaptive cognitive 
processing of emotional stimuli and therefore more effective emotion regulation, lower 
resting HRV is associated with more hyper-vigilant responses to emotional stimuli and 
maladaptive regulation of emotions, which can be detrimental to psychological wellbeing 
(Park & Thayer, 2014). In the patients with epilepsy in the current study, diminished HRV 
could therefore be associated with exacerbated, maladaptive attentional responses to 
threatening stimuli. In turn, this attentional hypervigilance could make these patients more 
likely to notice and focus on threatening information in their environment and therefore more 
	   140 
prone to more frequent autonomic responses to such stimuli, which can further alter their 
autonomic nervous system functioning and flexibility.  
The examination of the relationship between cortisol and HRV showed these two 
physiological markers were not significantly correlated in any of the groups. Considering the 
findings of the diurnal pattern in these measures reported in Chapter 3, the lack of association 
between HRV and cortisol measured as part of the Stroop test could be explained by the 
different times of day at which the experiment was conducted. As suggested by previous 
studies discussed in Chapter 3 (Looser et al., 2010), it is also possible that under resting 
conditions, these two physiological systems function relatively independently.  
 The attentional responses towards stress-related stimuli in the two patient groups were 
further explored by examining the moderating effects of self-reported stress, optimism and 
resilient coping on attentional biases. Although both patient groups reported higher levels of 
self-perceived stress than the healthy volunteers and patients with PNES reported lower 
levels of resilient coping in the baseline questionnaires, self-reported stress and resilient 
coping were not found to be significant moderating factors.  
There was, however, a significant moderating effect of optimism. The optimism by 
group interaction revealed that the patient group was significantly predictive of the 
attentional response in patients who scored high in optimism, namely, among those with 
epilepsy, people higher in optimism had significantly greater attentional bias, whereas in 
patients with PNES optimism did not moderate the degree of attentional bias. This is a rather 
counter-intuitive finding, suggesting that, for patients with epilepsy, being optimistic was 
associated with being overall more vigilant towards threat and particularly vigilant towards 
seizure-related information. There is mixed evidence in the literature for the relationship 
between optimism and attentional bias towards negative and positive stimuli. One study 
found that healthy participants with high health-related optimism paid more attention to 
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health-related threat than pessimists, particularly if the threat was perceived as self-relevant 
(Aspinwall & Brunhart, 1996). The finding of the current study that patients with epilepsy 
high in optimism had greater attentional bias towards seizure-related threat would seem to 
corroborate the finding of the study by Aspinwall and Brunhart. The lower attentional 
vigilance towards threat-related stimuli in epilepsy patients who were low in optimism would 
on the other hand suggest attentional avoidance of the threat stimuli. However, the Aspinwall 
and Brunhart study did not assess whether or how the attentional biases were related to 
coping responses or levels of stress or general psychological wellbeing and it is therefore 
difficult to establish whether such biases served an adaptive or a maladaptive function in the 
study participants. Several later studies found the opposite pattern, showing that optimists 
were more vigilant towards positive pictures and more avoidant of negative pictures 
compared to those low in optimism (Isaacowitz, 2005; Luo & Isaacowitz, 2007). It is also 
worth noting that the effects of optimism may differ between healthy individuals and people 
with disorders, as well as between different types of disorders. A study of patients with 
Parkinson’s disease and patients with multiple sclerosis showed that patients with multiple 
sclerosis benefited more from being optimistic than those with Parkinson’s disease (de 
Ridder et al., 2000). That study also suggested a possible curvilinear effect of optimism on 
adjustment and coping, whereby having medium levels of optimism may be more adaptive 
than being high or low in optimism (de Ridder et al., 2000).  
 The effectiveness of the kindness self-affirmation intervention was assessed by 
comparing the participants’ Stroop responses in the Time 1 and Time 2 Stroop test and by 
comparing the physiological stress measures taken across the experiment. The results suggest 
that the intervention was not associated with any significant changes in attentional responses 
in any of the three groups.  
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The heart rate variability patterns also remained unchanged throughout the 
experiment, although it should be noted that due to the relatively small sample in the present 
study, the tests might not have been sufficiently powered to achieve significance. Patients 
with PNES showed lower HRV compared to healthy volunteers across all four time-points, 
which is consistent with the findings of Bakvis et al. (2009a). 
There was, however, a significant change in salivary cortisol, with cortisol being 
lower after the second Stroop test than before the first Stroop test across all groups. In 
addition, when averaged across the two time-points, patients with epilepsy had higher levels 
of cortisol than healthy controls, perhaps suggesting a greater overall arousal in this patient 
group. The cortisol changes are difficult to interpret due to poor temporal resolution of the 
cortisol response, with studies of the salivary cortisol response typically sampling cortisol at 
a number of time points with intervals ranging from between five to 35 minutes (Kirschbaum 
& Hellhammer, 1994). Cortisol was only sampled at two time points in the current study, 
immediately before and immediately after the whole experiment. The reduction in cortisol 
from before the first Stroop test to after the second Stroop test could therefore have several 
different interpretations. The observed reduction in cortisol may be an indication of the 
desired positive effects of the self-affirmation intervention, which was performed before the 
second Stroop test, approximately 10 – 20 minutes prior to the second saliva sample 
collection. This would be consistent with previous studies in which a self-affirmation 
intervention was shown to reduce cortisol, epinephrine and norepinephrine responses to acute 
stressors (Creswell et al., 2005; Sherman et al., 2009). However, the cortisol reduction in the 
current study may also reflect a mere reduction in arousal throughout the experiment, 
regardless of the intervention, or it could have been affected by the diurnal fluctuation 
observed in the cortisol levels in Chapter 3. The participants were perhaps more aroused prior 
to performing the Stroop test for the first time and calmed down throughout the experiment. 
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This is somewhat unlikely, as studies showed that performing the Stroop test may be 
associated with a certain degree of stress (Renaud & Blondin, 1997). Although the emotional 
Stroop experiment in the current study was not designed to function as a stressor per se, it 
seems more likely that the evaluative nature of the task where participants were required to 
give fast and accurate responses would lead to increase rather than decrease in arousal. 
However, it is also possible that the decrease in arousal occurred during the second Stroop 
test as a result of habituation to the task rather than the effects of the intervention. Whether 
the change in cortisol was a result of the intervention effects, reduction of arousal throughout 
the experiment, habituation to the task or a combination of these effects is not possible to 
determine with certainty.  
4.5.1 Limitations 
The study has a number of limitations. The major limitation is the small sample size 
in each of the groups. Although the sample size is comparable to some of the previous studies 
exploring attentional biases in patients with seizures (Bakvis et al., 2009a; Lanteaume et al., 
2009), it is nevertheless possible that some effects were undetected by the current study due 
to its low statistical power.  
A further limitation is related to the heterogeneity of the two patient groups. Both 
patients with epilepsy and patients with PNES reported high levels of comorbid depression 
and anxiety and the majority of patients were taking anti-epileptic as well as other 
medication, many of which could have possible effects on the levels of cortisol (Hofstra & de 
Weerd, 2009). As the levels of depression and anxiety varied systematically between the 
groups, it was not possible to control for the effects of these disorders using analysis of 
covariance (Field, 2009) and the small group sizes did not allow for meaningful sub-group 
comparisons. Given that high levels of psychiatric comorbidity are typically found in these 
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patients (Kanner, 2009; LaFrance et al., 2013), the fact that patients in this study were not 
excluded on the basis of comorbid psychiatric disorders may make the results more 
generalisable. Furthermore, on a biological level, there are likely to be close multi-lateral 
relationships between epilepsy, PNES and comorbid psychiatric disorders such as depression 
or anxiety (for example, through the HPA axis) and it is therefore difficult to make a clear 
conceptual distinction between these conditions. Both epilepsy and PNES are bio-psycho-
socially determined conditions with a wide range of neuropsychiatric manifestations, which 
interact in complex ways (Elliott & Richardson, 2014; Kanner, 2009; LaFrance et al., 2008; 
Reuber, 2009), and it is therefore questionable whether it is desirable or appropriate to 
‘control’ for the associated psychopathology.  
Nevertheless, it is possible that the presence of anxiety, depression, or the effects of 
medication confounded some of the identified differences between patients and healthy 
volunteers in attentional biases and the physiological measures and the results therefore need 
to be interpreted with caution. In addition, previous studies identified at least two clusters of 
patients with PNES that may differ in their psychological characteristics and levels of 
psychological impairment (Brown et al., 2013; Uliaszek et al., 2012). It is therefore 
conceivable that the patterns of attentional biases may differ between different sub-groups of 
patients with PNES. 
Although an attempt was made to control the conditions during the Stroop experiment 
as much as possible, the environment in the telemetry ward in which the patients performed 
the test were nevertheless suboptimal. Due to the various medical and other procedures 
carried out in the ward, the Stroop test had to be performed at various times of the day and at 
various stages of the patients’ stay in the hospital (although most patients performed the test 
on the first or second day of their stay). In light of the findings reported in Chapter 3, which 
suggested that the experience of seizures may be associated with increased autonomic arousal 
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and self-perceived stress, it is also important to note that while most patients performed the 
Stroop experiment on days when no seizures had occurred prior to the experiment and the 
few patients who had experienced a seizure prior to the experiment completed the Stroop test 
at least one hour or more after the seizure, it is nevertheless possible that the experience of 
seizures could have had an influence on the Stroop test performance in some patients. 
Furthermore, the Stroop test was performed in a hospital bay, which was shared with other 
patients and although an attempt was made to keep any distractions to the minimum by 
having the bed curtains closed and asking the medical staff and visitors in the ward not to 
disturb the participant for the duration of the experiment, the environment was nevertheless 
relatively noisy and potentially distracting. In contrast, healthy volunteers performed the test 
in a quiet experimental room with no distractions.  
4.5.2 Implications and Conclusions 
Despite its limitations, this exploratory study presents novel findings about the 
patterns of attentional responses to stress-related stimuli in patients with epilepsy and patients 
with PNES and their relationships with physiological measures of stress including salivary 
cortisol and heart-rate variability. The attentional vigilance towards threatening stimuli, 
including stimuli related to seizures, and its association with reduced HRV found in the 
epilepsy patients in this study may represent a pattern of maladaptive cognitive and 
autonomic responses that contribute to the stress vulnerability of these patients. However, 
future studies could explore to what extent these attentional biases are indeed maladaptive, as 
well as whether and how they relate to the patients’ stress responses. For example, it would 
be interesting to examine whether greater attentional vigilance towards threat is associated 
with heightened endocrine, autonomic, cognitive or self-reported responses to an 
experimental stressor.  
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The fact that the attentional biases were not related to or moderated by levels of self-
reported stress could reflect the discrepancy between the more subjective self-report and the 
more objective cognitive and physiological stress measures, described in Chapter 3. This 
further emphasises the complexity of the stress-related vulnerability in this patient group and 
the importance of using a combination of implicit and explicit measures. One of the 
implications of these findings for future research in this area may be that simple self-reports 
cannot be used as a proxy of attentional biases or physiological arousal, which may still have 
significant effects on the life experience and functioning of patients with epilepsy and PNES. 
If we assume that the biased attentional responses are maladaptive, then these biases 
could be a target of information processing training interventions designed to refocus the 
attention away from factors that may be triggering stress responses. A few studies 
documented a successful application of such attention training programmes in individuals 
with anxiety disorders (Mathews et al., 2007; Schmidt et al., 2009). The feasibility of using 
such interventions for patients with epilepsy may be an interesting area for future research. 
Future studies could also further explore the role of optimism in the responses to emotional 
stimuli in this patient group.  
The current study failed to replicate the findings of previous studies that identified 
attentional biases in patients with PNES (Bakvis et al., 2009a; Bakvis et al., 2009b). Perhaps 
future studies could investigate attentional biases in these patients using a larger sample, 
comparing different types of stimuli (e.g., words versus pictures), different modes of stimuli 
presentation (masked versus unmasked), and examining sub-groups of patients, based on 
different levels of trauma or psychopathology.  
Although the self-affirmation intervention used in this study was not found to be 
effective in altering the attentional biases, it may have had some effects on the levels of 
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salivary cortisol. The effects of an intervention associated with the self-affirmation technique 
on a range of outcomes are further investigated and discussed in Chapter 5. 
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5. CHAPTER 5 
Study 2: A Pilot Study of a Self-Help Stress Management 
Intervention for Patients with Seizures 
 
5.1 Study Introduction 
This study focuses on a simple stress intervention designed to help patients with 
seizures presenting to neurologists cope with stress – regardless of whether the seizures are 
epileptic or non-epileptic in nature.  
With the exception of epilepsy surgery (which is only suitable for a small minority of 
patients with epilepsy) there are presently no truly ‘anti-epileptic’ treatments for epilepsy. 
Treatments used in clinical practice are mostly ‘anti-convulsant’ (i.e., anti-ictal), which 
means they merely control some of the manifestations but do not cure the disorder. As 
discussed in Chapter 2, many patients with epilepsy experience a high degree of stress, suffer 
from comorbid psychiatric conditions or struggle with the perceived or real stigma associated 
with epilepsy. All of this has a negative impact on the patients’ quality of life, and suggests 
that these patients could benefit from complementary psychosocial interventions (Kessler et 
al., 2012). Indeed, the latest National Institute for Health and Care Excellence (NICE) 
guidelines for the management of epilepsy recommend the use of psychological therapies in 
combination with other treatments (NICE, 2015).  
For patients with PNES, psychotherapy is the accepted treatment of choice (LaFrance 
et al., 2013). Although psychosocial interventions for epilepsy and PNES have been 
described and tested, only a minority of patients with these seizure disorders currently gain 
access to targeted psychological therapies and therefore the psychological and social 
problems associated with epilepsy and PNES often remain neglected (Mittan, 2009; Reuber 
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et al., 2005a). Furthermore, there is a lack of empirical studies evaluating the effectiveness of 
the available psychotherapeutic programmes (Mittan, 2009). The latest Cochrane reviews 
concluded that, due to methodological limitations and a low number of participants in the 
studies currently available, no firm conclusions can be drawn and more randomised 
controlled trials (RCTs) are necessary to provide a reliable evidence base for the 
effectiveness of different psychosocial treatments for epilepsy and PNES (Martlew et al., 
2007; Ramaratnam et al., 2008). Another limitation is that many studies have used outcome 
measures incapable of capturing the broader range of possible positive outcomes (Mittan, 
2009). Moreover, few of the programmes shown to be effective in research studies have been 
put into general use, presumably because perceived economic constraints and staffing 
implications associated with these interventions have outweighed expectations of patients 
benefit, raising questions about their more widespread utility in clinical services (Mittan, 
2009). There are a number of possibly more cost-effective interventions in the form of self-
help leaflets, books and Internet resources, which could provide standardised, low-intensity 
psychological treatment that patients could work through independently. However, these 
have not been evaluated by RCTs. 
An empirically tested, simple and widely applicable self-help intervention that would 
help people with epilepsy and PNES manage the stress they experience would be relatively 
easy to implement in NHS settings and could have positive effects on how stressed patients 
feel, the frequency of the patients’ seizures and their overall quality of life. The Medical 
Research Council (MRC) have developed a framework to provide guidance for development 
and evaluation of complex interventions, i.e., interventions comprising a number of 
interacting components (Craig et al., 2008). As shown in Figure 5.1, according to this 
framework, the process of developing and testing new interventions should have four main 
stages, including the development of the intervention based on appropriate evidence and 
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theory, assessment of feasibility and piloting of the methodology, evaluation of effectiveness, 
cost-effectiveness and change processes, and finally, publication and implementation of the 
intervention in clinical practice.  
 
Figure 5.1. Main stages in the development and evaluation process of complex interventions 
(taken from the MRC guidelines by Craig et al. (2008)) 
 
 
 
 
 
 
 
 
 
 
 
In accordance with this framework, a self-help intervention targeting stress in patients 
with seizures was developed as part of this study, as the first stage of the process outlined 
above. The intervention was assessed in a pilot trial in order to determine whether an 
evaluation in a larger randomised controlled trial would be justified. It is worth noting that, to 
date, there is a lack of consensus about the difference between ‘feasibility’ and ‘pilot studies’ 
(Lancaster, 2015). While the MRC guidelines use the terms more or less interchangeably, the 
National Institute for Health Research (NIHR) provide separate definitions for feasibility and 
pilot studies. According to the NIHR, feasibility studies are, ‘pieces of research done before 
a main study in order to answer the question “Can this study be done?” They are used to 
estimate important parameters that are needed to design the main study’, whereas a pilot 
study is ‘a smaller version of the main study used to test whether the components of the main 
study can all work together. It is focussed on the processes of the main study, for example to 
Feasibility/piloting 
* Testing procedures 
* Estimating recruitment/retention 
* Determining sample size 
Development 
* Identifying the evidence base 
* Identifying/developing theory 
* Modelling process and outcomes 
Evaluation  
* Assessing effectiveness  
* Understanding change process 
* Assessing cost-effectiveness 
Implementation 
* Dissemination  
* Surveillance and monitoring 
* Long-term follow-up 
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ensure that recruitment, randomisation, treatment, and follow-up assessments all run 
smoothly’ (Lancaster, 2015). Recent reviews highlight the fact that there is a major concern 
regarding the appropriate objectives of pilot studies. While these should primarily be focused 
on assessing feasibility and acceptability, testing the data collection and randomisation 
procedures, estimating rates of recruitment/retention, providing initial estimates for sample 
size calculations, and selecting appropriate outcome measures, the emphasis is often 
inappropriately placed on hypothesis-testing (Arain et al., 2010; Lancaster, 2015). It is 
therefore recommended that estimates of treatment effectiveness in pilot studies should be 
treated as preliminary and included as a secondary objective.  
In light of these recommendations, the present study was designed as a pilot of a 
randomised controlled trial (based on the NIHR definition), which aimed to assess the 
feasibility of the self-help intervention, to estimate recruitment and retention rates, and to 
assess the perceived acceptability and usefulness of the intervention by the study participants. 
The secondary aim of this pilot study was to provide a preliminary estimate of effect sizes to 
guide future larger scale RCTs and to assess possible effectiveness of the intervention in 
reducing levels of stress, improving the quality of life and reducing seizures in patients with 
epilepsy and those with PNES.  
5.2 Study Aims 
5.2.1 Primary Aims 
1. To develop a theory-based self-help intervention targeting stress in patients with 
epileptic and psychogenic non-epileptic seizures 
2. To assess feasibility and acceptability of the intervention in a pilot of a randomised 
controlled trial  
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5.2.2 Secondary Aims 
3. To provide estimates of effect sizes for power calculations to guide a future 
randomised controlled trial 
4. To provide preliminary evidence of effectiveness of the intervention in improving the 
patients’ quality of life, and reducing levels of self-reported stress, anxiety, depression 
and seizure frequency 
5.3 Methodology 
5.3.1 Development of the Intervention 
5.3.1.1 Theoretical framework 
The structure and content of the intervention were guided by the MRC and NICE 
guidelines. These emphasise that the key points to be considered at the development stage of 
a new intervention are awareness of relevant theory and existing evidence for what is likely 
to be effective, as well as understanding of the desired outcomes and the likely processes and 
mechanisms of change (Craig et al., 2008; NICE, 2007).  
The rationale for the development of the intervention was the fact that there is 
currently a lack of interventions targeting stress, developed specifically for and empirically 
tested in patients with seizures. Therefore, the aim was to compile a selection of simple, 
theory-guided techniques and strategies that are likely to work for this patient group, either 
based on previous studies and existing interventions for stress management, modified to be 
relevant to seizures, or techniques previously used in patients with seizures. The intervention 
has a number of different components, based on five theoretical approaches discussed below.  
 
	   153 
5.3.1.1.1 Integrative model of stress 
The overall framework for the structure of the intervention was based on the 
integrative model of stress presented in Chapter 1. According to the model, the experience of 
‘stress’ comprises interactions between environmental demands (stressors and life events), 
appraisal of demands and adaptive capacities, the resulting perceived stress, and the 
associated emotional, cognitive, behavioural and physiological stress responses (Cohen et al., 
1995). The intervention therefore includes techniques targeting all the different components 
of the model, i.e., strategies aimed at identifying stressors, a section addressing the appraisal 
of the stressors and coping skills, and a range of techniques targeting the different stress 
responses, including strategies for tackling negative thoughts and worries, relaxation and 
breathing techniques for reduction of negative emotions and physiological arousal, and 
strategies for overcoming maladaptive stress-related behaviours. The intervention suggests 
two different approaches to coping with stressors on the basis of their controllability. Based 
on the theory developed by Lazarus and Folkman, problem-focused coping is considered 
appropriate for more controllable stressors, whereas for stressors that are outside the 
individual’s control, emotion-focused coping is more appropriate (Lazarus & Folkman, 
1984). 
5.3.1.1.2 Core cognitive-behavioural techniques 
The specific techniques were selected on the basis of a review of literature about 
design of self-help and stress management interventions (Bergsma, 2008; Cuijpers & 
Schuurmans, 2007; Fledderus et al., 2013; Hasson et al., 2005; Lewis et al., 2012; Reeves & 
Stace, 2005; van Straten et al., 2008; Williams et al., 2011), as well as printed and on-line 
stress management materials. The core techniques and strategies selected for the intervention 
were mostly based on the cognitive-behavioural approach, which is at present the most 
empirically founded approach for stress and anxiety management (Cuijpers & Schuurmans, 
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2007; Kaczkurkin & Foa, 2015; NICE, 2011). The cognitive-behavioural techniques typically 
involve cognitive restructuring by learning to identify and challenge irrational or maladaptive 
thinking patterns, and behaviour modifications to reinforce adaptive behaviours and reduce 
levels of arousal (e.g., exposure, goal-oriented problem-solving strategies, applied relaxation, 
or changing levels of activity). These techniques are practical, as they tend to be relatively 
simple and can be broken down into easy steps (Cuijpers & Schuurmans, 2007).  
There is also promising preliminary evidence for the effectiveness of cognitive-
behavioural therapy (CBT) interventions for patients with epilepsy (Gandy et al., 2013; 
Goldstein et al., 2003; McLaughlin & McFarland, 2011) and PNES (Goldstein et al., 2010; 
Goldstein et al., 2004). These interventions include the additional use of behavioural and 
cognitive counter-measures to identify and avoid seizure triggers or to stop impending 
seizures from progressing (e.g., sensory grounding or breathing techniques), as well as 
strategies to reduce behavioural avoidance and minimise other maladaptive behaviours that 
may exacerbate seizures (as well stress), for example reducing alcohol consumption or 
promoting regular sleeping and eating habits (Goldstein et al., 2004; Goldstein et al., 2003).  
5.3.1.1.3 Psycho-education 
Psycho-education is a recognised treatment option for a range of mental health 
problems, based on improving patients’ understanding and self-management of their 
condition through education. Psycho-educational approaches and programmes have 
previously been described as potentially beneficial for patients with epilepsy (Laybourne et 
al., 2015; May & Pfafflin, 2002), as well as patients with PNES (Mayor et al., 2013). A brief 
psycho-educational section about stress and seizures was therefore included in the current 
intervention to provide greater insight into what stress is, its manifestations and symptoms 
and the different ways in which it may be related to both epileptic seizures and PNES.  
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5.3.1.1.4 Self-affirmation 
As discussed in Chapter 2, self-affirmation is a psychological technique that has been 
shown to have positive effects on both acute and chronic psychological and physiological 
stress responses as well as a range of other health-related behaviours (Creswell et al., 2013; 
Creswell et al., 2005; Epton & Harris, 2008; Sherman et al., 2009). A self-affirmation 
exercise was therefore included to enhance the effects of the intervention. The possible 
mechanism of action could be two-fold. Firstly, as discussed by Sherman and colleagues, 
reflecting on valued domains of the self may put the stressors the person experiences in a 
different perspective and thereby alter stress appraisal by changing its perceived significance 
and reducing the person’s additional concerns (e.g., negative ruminations, fear of failure) that 
may exacerbate the stress experience (Sherman et al., 2009). Secondly, as an alternative 
mechanism of restoring one’s self-integrity when faced with new information that threatens 
pre-existing beliefs, self-affirmation has been shown to decrease defensiveness and increase 
openness towards threatening information (Armitage et al., 2008; Griffin & Harris, 2011). 
The inclusion of a self-affirmation exercise could therefore make patients more receptive to, 
and accepting of, the information and advice presented in the booklet.  
The self-affirmation exercise was based on the traditional values-based self-
affirmation techniques (Creswell et al., 2005; Vernon & Allport, 1931), modified to be more 
interactive (i.e., involved drawing of a spider-diagram representing the person and their most 
important values and then writing a few sentences about one of the values, see Table 
5.1/Appendix 18).  
5.3.1.1.5 Implementation intentions 
Implementation intentions are simple, goal-oriented ‘if-then’ plans, designed to 
increase behavioural change by encouraging people to mentally link critical situations with 
desired behavioural responses (e.g., “If situation X arises, then I will perform goal-directed 
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behaviour Y!”) (Gollwitzer, 1999; Gollwitzer & Sheeran, 2006). A wealth of studies show 
that people’s goals and intentions do not easily translate into action, and this can be further 
exacerbated in people with mental health problems (Toli et al., 2015). The theory behind 
implementation intentions is that forming an implementation intention plan, which specifies 
when, where and/or how the goal-directed behaviour will be initiated, will lead to the 
relevant behavioural responses being elicited automatically when the critical situation is 
encountered in real life (Gollwitzer & Sheeran, 2006). 
The implementation intention technique has previously been found to enhance the 
effectiveness of self-help interventions (Varley et al., 2011) and has been successfully used in 
conjunction with the self-affirmation technique (Armitage et al., 2011). Implementation 
intentions have also previously been used to increase medication adherence in patients with 
seizures (Brown et al., 2009). Forming a brief implementation intention plan was therefore 
included in the present intervention to encourage patients to translate the stress management 
strategies they learn as part of the intervention into action. 
5.3.1.2 Description of the intervention 
The intervention is an unguided self-help intervention that takes the form of a brief, 
26- page A5 booklet (see Appendix 18). The booklet also includes a Compact Disc with two 
audio recordings (male and female voice) of a guided muscle relaxation taken from the Non-
epileptic Attacks website, with the permission of the authors (http://nonepilepticattacks.info). 
The booklet has six main parts, as detailed in Table 5.1.   
Previous studies of self-help interventions suggest that, in addition to the use of 
theory-guided strategies, effective interventions are characterised by simplicity and use a 
self-paced approach. In order to ensure simplicity of the intervention and to make it as 
accessible to patients with seizures as possible, the intervention was written in simple 
language and divided into sections, which were organised as a set of steps to follow (see 
	   157 
Table 5.1 and Appendix 18). The text and instructions were presented as bullet points, tables 
and diagrams. Where possible, interactive exercises with spaces for patients to write in were 
included. To encourage self-pacing, patients were instructed to go through the intervention 
and select and focus on the most relevant and helpful strategies.  
The booklet design and structure were discussed with and reviewed by a Cognitive 
Behavioural Therapist specialised in working with patients with seizures who suggested 
including a sensory grounding exercise, which was added to Section 4 of the booklet.  
To obtain initial indication of acceptability and relevance of the intervention, the 
design of the booklet was further discussed with service users attending the outpatient seizure 
clinics at the Royal Hallamshire Hospital. Nine patients (4 male) were approached and agreed 
to read through the booklet in the following week and provide feedback over telephone. Six 
of these patients responded to the telephone call. Of these, three patients confirmed they read 
the booklet and thought it was acceptable, comprehensible and relevant. The three remaining 
patients stated they did not read the booklet due to lack of time (N = 1) or lost interest in 
providing feedback (N = 2). The low response rate to this initial feedback alerted the 
researcher to the risk of high dropout rate and it was decided to include additional screening 
criteria (described in section 5.3.3) to ensure patients recruited in the pilot study felt stress is 
relevant to them and their seizures and were motivated to complete the study.  
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Table 5.1. Structure of the self-help booklet 
Booklet section Rationale/Aims of section Techniques and strategies 
Section 1  
‘Step 1: Understand 
stress’ 
Psychoeducational information aimed at 
increasing the understanding of stress, its 
effects and its interactions with seizures 
• Information about what is stress 
• Information about what causes stress  
• Information about the symptoms of stress 
• Information about how stress is related to 
seizures 
• The vicious cycle of stress diagram 
Section 2  
‘Step 2: Spot the 
stressors in your life’ 
A section based on the idea that patients 
may find it difficult to identify the sources 
of stress in their lives, aimed at increasing 
awareness of the degree of stress 
experienced and helping to identify and 
tackle stressors 
• Life events checklist with ratings of 
stressfulness 
• Writing down minor everyday stressors and 
hassles 
Section 3  
‘Step 3: Clarify your 
values and priorities’ 
A value-based self-affirmation exercise 
aimed at clarifying and reflecting on 
valued life domains in order to put 
stressors into perspective and reduce 
defensiveness 
• Drawing a value diagram 
• Identifying and writing down the most 
important value 
• Writing a few sentences 
about the identified value 
Section 4  
‘Step 4: Cope more 
effectively’ 
An explanation of two different ways of 
appraising and coping with stressors, 
depending on whether or not it is possible 
to change, control or avoid the sources of 
stress  
• For stressors that can be controlled or 
avoided, a problem-focused coping approach 
is recommended 
• For stressors that are not possible to control 
or avoid, an acceptance based, emotion-
focused coping approach is recommended 
o Ways of coping Goal/action-oriented, problem-focused 
coping strategies based on the CBT 
approach 
• Problem-solving exercise based on 
identifying the problem, listing all possible 
solutions, choosing the best one and 
breaking it down into steps 
• Time-management exercise to give shape to 
one’s day 
• Practicing to say ‘No’ 
o Coping with 
stressful thoughts 
CBT based techniques for cognitive 
restructuring by identifying and 
challenging stress-related negative 
cognitions 
• Learning to spot stressful thoughts using a 
checklist of common cognitive errors 
• Challenging thoughts 
• Taking control of worries 
o Coping with 
stressful feelings 
CBT and relaxation based techniques to 
reduce physiological arousal, negative 
emotions, and prevent impending seizures. 
 
• Learning to relax using a progressive muscle 
relaxation with guided audio instructions 
• Controlled breathing technique 
• Taking time out 
• Sensory grounding exercise 
• Taking a break and engaging in enjoyable 
activities 
• Connecting with others and seeking social 
support 
o Coping with a 
stressful lifestyle 
Basic advice and information about life 
hygiene aimed at encouraging a healthy 
lifestyle and reducing maladaptive stress 
related behaviour 
• Techniques for improving sleep 
• Techniques for improving diet and reducing 
alcohol consumption 
• Engaging in safe levels of exercise 
Section 5  
‘Step 5: Take action’ 
Implementation intention based goal plan 
aimed at encouraging patients to translate 
the coping techniques into action 
• Selecting the most helpful coping strategy 
from a list of the coping techniques 
introduced in the booklet 
• Forming a goal plan (‘If I feel stressed, 
tensed or worried, then I will use my X 
technique to help me cope!’) 
Section 6  
‘Step 6: Getting more 
help’ 
A list of additional resources and contact 
details for relevant support services 
• Books and CDs 
• Online resources 
• Useful contacts 
	   159 
5.3.2 Design of the Pilot Study 
The study was a pilot of a prospective randomised controlled trial. Participants were 
randomised to two groups, (1) an immediate intervention group who received the self-help 
intervention immediately after completion of a baseline assessment and (2) a delayed 
intervention group who received the intervention at one-month follow-up and served as a 
control group in the initial period, from baseline to one-month. Participants in both groups 
were assessed at baseline and subsequently followed up after one and after two months.  
5.3.3 Participants 
Consecutive patients were recruited in the Neurology Outpatient Clinic and the 
Specialist Epilepsy Nurse Clinics at the Royal Hallamshire Hospital, Sheffield. Adult patients 
with a clinical diagnosis of epilepsy or PNES were approached to participate in the study. 
Individuals who expressed interest in participating in the study were further screened and 
recruited on the basis of the criteria specified below.  
Inclusion Criteria: 
1. Clinically firm diagnosis of epilepsy, PNES or mixed (epileptic and non-
epileptic) seizures 
2. Over the age of 16 years 
3. Able to complete the self-report questionnaires without help 
4. Able to give informed consent 
5. At least some of the seizures are perceived to be precipitated by stress 
6. Currently experiencing a degree of stress and willing to try techniques to 
reduce stress  
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 Exclusion Criteria: 
1. Patients who were unable to give informed consent 
2. Patients who were unable to complete the self-report questionnaires and 
diary measure unaided 
3. Patients who have not experienced a seizure within the last 12 months 
4. Patients whose diagnosis was uncertain 
5. Patients who did not perceive stress to be relevant to their seizures and/or 
were not willing to try techniques to reduce stress 
The patients’ diagnosis was initially obtained from their medical notes and later 
confirmed by their consultant neurologists, all of whom were specialised in the treatment of 
seizure disorders. The diagnosis was considered ‘clinically firm’ if the consultant neurologist 
was sufficiently certain of the diagnosis based on the patient’s history, description of a typical 
seizure by a seizure witness and/or, where available, a video-EEG recording of a typical 
seizure. The additional inclusion criteria number 5 and 6 were added on the basis of the initial 
experience of the pre-pilot, in which a number of patients took the booklet but failed to 
engage further. An attempt was made to ensure that the recruited participants were motivated 
and committed to the study, as such a sample is more likely to represent the real-life 
population that would benefit from the intervention. 
5.3.4 Outcome Measures 
5.3.4.1 Telephone feedback questionnaire 
Patients were contacted by telephone one week after receiving the self-help 
intervention booklet and interviewed using a questionnaire developed as part of the study 
(Appendix 15). The questionnaire was designed to assess compliance with the instructions 
and to collect feedback on the acceptability and usefulness of the booklet. Compliance with 
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the instructions was assessed by a question asking whether or not the patient read through the 
booklet in the past week and if not, identifying reasons for not working through the booklet 
(the response options included, ‘I have not had time to do it’, ‘I have forgotten about it’, ‘I 
have lost the booklet’, ‘The booklet was too long’, ‘The booklet was too complicated’, ‘I have 
lost interest in the study’, and ‘Other reasons’). 
Feedback on the booklet was obtained through a set of rating scales and open-ended 
questions. The questionnaire included four questions rated on five-point rating scales, 
assessing (1) the overall helpfulness of the booklet (from ‘Not at all helpful’ to ‘Very 
helpful’), (2) whether or not the participant went through each of the nine sections of the 
booklet (‘Yes’ or ‘No’) and if so, the usefulness of each of the sections (‘Not at all useful’ to 
‘Very useful’), (3) the participant’s likelihood of using at least one of the techniques 
introduced in the booklet in the future (‘Very unlikely’ to ‘Very likely’), and (4) how much 
they would recommend the booklet to other people with seizures (‘Definitely not recommend’ 
to ‘Definitely recommend’). There were also three open-ended questions asking (1) what the 
participant liked the most about the booklet, (2) what they liked the least about the booklet, 
and (3) which particular coping technique they liked the most. In addition, the questionnaire 
included a final open-ended question giving the participant an opportunity to provide any 
further feedback or comments about the booklet.  
5.3.4.2 Self-report questionnaires 
A sub-set of the self-report questionnaires described in Chapter 3 was used for the 
baseline and follow-up assessments in this study. The questionnaires used in this study 
included a demographic questionnaire with questions about age, gender, education, 
employment status, duration of the seizure disorder, current medication, the nature of the 
seizures, the date of the last seizure, and whether the patient was currently receiving any 
psychological or psychiatric treatment. Patients also completed the Quality of Life in Newly 
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Diagnosed Epilepsy – 6 Dimensions Scale (NEWQOL-6D; (Mulhern et al., 2012), the 
Liverpool Seizure Severity Scale (LSSS-3; Scott-Lennox et al., 2001), a generalised rather 
than the momentary version of the Smith Stress Symptom Inventory assessing the 35 stress 
symptoms in the past month (SSSI; (Piiparinen & Smith, 2003), the Neurological Disorders 
Depression Inventory for Epilepsy (NDDI-E; Gilliam et al., 2006), the Generalised Anxiety 
Disorder 7-item Scale (GAD-7; Spitzer et al., 2006), the Single-Item Self-Esteem scale 
(SISE; Robins et al., 2001), and the Spontaneous Self-Affirmation Measure with the Habit 
Index of Positive Thinking scale (SSAM and HIPT; Harris et al., in preparation). In addition, 
the European Quality of Life – 5 Dimensions Scale (EQ-5D; Brooks, 1996) described below 
was used as a generic HRQoL measure. The questionnaire sent to patients at one- and two-
month follow-up included an additional question about changes in medication since the last 
assessment. 
5.3.4.2.1 European Quality of Life – 5 Dimensions Scale (Brooks, 1996) 
The EQ-5D is a standardised, generic measure of quality of life applicable to a range 
of health conditions and treatments (see Appendix 16). It consists of 5 descriptive items, 
including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, rated 
on 5-point scales (e.g., “I have no problems walking about”, “I have slight problems walking 
about”, “I have moderate problem walking about”, “I have severe problems walking about”, 
“I am unable to walk about”). The measure also includes a visual analogue scale (VAS), 
which records the respondent’s health on a 20 cm vertical 100-point scale with end-points 
labeled “the best health you can imagine” and “the worst health you can imagine”.  
Similarly to the NEWQOL-6D, the scoring is based on obtaining a unique health state 
by combining one level from each of the 5 descriptive items. There are a total of 3125 
possible health states, each of which is referred to in terms of a 5-digit code. For example, 
state 11111 indicates no problems on any of the 5 dimensions, while state 12345 indicates no 
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problems with mobility, slight problems with washing or dressing, moderate problems with 
doing usual activities, severe pain or discomfort and extreme anxiety or depression. Each of 
these health states can be converted into a single index value between 0 (poor health) and 1 
(perfect health). The VAS produces a single score ranging from 0 – 100. The EQ-5D has 
been translated into a number of languages and validated in a diverse patient population 
(Greiner et al., 2003; Shaw et al., 2005). The EQ-5D was included in the current study to 
enable possible future comparisons with other studies of different patient groups. 
5.3.4.3 Seizure diary 
The number of seizures experienced during each month was assessed by a simple 
seizure diary, previously used in a study of a psycho-educational intervention for patients 
with PNES (Mayor et al., 2013). For a copy of the seizure diary, see Appendix 17. 
5.3.5 Study Procedure 
5.3.5.1 Recruitment 
Patients attending the Neurology Outpatient and the Specialist Epilepsy Nurse Clinics to 
see a Neurologist or an Epilepsy Nurse for help with seizures were sent an invitation letter 
with an information sheet concerning the purposes and procedures of the study together with 
their appointment letter, approximately 2 - 6 weeks before their scheduled clinic visit. On the 
day of their appointment, I approached patients in the waiting room and gave them an 
opportunity to ask questions and revisit the information sheet. Interested participants were 
screened for their suitability to take part in the study on the basis of the exclusion/inclusion 
criteria described above and their motivation to participate. Recruitment took place over a 5-
month period between December 2014 and April 2015.  
 
	   164 
5.3.5.2 Baseline assessment and randomisation 
Patients identified as suitable for the study were asked to sign a consent form and 
complete the set of baseline questionnaires described above. Patients were also asked to keep 
a seizure diary throughout the duration of the study. 
Patients were subsequently randomly allocated to the immediate or delayed 
intervention groups. Each participant was assigned a consecutive study participation number, 
which had been randomised to either the immediate or the delayed intervention at the start of 
the study using an online randomisation tool (https://www.sealedenvelope.com/simple-
randomiser/v1/lists). Patients allocated to the immediate intervention group were provided 
with an envelope containing a detailed instruction letter, a seizure diary for the following 
month, and the self-help stress management booklet. They were encouraged to read and work 
through the booklet over the following week and I arranged to contact them by telephone 
approximately one week after the baseline assessment for a brief interview using the 
feedback questionnaire designed to check on their progress and to obtain feedback on the 
booklet. Patients in the delayed intervention group received an envelope with an instruction 
letter and the seizure diary but without the self-help booklet. They were informed that the 
self-help booklet would be sent to them by post as part of the one-month follow-up 
assessment and I arranged to contact them for the telephone interview approximately one 
week after they had received the one-month follow-up materials and had had a chance to 
work through the self-help booklet.  
5.3.5.3 Telephone interview 
Patients in the immediate intervention group were contacted by telephone one week 
after the baseline assessment. They were interviewed using the Telephone Feedback 
Questionnaire described above and their responses were recorded in the questionnaire sheet. 
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Responses to the open-ended questions were transcribed verbatim or paraphrased as closely 
as possible if the participant provided more information than was possible to transcribe. 
Participants who did not answer the call on the arranged date were contacted again or a 
message was left for them if they had previously given permission for this. Participants who 
did not respond to any of the two phone calls were sent the feedback questionnaire by post 
and asked to send it back using an enclosed prepaid envelope.  
5.3.5.4 One-month follow-up 
The first follow-up was arranged for both groups at one month after the initial 
assessment in the clinic. Participants were sent the follow-up materials by post. The follow-
up assessment involved completing the NEWQOL-6D and EQ-5D, the LSSS-3, NDDI-E, 
GAD-7, and SSSI questionnaires and submitting the seizure diary for the past month. Patients 
were also provided with a new seizure diary sheet to keep in the following month. Patients in 
the delayed intervention group received the self-help intervention booklet as part of the first 
follow-up assessment and were encouraged to use the booklet in the following week. Patients 
in the delayed intervention group were then further contacted by telephone one week after 
receiving the follow-up materials with the intervention booklet and asked to provide feedback 
on the booklet. The telephone interview was conducted following the same procedure as 
described above. 
5.3.5.5 Two-month follow-up 
Both groups were contacted again by post for the final follow-up assessment two 
months after the baseline assessment in the clinic. The two-month follow-up pack included 
the NEWQOL-6D and EQ-5D, the LSSS-3, NDDI-E, GAD-7, and SSSI questionnaires 
Participants were asked to return the questionnaires and the seizure diary they had been 
keeping in the past month using an enclosed prepaid envelope. 
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Participants who failed to return either of the one- or two-month follow-up materials 
within two weeks were contacted by telephone. Two telephone reminders were made and 
participants who did not respond to the calls or who failed to return the materials even after 
being reminded by telephone were sent a reminder letter explaining to them the importance 
of completing and returning the follow-up materials as soon as possible, and encouraging 
them to contact the research team if they had not received or if they had misplaced any of the 
study materials.  
5.3.6 Data Preparation and Statistical Analyses 
The questionnaires were scored according to their relevant scoring instructions. 
Where no formal instruction was available on how to treat missing data and where no more 
than 10% of scores were missing, the missing scores were replaced by the mean of completed 
items for the given scale. Mean replacement was performed on the SSSI (N = 7), GAD-7 (N 
= 2), SSAM (N = 2), and HIPT (N = 3) questionnaires.  
All data were analysed using SPSS (Version 22 for Mac; SPSS Inc., Chicago, IL, 
U.S.A.). As the main aims of this pilot study were to assess feasibility and acceptability of 
the intervention, the focus was on descriptive statistics to present the recruitment and 
retention rates and the baseline self-report measures. The distribution of the data was 
assessed using the Shapiro-Wilk test. Although the data on a number of outcome measures, 
including the EQ-5D, NEWQOL-6D, SSSI, GAD-7, HIPT, SISE, and the LSSS-3 were non-
normally distributed, parametric tests were used throughout and means and standard 
deviations are reported. All analyses were also run using non-parametric tests and any 
differences this made to the outcomes are highlighted. Where group comparisons were made, 
Chi-square analyses were used for categorical variables and t-tests were performed for 
continuous variables.   
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5.4 Results 
5.4.1 Participants 
5.4.1.1 Recruitment and retention rates 
Figure 5.2 shows the recruitment and retention rates in the study. A total of 429 
patients attending the clinics were approached and screened for eligibility. Of these, 178 
patients (41.5%) were not interested in participating in the study, and further 169 patients 
(39.4%) did not meet the eligibility criteria. This resulted in a sample of 82 interested, 
eligible patients (19.1%) who consented to taking part in the study and were randomised to 
one of the two intervention groups.  
Thirty-nine patients were randomised to the immediate intervention group, of whom 
36 completed the baseline assessment. The remaining three patients did not have enough time 
to complete the questionnaires in the clinic and said they would complete and send the 
materials back by post but failed to do so. Of the 36 patients who completed the baseline 
assessment, 14 (38.9%) completed and returned the one-month follow-up materials; 19 
(52.8%) did not return the one-month materials and did not respond to telephone and postal 
reminders; and three patients (8.3%) informed the researcher they wished to withdraw from 
the study. Twelve patients (33.3%) who completed the one-month follow-up also completed 
and returned the two-month follow-up questionnaires (i.e., completed the full study); two 
further patients (5.6%) dropped out at this stage. Five patients who did not return the one-
month questionnaires did complete and return the two-month follow-up questionnaires.  
Forty-three patients were allocated to the delayed intervention group and out of these, 
38 patients completed the baseline questionnaires. Of these 38 patients, 26 (68.4%) returned 
the one-month follow-up materials; nine (23.7%) failed to return the materials and did not 
respond to reminders; and three patients (7.9%) withdrew from the study. Twenty patients 
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(52.6%) who completed the one-month follow-up also returned the two-month follow-up 
materials (i.e., completed the full study); six further patients (15.8%) were lost to the second 
follow-up. Three patients who did not complete the one-month follow-up completed and 
returned the two-month follow-up only (see Figure 5.2). 
The patients’ diagnosis was later confirmed by their consultant neurologists. A 
diagnosis of epilepsy was confirmed in 57 patients, 12 patients had PNES, and two patients 
had both epileptic and psychogenic non-epileptic seizures. Patients whose diagnosis was 
uncertain were excluded from the analysis (N = 3). 
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Figure 5.2. Flow diagram of patient recruitment and retention in the study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Completed one and two-month follow-up (n = 12) 
♦	  Did not complete two-month follow-up (n = 2)	  	  
Completed one-month follow-up (n = 14) 
♦	  Did not complete one-month follow-up (n = 19)	  
♦	  Discontinued study (n = 3)	  
Allocated to immediate intervention (n = 39) 
♦ Completed baseline measures (n = 36)	  
♦ Did not complete baseline measures (n = 3)	  
Completed one-month follow-up (n = 26) 
♦ Did not complete one-month follow-up (n = 9)	  
♦	  Discontinued study (n = 3)	  
Allocated to delayed intervention (n = 43) 
♦	  Completed baseline measures (n = 38)	  
♦	  Did not complete baseline measures (n = 5)	  
Completed one and two-month follow-up (n= 20) 
♦	  Did not complete two-month follow-up (n = 6)	  	  	  	  
ONE-MONTH FOLLOW-UP 
Approached and assessed for 
eligibility (n = 429) 
Excluded  (n= 347) 
♦	  	  	  Not meeting inclusion criteria (n = 169) 
• Stress not relevant (n = 51) 
• Seizure-free (n = 33) 
• Severe learning disability (n = 51) 
• Insufficient command of English (n = 6) 
• Other reasons (n = 28) 
♦	  	  	  Declined to participate (n = 178) 
• Too busy (n = 3) 
• Taking part in other research (n = 1) 
• Feeling too unwell (n = 1) 
• No reason given (n = 173) 
 
BASELINE 
Randomised (n = 82) 
ENROLLMENT 
Analysed  (n = 35) 
♦	  Excluded (uncertain diagnosis) (n = 1)	   Analysed  (n = 36) ♦ Excluded (uncertain diagnosis) (n = 2)	  	  
TWO-MONTH FOLLOW-UP 
ANALYSIS 
Completed two-month follow-up only (n = 5)	   Completed two-month follow-up only (n = 3)	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5.4.1.2 Randomisation check 
The baseline demographic, clinical and psychological measures in the two 
intervention groups are summarised in Table 5.2. A series of Chi-square analyses for 
categorical variables and independent-samples t-tests for continuous variables showed there 
were no baseline differences between the immediate and the delayed intervention groups (p’s 
> .05).  
Table 5.2. Baseline demographic and clinical characteristics of the two intervention groups 
Note. SD = standard deviation; AED = anti-epileptic drugs; SSAM = Spontaneous Self-Affirmation Measure; HIPT = Habit 
Index of Positive Thinking; SISE = Single-Item Self-Esteem Scale; NEWQOL-6D = Quality of Life in Newly Diagnosed 
Epilepsy – 6 Dimensions; European Quality of Life-5 Dimension; SSSI = Smith Stress Symptom Inventory; GAD-7 = 
Generalised Anxiety Disorders 7-item Scale, NDDI-E = Neurological Disorders Depression Inventory for Epilepsy. 
Characteristic Immediate Intervention Group 
(N = 35) 
Mean (SD) 
Delayed Intervention Group 
(N = 36) 
Mean (SD) 
P-
value 
Age 40.49 (12.59) 43.22 (13.99) .390 
Gender (N female (%)) 23 females (65.7%) 27 females (75.0%) .391 
Years in education 13.66 (2.84) 13.88 (2.43) .735 
Economically active (N active (%)) 19 active (54.3%) 17 active (47.2%) .552 
Diagnosis (N (%))   .747 
   Epilepsy  26 (74.3%) 31 (86.1%)  
      Idiopathic generalised epilepsy 7 5  
      Focal epilepsy 18 22  
      Unclassifiable epilepsy 1 4  
   PNES 7 (20.0%) 5 (13.9%)  
   Mixed epilepsy and PNES 2 (5.7%) 0  
Seizure disorder duration (years) 17.88 (16.84) 16.25 (13.51) .654 
Median seizure frequency 
(seizures/month) 3.00 (16.00) 2.00 (4.00) .492 
Seizure severity 55.20 (21.65) 56.72 (18.14) .757 
AED use (N (%))   .199 
   None 5 (15.2%) 1 (2.9%)  
   AED Monotherapy 15 (45.5%) 19 (54.3%)  
   AED Polytherapy 13 (39.4%) 15 (42.9%)  
SSAM 3.77 (1.54) 4.19 (1.69) .285 
HIPT 3.34 (1.57) 3.92 (1.96) .176 
SISE 2.46 (1.15) 3.00 (1.39) .082 
NEWQOL-6D index value 0.70 (0.14) 0.74 (0.14) .194 
EQ-5D index value 0.69 (0.23) 0.64 (0.30) .448 
EQ-5D visual analogue scale 70.03 (15.61) 63.56 (20.10) .139 
SSSI 2.47 (0.66) 2.37 (0.64) .530 
GAD-7 9.74 (6.29) 9.25 (6.26) .747 
NDDI-E 15.23 (3.66) 15.08 (4.22) .639 
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5.4.1.3 Baseline measures in completers versus non-completers 
Considering the high dropout rate, the baseline characteristics were compared 
between those participants who completed the whole study (‘completers’; N = 29) and those 
who dropped out or withdrew from the study (‘non-completers’; N = 42). The baseline 
measures are summarised in Table 5.3. 
A series of Chi-square and independent-samples t-test analyses were performed to 
examine whether there were any baseline differences between completers and non-
completers. The analyses revealed that there was a significant difference in age, t(69) = -2.83, 
p = .006. As can be seen in Table 5.3, participants who completed the study were older than 
those who did not complete it. There were no other significant differences between the 
groups in any of the other variables.  
Table 5.3. Baseline demographic and clinical characteristics of completers and non-
completers 
Characteristic Completers 
(N = 29) 
Mean (SD) 
Non-completers 
(N = 42) 
Mean (SD) 
P-
value 
Age  47.00 (13.76) 38.00 (11.88) .006 
Gender (N female (%)) 23 females (79.3%) 27 females (64.3%) .173 
Years in education 14.15 (2.60) 13.50 (2.64) .330 
Economically active (N active 
(%)) 12 active (41.4%) 24 active (57.1%) .192 
Diagnosis (N (%))   .694 
   Epilepsy  23 (79.3%) 34 (81.0%)  
   PNES 4 (13.8%%) 8 (19.0%)  
   Mixed epilepsy and PNES 2 (6.9%) 0  
Seizure disorder duration (years) 19.16 (15.80) 15.61 (14.71) .335 
Median seizure frequency 
(seizures/month) 3.00 (14.00) 2.00 (4.50) .224 
Seizure severity 50.38 (22.08) 59.59 (17.57) .065 
AED use (N (%))   .854 
   None 2 (7.1%) 4 (10.0%)  
   AED Monotherapy 15 (53.6%) 19 (47.5%)  
   AED Polytherapy 11 (39.3%) 17 (42.5%)  
SSAM 4.30 (1.51) 3.77 (1.67) .185 
HIPT 3.94 (1.67) 3.44 (1.86) .266 
SISE 3.07 (1.18) 2.52 (1.35) .087 
NEWQOL-6D index value 0.75 (0.13) 0.70 (0.15) .114 
EQ-5D index value 0.69 (0.28) 0.64 (0.26) .474 
EQ-5D visual analogue scale 66.54 (21.15)  66.81 (16.26) .951 
SSSI 2.39 (0.61) 2.44 (0.68) .732 
GAD-7 9.61 (6.10) 9.41 (6.41) .895 
NDDI-E 15.11 (3.79) 15.43 (4.10) .740 
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5.4.1.4 Baseline measures in patients with epilepsy and patients with PNES 
The baseline measures were further explored in patients with epilepsy and patients 
with PNES (Table 5.4). For the purposes of the baseline comparisons, patients with mixed 
seizures were included in the PNES group, as previous studies suggested that the 
psychological profile of these patients is more similar to those of patients with PNES 
(Galimberti et al., 2003). Analysis showed that higher proportion of patients with epilepsy 
were taking at least one anti-epileptic drug, compared to patients with PNES, X2 (2) = 27.85, 
p <. 001. A series of independent-samples t-tests suggested that patients with PNES had 
lower quality of life as measured by the NEWQOL, t(67) = 2.66, p = .010 and the EQ-5D 
t(67) = 2.40, p = .019), and higher levels of self-reported depression as indicated by the 
NDDI-E, t(68) = -2.00, p = 0.49. There were no other differences between patients with 
epilepsy and patients with PNES in the baseline measures5.  
Table 5.4. Baseline demographic and clinical characteristics of the two patient groups 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
5 Comparison of the baseline measures between patients with epilepsy and patients with PNES using a series of non-
parametric Mann-Whitney U-tests additionally suggested that patients with PNES also had lower levels of spontaneous 
tendency to self-affirm as measured by the SSAM (U = 214.00, p = .050). 
Characteristic Epilepsy 
(N = 57) 
Mean (SD) 
PNES 
(N = 14) 
Mean (SD) 
P-
value 
Age 42.39 (12.54) 39.79 (16.37) .516 
Gender (N female (%)) 40 female (70.2%) 10 female (71.4%) .145 
Years in education 13.92 (2.72) 13.15 (2.15) .348 
Economically active (N active (%)) 30 active (52.6%) 6 active (42.9%) .132 
Seizure disorder duration (years) 18.55 (15.59) 10.98 (11.83) .094 
Median seizure frequency 
(seizures/month) 2.00 (4.50) 3.00 (14.00) .549 
Seizure severity 55.16 (20.93) 59.55 (14.00) .493 
AED use (N (%))   <.001 
   None 0 6 (42.9%)  
   AED Monotherapy 31 (54.4%) 4 (28.6%)  
   AED Polytherapy 25 (43.9%)  3 (21.4%)  
SSAM 4.15 (1.64) 3.21 (1.34) .070 
HIPT 3.80 (1.79) 2.90 (1.66) .113 
SISE 2.84 (1.31) 2.25 (1.22) .154 
NEWQOL-6D index value 0.74 (0.13) 0.63 (0.14) .010 
EQ-5D index value 0.70 (0.25) 0.51 (0.29) .019 
EQ-5D visual analogue scale 68.40 (16.38) 59.23 (24.14) .102 
SSSI 2.36 (0.67) 2.67 (0.52) .101 
GAD-7 8.83 (5.99) 12.39 (6.68) .063 
NDDI-E 14.86 (3.81) 17.23 (4.10) .049 
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5.4.2 Participants’ Feedback 
Forty-four patients provided telephone feedback on the booklet (20 in the immediate 
intervention group, 24 in the delayed intervention group). Overall, the feedback received 
from participants who worked through the booklet and responded to the questionnaire was 
positive, with most participants finding the booklet helpful and informative. A more detailed 
analysis of the responses to the rating scales and the open-ended questions is provided below.  
5.4.2.1 Usefulness ratings 
 Of the 44 patients who responded to the feedback questionnaire, 40 provided 
feedback on each of the separate sections of the intervention. Table 5.5 summarises the 
numbers of patients who reported reading through the relevant section of the booklet and 
their ratings of the perceived usefulness of the booklet overall as well as each of the different 
booklet sections. The ratings were further broken down into three categories, based on 
whether people rated the booklet as very useful/useful (rating of 5 or 4), neutral (rating of 3), 
or not useful/not at all useful (rating of 2 or 1). 
Table 5.5. Usefulness ratings of the different parts of the intervention  
 
Booklet Section N 
read 
Mean 
usefulness 
rating (SD) 
N (%) useful 
(rated 4 or 5) 
N  (%) neutral 
(rated 3) 
N  (%) not useful 
(rated 1 or 2) 
Booklet overall 44  3.84 (0.94) 28 (63.6%) 14 (31.8%) 2 (4.6%) 
   Section 1 Understand stress 39  4.03 (1.04) 28 (71.8%) 8 (20.5%) 3 (7.7%) 
   Section 2 Spot the stressors 40  4.20 (0.85) 31 (77.5%) 8 (20.0%) 1 (2.5%) 
   Section 3 Clarify your values 37  3.86 (1.00) 23 (62.2%) 12 (32.4%) 2 (5.4%) 
   Section 4 Cope more 
effectively 
     
     4.1 Ways of coping 38  3.71 (1.10) 21 (55.26%) 11 (28.9%) 6 (15.8%) 
     4.2 Coping with thoughts 38  4.00 (0.96) 25 (65.8%) 11 (28.9%) 2 (5.3%) 
     4.3 Coping with feelings 37  3.95 (0.97) 27 (73.0%) 6 (16.2%) 4 (10.8%) 
     4.4 Coping with lifestyle 35  3.91 (0.85) 25 (71.4%) 8 (22.9%) 2 (5.7%) 
   Section 5 Take action 27  3.96 (0.90) 18 (66.7%) 8 (29.6%) 1 (3.7%) 
   Section 6 Getting more help 24  4.29 (0.81) 19 (79.2%) 5 (20.8%) 0 (0%) 
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5.4.2.2 Ratings of likelihood of future use and recommendation to others 
Forty patients responded to the question ‘How likely are you to use at least one of the 
coping techniques from the booklet in the future?’ The mean likelihood rating was 4.45 (SD 
= 0.78), with 33 patients (82.5%) reporting being likely or very likely to use at least one of 
the techniques in the future (rating of 4 or 5), seven patients (17.5%) being neutral or 
undecided (rating of 3), and no patients being unlikely or very unlikely to use at least one of 
the techniques (rating of 1 or 2).  
 The question ‘Would you recommend the booklet to other people with seizures?’ was 
answered by 42 patients. The mean rating was 4.54 (SD = 0.71), with 37 patients (88.1%) 
stating they would recommend or definitely recommend the booklet (rating of 4 or 5) and 5 
patients (11.9%) being neutral or undecided. No patients stated they would not recommend or 
definitely not recommend the booklet to other people with seizures (rating of 1 or 2).   
5.4.2.3 Feedback from open-ended questions 
The three open-ended questions asked about the coping technique or section of the 
booklet that people liked the most, as well as what people generally liked the most about the 
booklet and what they liked the least.  
Figure 5.3 shows the most popular coping techniques. As can be seen from the graph, 
the most frequently mentioned techniques included the identification of stressors (preferred 
by 12 out of the 44 patients), the problem-solving exercise (10 out of 44 patients), practising 
to say ‘No’ and the audio-guided muscle relaxation exercise (7 out of the 44 patients).  
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Figure 5.3. The most frequently mentioned coping techniques 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.4.2.3.1 Positive aspects 
 Several common points emerged from people’s comments on the most and least liked 
aspects of the booklet. From the positive comments, the aspects people appreciated the most 
included the material being explained in a way that was easy to understand and written in an 
informal, ‘friendly’ language (mentioned by 8 patients). One of the patients commented,  
“It is written in a really sympathetic language, it makes you feel you're not on your own. It's 
friendly and informative”. Another patient stated, “It's more worldly and comforting than 
other booklets, less formal” and one patient said, “It was written in a language that we can 
understand. It would encourage you to follow the advice.” 
Another positive aspect people mentioned was the way the intervention enabled them 
to self-assess their stressors and thoughts and to respond in a proactive, constructive way 
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rather than getting overwhelmed (mentioned by 8 patients). One patient said they liked 
“Being able to self-assess my thought patterns and activities, put things into perspective and 
analyse them and tackle them one by one rather than worrying about them and being 
overwhelmed”; another person appreciated “Prioritising the stress and the worries, writing 
things down rather than having it all in your mind.” 
A number of people also felt the intervention increased their understanding of stress 
and/or the links between stress and seizures (mentioned by 6 patients). One patient said they 
liked “The ways it helped me realise what stress was all about”. Another patient said, “All of 
it was useful, especially the point about the stress and seizure link”.  
People also felt that the intervention introduced new information and techniques and 
gave them a new perspective (mentioned by 5 patients). One patient said, “It has given me a 
few things and techniques to try. The 'take time out' is very good for sleepless nights, 
something I didn't know about before”. Other comments included, “It makes you think” or 
“It gives you a different perspective”.  
Another common positive comment was that the booklet was a good point of 
reference and included useful resources (mentioned by 5 patients). One participant said, 
“This is a great help. I have written useful parts down and carry it around with me and I 
recommended ideas and techniques to others already”.  
People also mentioned they liked the fact that the intervention was comprehensive, 
relevant to people with seizures, practical, interactive with enough space for writing notes 
and that it was possible to select and focus on different sections.  
5.4.2.3.2 Negative aspects 
 With regard to the least liked aspects, most people said that there were no particular 
things they disliked about the intervention (29 participants). However, some participants felt 
the intervention was too detailed and complex (mentioned by 5 patients) and that there was a 
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lot of text and the font was too small (mentioned by 3 patients). One participant felt, “There 
may be too much information, it's too complex and ambitious”. One participant who hadn’t 
worked through the whole booklet at the time of the interview said, “I will go through it 
more carefully but I was put off by the amount of information, it could be daunting for 
people”.  
 On the other hand, a number of people said that some of the information was not new 
to them and that the booklet covered material they were already familiar with (mentioned by 
3 patients). One patient said, “A lot of it is similar to the CBT materials I came across before 
but it's a good thing to remember and be reminded of”. Another patient commented, “It 
wasn't new to me, it was information I already knew instead of suggestions that are different 
or new. It's more for people who don't know anything about the triggers of stress. It would be 
good for a lot of people but it would be nice to have something a bit more advanced for 
people who already have the basic knowledge.” 
 Two people felt that the intervention or some of the material was not personally 
relevant to them, for example, one of them said, “It was not relevant for me. I have a lot of 
support from my family and I have my ways of coping when I am stressed out. It might be 
useful for other people but not me”. Two people also mentioned that although the 
intervention was useful in terms of coping with stress, they did not feel it had an impact on 
their seizure frequency.   
5.4.2.3.3 Patients’ suggestions and recommendations 
 When asked about any further general feedback, two participants suggested it would 
have been helpful to have someone to guide them through the intervention and help them 
work through the exercises, for example, an epilepsy nurse or an occupational therapist. 
There was also a recommendation to make the booklet into a two-step intervention, with an 
initial brief introduction to the basic material and a more advanced version with more 
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detailed and complex information. One participant further pointed out that it might be useful 
to include more information about the effects of anti-epileptic medication. 
5.4.3 Preliminary Evaluation of Effectiveness 
As a secondary aim of this pilot study, a preliminary test of the effectiveness of the 
intervention was conducted and the effect sizes were estimated. Given the low retention rate 
in the study, the pre- and post-intervention outcome measures from the two intervention 
groups were combined and compared using a paired-samples t-test, in order to maximise the 
sample size. The effects are reported both with and without Bonferroni correction for 
multiple tests. The tests were only performed for a selection of the main outcome measures of 
interest, including quality of life measured by the EQ-5D index value, self-reported stress 
measured by the SSSI, anxiety measured by the GAD-7, depression measured by the NDDI-
E, and seizure frequency reported in the LSSS-3. Before combining, the baseline versus one-
month follow-up measures were compared in the delayed intervention group to assess 
whether any spontaneous changes occurred during this control (i.e., no intervention) period. 
Cohen’s dz measure of effect size was calculated using a power analysis software 
G*Power (Erdfelder et al., 1996). The Cohen’s dz is a standardised mean difference effect 
size appropriate for paired-samples t-test analyses, as it accounts for the correlation 
coefficient between the paired measures (Lakens, 2013). It is calculated as: 
Cohen’s dz = 
Mdiff   Σ Xdiff−Mdiff 2𝑁−1  
Where the numerator Mdiff is the mean of the difference scores and the denominator is the 
standard deviation of the difference scores. 
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5.4.3.1 Spontaneous changes in the delayed intervention group  
The outcome measures at baseline (T0) and at one-month follow-up (T1) in the 
delayed intervention group are summarised in Table 5.6. A series of paired-samples t-tests 
revealed that there were no significant differences between any of the baseline and the one-
month follow-up measures (p’s > .05). This indicates that there were no statistically 
significant spontaneous changes in these measures during the no-intervention period.  
Table 5.6. Mean outcome measures at baseline and at one-month in the delayed intervention 
group 
 
 
 
5.4.3.2 Comparison of the pre- versus post-intervention outcome measures 
Table 5.7 summarises the pre- and post-intervention outcome measures from patients 
in both intervention groups combined (i.e., the baseline (T0) versus the one-month follow-up 
(T1) measures in the immediate intervention group, and the one-month follow-up (T1) versus 
the two-month follow-up (T2) measures in the delayed intervention group), as well as the 
associated effect sizes.  
As shown in Table 5.7, there was a significant reduction in self-reported stress from 
pre- to post-intervention, t(28) = 2.74, p = .011. Applying Bonferroni correction for the five 
tests would lead to an adjusted significance level of .01 (.05/5), which would mean this effect 
Outcome Measure (N = 24) Baseline (T0) 
Mean (SD) 
One-month (T1) 
Mean (SD) 
P-value Cohen’s dz 
EQ-5D index value 0.65 (0.29) 0.70 (0.26) .422 0.195 
SSSI 2.45 (0.65) 2.42 (0.78) .675 0.069 
GAD-7 10.58 (6.07) 9.21 (6.93) .167 0.288 
NDDI-E 16.04 (3.71) 15.96 (4.37) .909 0.023 
Seizure frequency 16.13 (56.50) 9.46 (17.41) .439 0.161 
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would still approach significance6. The associated effect size was dz = 0.509, indicating a 
medium effect size.  
There were no significant improvements in quality of life, anxiety, depression, or 
seizure frequency (p’s > .05) and the associated effect sizes were small, as can be seen in 
Table 5.7. 
Table 5.7. Mean pre- and post-intervention outcome measures and associated effect sizes 
 
 
5.4.4  Analysis Plan and Sample Size Calculation for a Future Randomised 
Controlled Trial 
Based on the estimate of effect size reported above, a preliminary sample-size 
calculation was performed, in order to determine the sample size that would be needed for an 
appropriately powered randomised controlled trial of the intervention. One possible way of 
analysing the data would be to perform a series of 2 x 2 analyses of covariance (ANCOVAs) 
for mixed designs for each of the five main outcome measures, with the intervention group 
(immediate versus delayed intervention group) as a between-participants independent 
variable, time (one-month follow-up versus two-month follow-up) as a within-participants 
independent variable and the relevant outcome measure at baseline as a covariate. If the 
intervention was effective, a significant group by time interaction would be expected, with 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  6	  Comparison of the pre- versus post-intervention self-reported stress using non-parametric Wilcoxon signed-
rank test yielded a significant difference, Z = -2.60, p = .009, which would remain significant even after 
applying the Bonferroni correction for multiple tests. 	  
Outcome Measure N Pre-intervention 
Mean (SD) 
Post-intervention 
Mean (SD) 
P-value Cohen’s dz 
EQ-5D index value 29 0.72 (0.24) 0.71 (0.21) .767 0.056 
SSSI 29 2.32 (0.65) 2.12 (0.59) .011 0.509 
GAD-7 30 9.10 (6.43) 8.30 (4.87) .334 0.179 
NDDI-E 30 15.00 (3.95) 15.20 (3.23) .659 0.082 
Seizure frequency 31 18.81 (51.10) 13.58 (25.34) .302 0.188 
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the immediate intervention group scoring significantly better than the delayed intervention 
group at one-month follow-up, and with the two groups having comparable scores at two-
month follow up.  
The G*Power software was used to calculate the sample size required to achieve 
sufficient power using a series of ANCOVAs. In order to reduce the risk of Type 1 error, a 
Bonferroni correction was applied to correct for the five tests of the five main outcome 
measures and an adjusted significance level of 0.01 was used for the sample size calculation. 
Using a significance level of 0.01 and assuming a small to medium effect size, the total 
sample size needed to achieve 80% power with an analysis of covariance would be N = 191. 
This means approximately 96 participants in each intervention group. However, taking into 
an account the high dropout rate observed in the present study, future studies should expect 
dropout rates of at least 50%. In order to allow for such level of attrition, the sample recruited 
into the RCT would need to be at least N = 382 (i.e., 191 participants in each intervention 
group). 
5.5 Discussion 
This chapter described the theoretical rationale for and the development of a self-help 
intervention designed to help patients with seizures cope with stress. The intervention was 
assessed in a pilot of a randomised controlled trial, aimed at testing the feasibility of the study 
procedures, estimating rates of recruitment and retention, and assessing the acceptability of 
the intervention. In addition, the study provided a preliminary evaluation of the effectiveness 
of the intervention and the associated effect sizes as a basis for an estimate of sample size for 
a potential future RCT.  
In terms of feasibility of the study procedures, recruitment and retention in this pilot 
study posed a significant challenge, due to the short recruitment period and relatively high 
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proportion of patients who were not eligible or interested in taking part in the study. Some of 
the reasons for not wanting to take part mentioned by the patients included being too busy, 
taking part in other research or not feeling well enough; however, most patients did not 
provide a reason and were not specifically asked about it, which is something that could be 
further explored in future research. Similar recruitment challenges have previously been 
reported in a pilot study of a self-management programme for epilepsy, conducted in a 
similar setting of a specialist outpatient epilepsy service (Pramuka et al., 2007). 
Nevertheless, the fact that out of all the patients who were screened and approached 
by the researcher, 19.1% fulfilled the screening criteria, which required them to consider 
stress to be a relevant factor for their seizures and to be motivated enough to attempt to 
reduce their stress, suggests that stress is an important issue for many patients with seizures. 
However, this real world number of people who are willing to engage in an intervention 
targeting stress seems lower than the percentages of patients with seizures who report stress 
to be a potential trigger for their seizures, which have been reported in previous studies 
(Nakken et al., 2005; Privitera et al., 2014).  
Despite the relatively strict screening criteria and an attempt to recruit motivated 
individuals, there was a high dropout rate among those who consented to participate in the 
study. Comparison of the two intervention groups at baseline suggested that the 
randomisation procedure did not lead to any significant differences between the two 
intervention groups at the start of the study. There were also no apparent baseline differences 
between those who completed and those who did not complete the study. However, it should 
be noted that the statistical power of the tests was relatively low. The only identified 
difference between completers and non-completers was age, with older participants being 
more likely to complete the study. The reason for this is unclear and the evidence for 
predictors of retention in studies of self-help interventions is mixed, with some studies 
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reporting older age to be one of the predictors of higher retention while others reporting 
younger age to be associated with higher retention (Christensen et al., 2009; Lange et al., 
2003; Reeves & Stace, 2005).  
Importantly, the levels of attrition were different in the two intervention groups. 
While only 38.9% of patients in the immediate intervention group responded to the first 
follow-up, the retention rate in the delayed intervention group was 68.4%. Similarly, while 
only one third of patients (33.3%) in the immediate intervention group completed the whole 
study, more than half of the patients (52.6%) in the delayed intervention group completed the 
whole study. Differential attrition in randomised trials where participants do not differ at 
baseline is likely to be associated with some aspect of being allocated to the intervention 
versus the control condition, and can pose a problem for the internal validity of the study. 
However, the understanding of differential attrition in RCTs is limited (Crutzen et al., 2015).  
One reason for the differential dropout rate in the current study could be the 
expectations of receiving the intervention in those randomised to the delayed intervention 
group. It is conceivable that the anticipation of receiving and benefiting from the intervention 
served as an incentive for participants in the delayed intervention group to stay in the study 
and respond to the first follow-up, as opposed to patients in the immediate intervention group 
who did not have to wait and received the booklet as part of the baseline assessment. Another 
possible explanation, suggested by a recent systematic review of differential attrition in 
health behaviour change trials, is that participants in the immediate intervention group may 
have also had expectations about the benefits of the intervention, which were not met by the 
intervention and therefore led to reduced motivation to complete the follow-up (Crutzen et 
al., 2015). Alternatively, it is possible that a higher proportion of patients in the immediate 
intervention group dropped out early on due to the initial demands of having to complete the 
baseline assessment, work through the intervention and provide feedback within the first 
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week of enrolment into the study. The demands on participants associated with the study 
intervention have been proposed as one of the challenges of retention in clinical trials (Gul & 
Ali, 2010), and it would also be supported by the findings of a previous study of a self-help 
treatment programme for individuals with post-traumatic stress disorder, which showed that 
participants were more likely to drop out during the initial, most intense phase of the 
treatment programme (Lange et al., 2003). Although there is a great variability in the 
recruitment and retention rates of different self-help intervention studies, this pattern of 
dropout is consistent with a number of previous studies. Two systematic reviews of self-
management interventions for anxiety, depression, and psychological distress report that in 
many of the reviewed studies dropout rates were lower in the control group than in the 
intervention group (Christensen et al., 2009; Matcham et al., 2014). However, the reasons for 
this have not been addressed in-depth in any of the reviews. 
Overall, the dropout rate of approximately 50 – 70% found in the present study is 
comparable to other similar studies of self-help interventions. Dropout rates greater than 50% 
have been found in studies of self-help programmes for affective disorders (Christensen et al., 
2009; Reeves & Stace, 2005; Spek et al., 2007). This level of dropout also seems to reflect 
the interest in and engagement with psychological treatment in patients with non-epileptic 
seizures. For example, a feasibility study of a psychoeducational intervention for patients 
with PNES reported a 45% completion rate (Mayor et al., 2013). In contrast, a recent RCT of 
an online CBT-based intervention for depression in patients with epilepsy reported 
completion rate of 72% (Schroder et al., 2014). The relatively low dropout in the Schroder et 
al. study could be explained by the mode of recruitment, as the participants were recruited 
from epilepsy-specific online forums and it is therefore likely that the sample included 
proactive individuals who independently seek help and support online. Such participants are 
likely to be more motivated than the convenience sample of patients attending outpatient 
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neurology clinics recruited for the present study. Furthermore, the study by Schroder and 
colleagues used fewer outcome measures, and the fact that the whole study and data 
collection was conducted online may have made it easier for the participants to complete the 
study.  
 Regarding the acceptability of the self-help intervention in the present study, the 
feedback collected from patients in the telephone interview suggested that, overall, the 
booklet was perceived as being acceptable, with more than half of the participants rating the 
booklet as helpful or very helpful. The majority of patients also reported they intended to 
continue using at least one of the techniques introduced in the booklet in the future, and 
stated they would recommend the booklet to other people with seizures. The content and 
format of the intervention seemed acceptable as well and a number of participants 
commented positively on the language and tone in which the booklet was written, as well as 
the relevance of the information about stress and seizures and the usefulness of the coping 
techniques introduced in the booklet. A number of patients appreciated the constructive, 
problem-focused approach, which allowed them to identify their problems and tackle them in 
a systematic fashion. This was also reflected by the preference for the identification of 
stressors and the problem-solving techniques, indicated by patients when asked about their 
favourite coping strategy. Patients also seemed to find the advice on learning to say ‘No’ 
helpful, as well as the relaxation exercise, the strategies for coping with negative thoughts 
and worries and the controlled breathing technique. Interestingly, the order of preference for 
the specific coping techniques more or less reflected the order in which these techniques were 
presented in the booklet, which suggests that people’s preferences may have been affected by 
order effects. It is also possible that some participants only read the first few sections of the 
booklet, although most participants reported reading through most sections.  
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Although the overall feedback was positive, it is important to note that there may be a degree 
of bias, as it is possible that the booklet was not perceived to be helpful by those participants 
who dropped out, withdrew from the study or did not respond to the feedback questionnaire. 
 With regard to possible improvements to the intervention, the main negative feedback 
on the booklet was related to the amount of information and text in the booklet, which was 
perceived as daunting by some participants. A few participants also expressed an interest in 
receiving more guidance and having someone to introduce and work through the intervention 
with them. Based on these comments and suggestions, there are a number of practical ways in 
which the intervention could be improved. For example, it may be desirable to re-print the 
booklet using larger font to make it easier to read and perhaps improve the aesthetic appeal of 
the booklet by adding pictures or photos. In addition, providing more guidance on the use of 
the booklet could enhance its effectiveness. Indeed, previous studies suggest that guided self-
help interventions tend to be more effective than unguided self-help for the management of 
affective disorders (Cuijpers & Schuurmans, 2007; Gellatly et al., 2007; Lewis et al., 2012). 
While this would increase the time and staffing resources required, it should be relatively 
simple for someone with minimal psychological training or experience, for example, an 
epilepsy nurse, or an occupational therapist to administer the intervention.  
 The secondary objective of this study was to provide preliminary evidence of 
effectiveness of the intervention. The high dropout rate and the resulting low number of 
participants who responded to and completed all of the outcome measures compromised the 
statistical analysis of the data, as it was not feasible to perform the analysis using data from 
all the three assessment points. Nevertheless, the preliminary analysis of the data revealed 
promising findings. The results suggested that the intervention was associated with reduction 
in self-perceived stress and the effect size of this change was moderate. Considering the self-
reported importance of stress and stress management for patients with seizures, this 
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preliminary finding is encouraging. There are no previous studies of self-help interventions 
targeting stress management in patients with seizures but the effect size found in the present 
study seems comparable to other interventions aimed at reducing the symptoms of emotional 
disorders including depression and anxiety, which reported effect sizes ranging from d = 0.41 
– 0.96 (Cuijpers & Schuurmans, 2007; Gellatly et al., 2007; Lewis et al., 2012).  
No changes were found in depression, anxiety or quality of life. The reasons for this 
could be the lack of statistical power to detect changes in these measures or the fact that the 
intervention was designed to specifically target stress, rather than anxiety or depression. 
There were also no improvements in seizure frequency, suggesting that while the intervention 
may be helpful for the management of perceived stress, it may not necessarily be effective in 
reducing seizures. Indeed, some participants commented that they found the intervention 
useful in terms of stress but did not feel it had a direct effect on the frequency of their 
seizures. One reason for this may be the relatively low baseline seizure frequency of the 
participants in the current study. While there was a great variability between patients, the 
median seizure frequency at baseline was only 2 – 3 seizures per month. Most intervention 
studies of anti-epileptic medication typically require patients to experience at least 3 seizures 
per month (Fertig et al., 2014), whereas the only exclusion criterion in the present study was 
seizure freedom in the past 12 months. The evidence for effectiveness of psychological 
interventions on the reduction of seizures is mixed (Ramaratnam et al., 2008). In 
consideration of the findings of Study 1 of this thesis, the role of stress in directly triggering 
seizures remains uncertain and it may therefore be rather ambitious to expect a self-help 
stress management intervention to directly reduce seizure frequency, particularly in patients 
with small numbers of seizures. However, the occurrence of seizures in patients in Study 1 
seemed to be associated with increased levels of self-perceived stress and autonomic arousal, 
and patients with epilepsy also exhibited increased attentional vigilance towards stress-
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related stimuli. Reducing the perceived stress associated with the experience of seizures is 
therefore valuable in itself. Furthermore, a number of studies emphasised that the complex 
psychosocial complications associated with having a seizure disorder can be equally or even 
more disabling than the seizures themselves and it is therefore important to develop 
treatments targeting all the different difficulties associated with the disorders (Elliott & 
Richardson, 2014; Hermann & Jacoby, 2009; Lu & Elliott, 2012).  
Additionally, as discussed in previous chapters, there may be a sub-group of patients 
in whom stress does directly trigger seizures. While the present study was not powered to 
explore sub-groups of patients, this is something that could be further investigated in future 
studies. There is evidence for the potential of stress management interventions to lead to 
improvements not only on a psychological but also on a biological level, for example, a RCT 
of a stress management therapy for patients with multiple sclerosis was found to be 
associated with a reduction of formation of new brain lesions (Mohr et al., 2012). It would 
therefore be interesting to test whether the stress management intervention developed as part 
of the present study could have direct effects on seizure reduction in patients with stress-
precipitated seizures. 
5.5.1 Limitations 
This pilot study has a number of limitations. One of the main limitations was the low 
retention rate, which was further hindered by the limited time available for data collection 
within the time frame of the PhD project, resulting in a small sample size. This study was 
designed as a pilot study and the evaluation of the intervention effectiveness was a secondary 
aim. The small sample size and the lack of statistical power mean that although the results 
seem promising, they cannot be confidently generalised at this point.   
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There are further inherent limitations associated with self-help interventions. In 
addition to the risk of a high proportion of patients not finishing the treatment, there is also a 
lack of professional assessment and a limited opportunity to monitor patients’ adherence to 
the intervention. This means that patients may not complete the intervention or may apply the 
treatment inappropriately. Apart from asking patients which sections of the booklet they read 
through as part of the telephone interview, adherence was not formally assessed in this pilot 
study. It is therefore unclear to what extent patients actually read through the different 
booklet sections and in what way they used the content of the intervention. One way of 
assessing this, which was considered at the design stage of the study, would be to ask 
participants to return the booklet to the research team once they have read through it and to 
examine how many of the interactive exercises they completed. However, it was decided this 
was not feasible, as it is likely that many patients would not return the booklet and it would 
not be possible to reliably assess how much of the non-interactive parts of the intervention 
patients read through. It would also mean that patients would not be able to keep the booklet 
for future reference. Another option would have been to ask participants to record their use of 
the intervention as part of their seizure diary; however, this would have further increased the 
burden of the study and thereby further reduced the retention rates. A better way of assessing 
adherence would be to convert the booklet into an online intervention and electronically 
monitor how many sections people accessed and completed. In an on-line version of the 
intervention it would perhaps also be desirable to assess whether the order in which 
participants accessed and completed the different sections affected their preferences for the 
different coping strategies or their effectiveness. 
Another limitation is that the feedback provided by patients in the telephone interview 
was not audio-recorded or formally transcribed and the responses to the open-ended 
questions were not analysed using a formal qualitative analysis. Furthermore, patients’ 
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responses were assessed by one researcher who was not blinded to the intervention group or 
the identity of the patients, and who is likely to have been perceived by the patients as the 
author of the intervention. While undertaking a qualitative analysis was not an aim of this 
study and while every effort was made to transcribe and evaluate the responses as objectively 
as possible, there may have nevertheless been a certain degree of bias.  
A video-EEG confirmed diagnosis was not required for this study and in most cases, 
the diagnosis was established clinically by the patient’s consultant neurologist. Although 
patients for whom there was clinical uncertainty about the diagnosis were excluded from the 
analyses and although the patients were recruited from a specialist neurology service and 
diagnosed by experienced epileptologists, it is possible that some patients may have received 
an incorrect diagnosis. However, the intervention was designed for both patients with 
epilepsy and those with PNES and the diagnostic distinction was therefore not an essential 
part of this pilot study. Having said that, it would be interesting to explore the effects of the 
intervention in patients with epilepsy and patients with PNES separately, particularly 
considering that the patients with PNES in this study reported higher levels of depression, 
and lower quality of life. Unfortunately, the number of patients with PNES recruited in this 
pilot study was too low to perform any meaningful sub-group comparisons.  
Similarly to the patient groups in Study 1, the majority of patients in the current study 
were taking a number of anti-epileptic and other medications and a number of patients were 
suffering from a range of comorbid psychological problems. Patients were not excluded on 
the basis of their medication use or comorbid psychological conditions, as doing so would 
mean that the sample would not be representative of the clinical reality of this patient 
population. The study was not powered to control for these variables and it is therefore not 
possible to determine whether these factors had any confounding effects on the intervention. 
Nevertheless, any possible confounding effects were partly controlled for by the randomised 
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design of the study, the fact that the two intervention groups did not differ on any of these 
baseline characteristics, and the observation that there was no significant change in the 
delayed intervention group during the no-intervention period. 
 Finally, a further limitation of the study is its reliance on self-report measures. 
Although a selection of standardised, well-established measures was used in the study, the 
self-report questionnaires are still prone to a number of recall and response biases, 
particularly in patients with epilepsy and PNES who may have limited emotional insight, as 
discussed in the previous chapters.  
5.5.2 Future Research 
Based on the findings of this pilot study, a larger-scale randomised controlled trial of 
the intervention would require a considerably larger sample size and would need to account 
for a high dropout rate of at least 50% or more. There are a number of approaches to the 
statistical analysis of the data, including complete observations analyses or more complex 
modelling approaches, which could account for the missing data or differential attrition rates, 
such as an intention to treat analysis with the last observation carried forward or multiple 
imputation techniques (Christensen et al., 2009; Dziura et al., 2013). Considering the risk of 
high levels of attrition, it would be important to carefully consider the most appropriate 
approach if a future RCT was to be conducted. 
There are also ways in which the recruitment and retention in the study could be 
maximised, including a longer recruitment period, extending the recruitment to multiple sites 
or employing a wider range of recruitment methods in different settings, for example, through 
online forums or epilepsy and PNES support groups. As discussed above, providing an initial 
guidance on the intervention or embedding the booklet in an epilepsy nurse-led intervention 
could enhance the retention in the study and the impact of the intervention itself.  
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As suggested by the MRC guidelines, future research should also assess the cost-
effectiveness of the intervention and include a longer follow-up period, in order to assess 
long-term benefits of the intervention. It may also be desirable to monitor adherence to the 
intervention and examine the relationship between the degree of adherence and the treatment 
outcomes. It would also be interesting to explore the mechanisms of change and possible 
moderators of improvement, for example individual resilience factors, as well as to examine 
the effects of the intervention separately in patients with epilepsy and those with PNES, or in 
a sub-group of patients in whom stress is directly linked to their seizure occurrence.  
5.5.3 Implications and Conclusions 
In conclusion, despite its limitations, this pilot study provided a description of the 
development of a theory-based intervention specifically targeting stress in patients with 
seizures, and demonstrated its acceptability and perceived helpfulness to patients. 
Furthermore, the preliminary results of the study suggest that this simple intervention may 
have potential beneficial effects on the reduction of perceived stress – one of the main self-
reported seizure precipitants in patients with seizures. While an appropriately powered 
randomised controlled trial of the intervention is needed to provide definitive evidence for its 
effectiveness and cost-effectiveness, this pilot study suggests that in motivated individuals 
who perceive stress to be a factor contributing to their seizures, this self-help intervention 
could offer a useful tool to help them manage their stress better. Given the current lack of 
targeted stress-management interventions for patients with seizures, the booklet could be a 
relatively low-cost, low-threshold complementary treatment option that could be easily 
integrated into existing services and offered to patients who do not require intensive 
psychotherapy or as a first step before a more complex intervention and it could also be 
helpful to patients for whom psychological help may not be readily accessible.  
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6. CHAPTER 6 
Summary and Conclusions 
 
 
The relationship between stress and epilepsy has received scientific attention in recent 
years; however, most research to date has focused on the role of stress in epileptogenesis or 
on stress caused by epileptic seizures. Similarly, stressful life events have been studied as a 
risk factor for the development of PNES but fewer studies have considered the role of stress 
as an immediate trigger for non-epileptic seizures, although a close link between PNES and 
acute arousal has been hypothesised (Goldstein & Mellers, 2006). The evidence presented in 
Chapter 2 showed that the question whether, how or in whom stress facilitates seizures in 
patients with existing epilepsy or PNES is important. Many patients consider stress to be a 
trigger of their seizures and the identification and effective elimination of stress could reduce 
seizure frequency, as well as the uncertainty and distress surrounding seizure occurrence. The 
overall objective of this PhD programme was therefore further to explore the relationship 
between stress and seizures, and to develop and pilot-test a simple psychological self-help 
intervention that could reduce the stress patients experience and have potential beneficial 
effects on seizure occurrence and health-related quality of life. 
6.1 Key Findings 
Study 1a of this PhD project aimed to explore the links between stress and seizure 
occurrence using prospective assessment of a combination of subjective measures of self-
perceived stress and objective measures of physiological stress markers, including levels of 
salivary cortisol and HRV parameters. As part of the study, the diurnal patterns of these stress 
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measures and the relationships among them were also examined, in an attempt to provide 
further insight into the complex interactions of the different stress markers.  
The results showed a diurnal pattern in the physiological measures in both patients 
with epilepsy and those with PNES, similar to that typically found in healthy individuals, 
with high cortisol levels, high sympathetic nervous system tone and low parasympathetic 
(vagal) tone in the morning, and lower levels of cortisol, lower sympathetic tone and higher 
vagal tone in the evening. No diurnal fluctuation was found in self-reported stress in any of 
the two patient groups.  
Notably, no differences were found in the diurnal levels of cortisol between patients 
with epilepsy, patients with PNES, and a normative sample of healthy volunteers, suggesting 
there were no abnormalities in the cortisol levels or the cortisol circadian rhythm in the 
epilepsy and PNES patients in the present study. Normative diurnal HRV data were not 
available but comparison of the HRV between patients with epilepsy and patients with PNES 
suggested that patients with PNES had higher sympathetic tone than patients with epilepsy. 
This is consistent with a number of previous studies (Bakvis et al., 2009a; Bakvis et al., 2011; 
Roberts et al., 2012) and suggests patients with PNES may have high levels of autonomic 
arousal even in baseline or resting states.  
Exploration of the relationships among the measures showed that cortisol was 
correlated with some of the HRV parameters in the morning in both patient groups combined. 
No correlations were found between the physiological measures in the evening, which is 
something that would be expected, considering the very low levels of nocturnal cortisol. 
There were no relationships between the physiological measures and self-reported stress in 
any of the two patient groups. These correlational patterns suggest a degree of association 
between the endocrine and autonomic stress markers that is not reflected in self-perceived 
experience. This may indicate a discrepancy between the subjective and objective measures, 
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previously reported in patients with PNES (Dimaro et al., 2014; Dimaro et al., 2015), which 
is perhaps partly attributable to the relatively high levels of alexithymia found in both 
patients with epilepsy and patients with PNES (Myers et al., 2013). However, as discussed 
previously, it is also plausible that the different components of the stress system function 
relatively independently under resting conditions and may become more synchronised in 
highly stressful situations, under heightened arousal or when there has been any other 
relatively sudden or acute change in stress levels. The finding in study 1a that the occurrence 
of seizures was associated with both increased self-reported stress and autonomic arousal 
indicated by reduced HRV in the 12 hours after a seizure is consistent with this idea.  
 Importantly, the examination of the link between stress and seizure occurrence 
showed that none of the physiological or self-reported stress measures predicted seizure 
occurrence in the subsequent 12 hours in any of the two patient groups. Instead, occurrence 
of seizures was predictive of increased autonomic arousal and higher self-perceived stress, 
indicating that the experience of seizures was associated with increased stress for up to 12 
hours after the seizure in both patient groups. While the 12-hour window may have been too 
long to capture more immediate pre-ictal stress changes leading up to the seizures, these 
findings seem to suggest that, at least in the patients who participated in this study, stress was 
not a reliable seizure predictor. Based on this and the discrepancy found between the patients’ 
daily physiological stress measures and their subjective self-reports, it could be hypothesised 
that people’s retrospective appraisals of pre-ictal events may be inaccurate and possibly 
influenced by the post-ictal distress associated with the seizure itself. This could explain the 
disparity between studies in which a large percentage of patients reported stress as the main 
trigger for their seizures, and the mixed evidence for a direct link between stress and seizures 
found in prospective studies and in animal experiments. It is also possible that there may be a 
sub-group of patients with stress-precipitated seizures or with a greater susceptibility for 
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stress to trigger their seizures, which was not detected or examined as part of this study due 
to the small sample size. 
In order to provide as comprehensive evidence as possible within the scope of this 
exploratory study, study 1b experimentally assessed implicit attentional responses to stress-
related stimuli, which have previously been studied in patients with PNES and epilepsy 
(Bakvis et al., 2009a; Bakvis et al., 2009b; Bakvis et al., 2011; Lanteaume et al., 2009), as 
well as their relation to the physiological stress markers in patients with seizures compared to 
a group of healthy volunteers. Attentional bias towards threat has been proposed to reflect 
cognitive hyper-vigilance that can contribute towards exacerbation and maintenance of a 
number of affective disorders, and could therefore play a role in stress vulnerability. In 
addition, the experiment also examined whether implicit attentional responses in any of the 
three groups were moderated by self-perceived stress, optimism or resilient coping, and 
tested whether the attentional responses or any of the physiological measures could be altered 
by a simple intervention based on the self-affirmation technique.  
An emotional Stroop test was developed to assess the attentional biases, using a 
selection of threatening words from seizure-related, somatic, social and general threat 
categories, which had been evaluated as part of the study and demonstrated to be perceived as 
threatening and relevant to patients with seizures. The findings from the Stroop experiment 
revealed significant positive attentional bias towards seizure-related words compared to 
neutral words in patients with epilepsy, and patients with epilepsy also had significantly 
greater attentional biases towards threatening words across all the word categories when 
compared to healthy volunteers. Although not statistically significant, a similar positive 
attentional bias pattern towards threatening words was also seen in patients with PNES but 
this was not significantly different from healthy volunteers or from patients with epilepsy. 
The responses in healthy volunteers were characterised by a negative attentional bias, 
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suggesting avoidance of, rather than vigilance towards the threatening stimuli. The attentional 
bias towards somatic threat in patients with epilepsy was further related to reduced HRV, 
indicating a possible alteration in the networks involved in the regulation of cognitive, 
emotional, and autonomic regulation. Abnormalities in this pathway characterised by 
emotional and cognitive hyper-vigilance and over-excitability, defensive behavioural 
responses, and impaired ANS flexibility have been previously linked to a range of 
psychopathologies (Park & Thayer, 2014). This may represent a mechanism that may 
contribute to the vulnerability to maladaptive stress responses in patients with epilepsy 
whereby attentional hypervigilance to threat could make these patients more prone to 
noticing and focusing on threatening information in their environment and therefore more 
susceptible to more frequent autonomic arousal responses, which could in turn alter their 
ANS functioning and flexibility. This could be further explored in future studies and targeted 
by interventions focused on information processing training. Interestingly, the attentional 
biases in patients with epilepsy were moderated by optimism, suggesting that patients with 
high self-reported optimism were more prone to attentional biases. The role of optimism in 
the responses to and coping with stress in patients with epilepsy remains to be investigated in 
future studies.  
 The self-affirmation intervention tested as part of the Stroop experiment was not 
found to be effective in reducing attentional biases or improving HRV in any of the three 
groups, however the intervention was associated with reduction in salivary cortisol when all 
three groups were combined. While this cannot be confidently attributed to the effects of the 
intervention alone, it may be interesting to further examine the effects of self-affirmation on 
the reduction of cortisol in a larger patient sample.  
The results of previous studies of psychological and other non-pharmacological 
interventions for epilepsy and PNES suggest a potential for development and evaluation of 
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psychological interventions targeting stress as a trigger for both epileptic seizures and PNES. 
Consequently, in study 2, a self-help intervention in a form of a short booklet was developed, 
based on the integrative model of stress and incorporating theory and techniques from 
cognitive-behavioural, psycho-educational, self-affirmation and implementation-intention 
approaches to target stress as a seizure-facilitating factor. A pilot study of the intervention 
revealed that 19% of the 429 patients approached to take part in the study felt stress was 
relevant to them and their seizures and were prepared to try to improve their coping strategies 
and reduce stress using the intervention. As discussed in Chapter 5, this number is lower 
compared to the studies summarised in Chapter 2, where more than half of the patients with 
epilepsy identified or endorsed stress to be one of the main triggers for their seizures (Hart & 
Shorvon, 1995; Nakken et al., 2005). It is plausible that many people are likely to report 
stress as a seizure trigger when asked in a survey or a self-report questionnaire, however, the 
real world number of patients who are also willing to take steps to reduce the stress they 
experience by engaging with a study that requires completing an intervention and providing 
follow-up data and is therefore more demanding, is much lower. In the light of this, the fact 
that 19% of patients in the study reported in this thesis were motivated enough to enrol in the 
study indicates that stress is still important to many people with seizures. Nevertheless, the 
retention in the study was a major challenge and a high dropout of 50-70% was observed, 
particularly in the immediate intervention group. Feedback from patients who did complete 
the intervention was positive overall, with most patients rating the booklet as helpful, and 
stating they planned to continue using some of the coping techniques in the future and that 
they would recommend it to others with seizures. While most of the feedback was 
favourable, a few patients felt the booklet contained too much text and information and that it 
would have been useful to receive more guidance on how to complete it. These results 
indicate that a future RCT of the intervention would need to maximise recruitment and 
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retention and that there is a scope for further improvement of the intervention itself, including 
possible changes to the design and/or mode of delivery. 
A preliminary evaluation of effectiveness undertaken as part of the pilot study yielded 
promising findings, suggesting that the intervention was associated with reduction of self-
perceived stress and the effect size of this change was moderate. An appropriately powered 
trial would be necessary to determine possible effects of the intervention on other outcome 
measures not found to be affected by the intervention in the present pilot study, including 
reduction of seizure frequency, anxiety, depression, and improvement of quality of life. 
Based on the effect sizes and attrition rates estimated as part of the pilot, a sample size 
calculation for a future RCT was performed, indicating that a sample of at least 382 patients 
would be needed to achieve sufficient power. Given the encouraging results of the pilot 
study, if the challenges of recruitment and retention demonstrated in the pilot study were 
appropriately addressed and accounted for, a future RCT of the intervention developed as 
part of this PhD programme may be justified. Such future study may need to consider using a 
different recruitment and/or data collection method, including monitoring of adherence, for 
example, by converting the booklet into an on-line intervention, and perhaps using a different 
mode of delivery, such as guided self-help with follow-up phone calls to discuss 
effectiveness and adherence.  
6.2 Limitations  
As discussed in the relevant chapters, the studies conducted as part of this PhD 
programme had several limitations. To highlight the major weaknesses, despite being the 
largest studies of this kind to date, both studies presented in this thesis were limited by small 
sample sizes, which may have compromised the power of the statistical tests performed and 
the results therefore need to be interpreted cautiously. Despite collecting a large amount of 
	   200 
data across multiple days, study 1a was limited by relatively small number of data points, 
which did not allow for more precise assessment of the dynamic changes in the different 
stress measures, the effects of acute events occurring throughout the day or the exact 
temporal relationships between the stress measures at various time periods before and after 
seizures. Furthermore, due to the lack of prospective studies in this area, the study was 
exploratory in nature and as such was not designed to test a specific hypothesis; however, the 
findings and effect sizes presented in this thesis should enable researchers to formulate and 
test directional hypotheses and/or assess the relationships using experimental designs in the 
future.  
Both studies also included heterogeneous samples of patients with different seizure 
types, greatly variable seizure frequencies, taking a range of anti-epileptic and other 
medication, and reporting varying degrees of concurrent anxiety and depression, all of which 
may have affected the measures and outcomes in different ways. While the effects of these 
factors were not systematically assessed as part of the this thesis, considering the 
heterogeneity of patients with seizures and the complexity of the experience of stress, future 
studies should examine these variables more closely and explore different sub-groups of 
patients.  
6.3 Strengths 
 Despite their limitations, the studies reported in this thesis contribute valuable 
exploratory work to the study of the role of stress in ictogenesis, where most evidence to date 
has come from anecdotal, self-report and retrospective studies or animal research. A 
particular strength of the two studies is the use of an integrative approach to stress, taking 
into an account the complexity and the multi-faceted nature of the ‘stress’ experience and 
assessing and targeting its different components, including endocrine markers of the HPA 
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axis, autonomic measures of the SAM system, implicit cognitive responses, and subjective 
appraisals, in order to contribute to a more complete understanding of the relationships 
between stress and seizures.  
The prospective assessment of the links between stress and seizure occurrence 
conducted as part of the first study of this thesis adds to two previous diary studies, which 
investigated the links in patients with epilepsy (Haut et al., 2012; Haut et al., 2007), and 
expands on them by including physiological stress markers, examining the relationship in 
both patients with epilepsy and patients with PNES, and by exploring the relationship in both 
directions. Study 1a of this thesis yielded an interesting finding about the direction of the 
relationship, suggesting that it is more likely for seizures to cause self-perceived stress and 
increase autonomic arousal than it is for increased stress to directly trigger seizures, although 
the limitations of the study, particularly related to the limited number of data collection 
points, need to be taken into consideration. This finding facilitates a generation of a number 
of hypotheses to test this further, for example by more frequent assessment of the different 
stress measures before and after seizure occurrence. 
The first study presented in this thesis also provided a description of the diurnal 
patterns of the different stress measures and how they relate to each other, which has not been 
systematically assessed before. The finding of the diurnal pattern of cortisol and HRV in both 
patients with epilepsy and patients with PNES merits further investigation by more frequent 
or on-line assessment of the measures throughout the day and examining day curves, ideally 
in a controlled study, which would allow for direct comparisons with a matched group of 
healthy volunteers to identify any abnormalities in patients.  
Implicit attentional responses have previously been studied in both patients with 
epilepsy and patients with PNES, with a focus on a particular type of threat, such as angry 
faces (Bakvis et al., 2009a) or generic threat words (Lanteaume et al., 2009). The emotional 
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Stroop test in the study reported in this thesis assessed a broader range of different categories 
of threat, all relevant to patients with seizures. The finding of a significant attentional bias 
towards all categories of threat and seizure-related stimuli in particular in patients with 
epilepsy, as well as the relationship of the biases to HRV contributes further evidence for 
mutually interdependent cognitive an autonomic vulnerability to stress in these patients. The 
Stroop study also yielded a novel finding about the potential moderating effects of optimism, 
suggesting that the role of different individual characteristics and traits in the susceptibility to 
stress may be worth exploring further.  
Finally, as part of the second study, a novel, theory-based intervention specifically 
targeting stress in patients with seizures has been developed and an initial stage of its 
empirical evaluation has been undertaken. The pilot study showed a potential for the 
intervention to reduce patients’ self-perceived stress and the effect size estimates and sample 
size calculation provided as part of the study can serve to facilitate future assessment of the 
intervention in a larger trial. Furthermore, if the intervention proved effective in a sufficiently 
powered RCT, it could have application in clinical practice and it could be offered to patients 
as a low-cost, stand-alone self-help tool or be incorporated into other psychotherapeutic or 
epilepsy nurse-led treatment programmes.  
6.4 Implications for Future Research 
Some ideas for further research were presented in the relevant chapters, however 
some additional ideas are highlighted here. The findings of the studies presented in this thesis 
further emphasise the complexity of stress and its multi-faceted nature and it is therefore 
clear that future studies should attempt to employ a more integrative and interdisciplinary 
methodological approach rather than rely on patients’ self-reports. Future research could 
further explore the causal and temporal links between the psychological and physiological 
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stress and seizures in studies with more frequent assessment points or with an experimental 
design. It would be desirable for future studies to assess the measures over a longer 
monitoring period than the 3-5 days in study 1 of this thesis, and to account for stressful 
events occurring during the day. As discussed previously, prospective stress and seizure 
monitoring could be combined with an experimental assessment of the endocrine, autonomic, 
cognitive and self-perceived responses to an acute laboratory stressor, for example the 
commonly used Trier Social Stress Test (Kirschbaum et al., 1993). Based on the finding of 
the diurnal fluctuations of the physiological measures, it will be important for future studies 
to carefully consider the timing of the study procedures. Our research team is currently 
planning further refinement of the HRV parameter analysis using shifting time-windows to 
enable more precise and dynamic examination of the peri-ictal states, which may have the 
potential to clarify the relationships further. This methodology has recently been used as a 
seizure-detection tool in patients with epilepsy (Jeppesen et al., 2015). 
The attentional responses and their role in the susceptibility to stress should also be 
investigated further, particularly in patients with epilepsy and in relation to their interactions 
with the autonomic nervous system. As discussed, the emotional words used in this thesis 
may not be the most salient threat stimuli and different implicit cognition paradigms could 
therefore be employed, for example, using emotional faces previously used in the study by 
Bakvis and colleagues (Bakvis et al., 2009a), or other emotional images (Roberts et al., 
2012), or video clips previously used in other patient groups (Park & Thayer, 2014), or using 
tests such as the task-switching paradigm (Gul & Ahmad, 2014). It may also be interesting to 
assess the possible cognitive, affective and autonomic responsiveness and regulation in these 
patients within the framework of the neurovisceral integration model (Thayer & Lane, 2000). 
For example, the underlying physiological processes could be further explored by additional 
examination of the structural and functional brain networks using electroencephalography or 
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neuroimaging methods. Several recent studies have demonstrated abnormalities in the 
functional connectivity in brain areas involved in emotional, attentional and sensorimotor 
regulation in patients with PNES, using scalp EEG (Barzegaran et al., 2012) and functional 
magnetic resonance imaging (fMRI) (Ding et al., 2013; van der Kruijs et al., 2014) and it 
may be interesting to explore these in relation to stress responsiveness in both patients with 
PNES and patients with epilepsy.  
Future researchers may also want to consider combining quantitative and qualitative 
research methodology. Although the direct links between stress and seizures may presently 
seem unclear and while there seem to be discrepancies between patients’ subjective 
perceptions and their underlying physiological responses, ‘stress’ does seem to be 
subjectively important for many patients with seizures. Considering the complexity of the 
stress and seizure experience and their interactions, it may therefore be desirable to attempt to 
gain a more in-depth understanding of what patients with epilepsy and those with PNES 
mean by ‘stress’ and how they think about their seizure triggers. Previous studies 
demonstrated differences in the metaphors patients with epilepsy and patients with PNES use 
to describe their seizures (Plug et al., 2009) and interesting work has been done in these 
patients using conversational analysis, interpretative phenomenological analysis or thematic 
content analysis (Dickinson et al., 2011; Monzoni & Reuber, 2009; Thompson et al., 2009). 
Future studies could therefore include qualitative analyses of patients’ narratives.  
On a related note, future studies should also attempt to account for a broader range of 
possible moderating factors, examining stress susceptibility within the bio-psycho-social 
context of epilepsy and PNES. As discussed previously, future studies could explore the 
relationships between stress and seizures in patients with different seizure types, seizure 
frequency or seizure severity, further examine the role of anti-epileptic and other medication, 
and examine the role of stress in patients with different psychological profiles, accounting for 
	   205 
different levels of concurrent anxiety, depression, other psychiatric comorbidity, history of 
sexual or other trauma, or avoidant coping, as well as protective or resilience factors 
previously suggested to play a role in these disorders and in the resilience to stress, such as 
self-esteem (Dimaro et al., 2015), or attachment style (Brown et al., 2013; Smeets, 2010). 
Specific clusters of patients with PNES as well as patients with different epilepsy sub-types 
have previously been suggested (Brown et al., 2013; Magaudda et al., 2011; Uliaszek et al., 
2012) and it may be interesting to explore these sub-groups further. It would also be 
interesting, for example, to investigate the underlying genetic factors that may predispose 
individuals to be more vulnerable to the pathological effects of stress. Focus of further 
research and intervention may then be narrowed down to a specific group of patients 
identified as particularly vulnerable.  
Based on the sample size calculations provided as part of the pilot study of the self-
help intervention, a larger RCT could be run to further confirm its clinical utility. There is 
also scope for further development of different types of interventions targeting the different 
components of ‘stress’ in patients with seizures. For example, a recent proof-of-concept study 
of skin conductance biofeedback for patients with self-reported stress-precipitated temporal 
lobe seizures demonstrated reduction in seizure frequency through training patients to alter 
their sympathetic nervous system tone in order to reduce cortical excitability (Micoulaud-
Franchi et al., 2014). A large multi-centre randomised controlled trial of a stress management 
intervention for epilepsy (Stress Management Intervention for Living with Epilepsy; the 
SMILE study), run by researchers at the University of Cincinnati who previously studied 
stress in patients with epilepsy using self-report surveys and stress and seizure diaries (Haut 
et al., 2012; Privitera et al., 2014), is also currently under way. Their study involves an 
observational phase, during which stress and seizures are monitored using smart phones, and 
an intervention phase, based on focused-attention and relaxation exercises (Privitera, 2015). 
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It will be interesting in the future to compare and integrate the results of the SMILE trial with 
the findings reported as part of this thesis. More broadly, there is a growing emphasis on the 
importance of complementary psychosocial interventions and promotion of self-management 
in patients with seizures (Edward et al., 2015), and further investigation of the role of stress 
in seizure disorders and interventions targeting stress in patients with seizures therefore 
continues to be an important area for future research. 
6.5 Conclusions 
Overall, this thesis investigated the relationships between physiological and 
psychological stress markers and the occurrence of epileptic and psychogenic non-epileptic 
seizures, and developed a targeted intervention aimed at reducing stress, seizures and 
improving patients’ quality of life. The findings of the studies presented throughout the thesis 
highlight the complexity of the different components of stress, and suggest that these do not 
always correlate with each other. While none of the examined stress measures were found to 
predict seizure occurrence, the occurrence of seizures was predictive of increased 
psychological stress and autonomic arousal in both patients with epilepsy and those with 
PNES. Patients with epilepsy were further found to be cognitively and physiologically 
vulnerable to heightened responses to stress-related stimuli, which could make them more 
vulnerable to the pathological effects of stress. The pilot study of the self-help intervention 
developed as part of this thesis showed that many patients consider stress to be related to 
their seizures, and are willing to learn strategies to reduce their stress. Preliminary evaluation 
of the intervention suggested that self-perceived stress could indeed be reduced in motivated 
individuals using a simple self-help tool tailored for people with seizures, which could be 
easily implemented within the NHS at a relatively low cost.  
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Appendices 
 
 
Appendix 1. Demographic Questionnaire 
 
Personal	  Information	  
Please	  answer	  the	  following	  questions	  about	  yourself.	  The	  information	  you	  are	  giving	  us	  will	  
be	  treated	  as	  confidential	  and	  will	  be	  anonymised.	  Do	  not	  put	  your	  name	  on	  the	  
questionnaire.	  
	  
Subject	  ID:	  	  ………………………………………………………	  (to	  be	  completed	  by	  the	  investigator)	  
	  
1. Today’s	  date:	  …………………………………………...	  
	  
2. Date	  of	  birth:	  …………………………………………...	  
	  
3. Gender:	  	  (please	  tick	  the	  correct	  option)	   	   	   	  
	  
Male	   	   	   Female	  
	  
	  
4. Work:	  	  	  (please	  tick	  the	  correct	  option)	   	   	   I	  am	  at	  school/college	  
I	  am	  at	  university	  
I	  am	  employed	  
I	  am	  self-­‐employed	  
I	  am	  unemployed	  
I	  receive	  disability	  benefits	  
I	  have	  retired	  on	  health-­‐grounds	  
I	  receive	  an	  old-­‐age	  pension.	  
	  
5. For	  how	  many	  years	  in	  total	  did	  you	  go	  to	  school/college/university?	  …………………………	  years	  
	  
	  
6. Have	  you	  ever	  felt	  that	  some	  of	  your	  seizures	  occur	  as	  a	  result	  of	  stress?	  (please	  tick)	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  YES	   	   	   	  	  	  	  NO	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Appendix 2. Perceived Stress Scale 4-Item (PSS-4) 
 
PSS- 4 
The questions in this scale ask you about your feelings and thoughts during the last month.  In 
each case, please indicate with a check how often you felt or thought a certain way.  
 
  
1.  In the last month, how often have you felt that you were unable to control the important 
things in your life? 
 ___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often  
 
2.  In the last month, how often have you felt confident about your ability to handle your 
personal problems? 
 ___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often 
3.  In the last month, how often have you felt that things were going your way? 
 ___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often 
4.  In the last month, how often have you felt difficulties were piling up so high that you 
could not overcome them? 
 ___0=never ___1=almost never ___2=sometimes ___3=fairly often ___4=very often 
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Appendix 3. Liverpool Seizure Severity Scale (LSSS-3) 
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Appendix 4. Quality of Life in Newly Diagnosed Epilepsy – 6 Dimensions 
(NEWQOL-6D)  
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Appendix 5. Life Orientation Test – Revised (LOT-R) 
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Appendix 6. Spontaneous Self-Affirmation Measure (SSAM) and Single-Item 
Self-Esteem Scale (SISE) 
 
1. When we think about ourselves, our thoughts are sometimes negative and sometimes positive. In 
this study we are interested in the POSITIVE thoughts you have about yourself. 
For each of the following statements, circle the number that indicates how much you agree or 
disagree with the statement.  
Thinking POSITIVELY about myself is something ... 
    disagree agree 
  completely completely 
… I do automatically. 1-------2-------3-------4-------5-------6-------7 
… that feels sort of natural to me. 1-------2-------3-------4-------5-------6-------7 
… I do without further thinking. 1-------2-------3-------4-------5-------6-------7 
… I would find hard not to do. 1-------2-------3-------4-------5-------6-------7 
… that’s typically “me”. 1-------2-------3-------4-------5-------6-------7 
 
2. Sometimes when we face difficulties, challenges or problems in our daily lives we can find 
ourselves thinking about ourselves. We are interested in how often you find yourself thinking about 
yourself when things start to bother you. 
When I feel threatened or anxious by people or events I find myself … 
    disagree agree 
  completely completely 
…thinking about my strengths.    1-------2-------3-------4-------5-------6-------7 
  
…thinking about my values.   1-------2-------3-------4-------5-------6-------7 
 
…thinking about my principles.    1-------2-------3-------4-------5-------6-------7 
 
…thinking about what I stand for.  1-------2-------3-------4-------5-------6-------7 
 
…thinking about my family.    1-------2-------3-------4-------5-------6-------7 
 
…thinking about my friends.    1-------2-------3-------4-------5-------6-------7 
 
…thinking about the things I am good at.  1-------2-------3-------4-------5-------6-------7 
 
…thinking about the things I like   1-------2-------3-------4-------5-------6-------7 
    about myself. 
 
…thinking about my failings.    1-------2-------3-------4-------5-------6-------7 
 
…thinking about the people I love   1-------2-------3-------4-------5-------6-------7 
 
I have high self-esteem. 
Not very true of me  1 2 3 4 5        Very true of me 
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Appendix 7. Brief Resilient Coping Scale (BRCS) 
 
 
BRCS 
Consider how well the following statements describe your behaviour and actions on 
a scale from 1 to 5, where 1 means the statement does not describe you at all and 5 
means it describes you very well. 
 
1. I look for creative ways to alter difficult situations. 
1  2  3  4  5 
Not true of me at all      Very true of me 
 
 
2. Regardless of what happens to me, I believe I can control my reaction to 
it. 
 
1  2  3  4  5 
Not true of me at all      Very true of me 
 
 
3. I believe I can grow in positive ways by dealing with difficult situations 
 
1  2  3  4  5 
Not true of me at all      Very true of me 
 
 
4. I actively look for ways to replace the losses I encounter in life. 
 
1  2  3  4  5 
Not true of me at all      Very true of me 
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Appendix 8. Neurological Disorders Depression Inventory for Epilepsy 
(NDDIE) 
NDDI-E 
Please choose the answer that best describes you within the past few weeks, 
including today. 
 
1. Everything is a struggle 
  Always or Often Sometimes Rarely         Never 
 
2. Nothing I do is right 
 Always or Often                    Sometimes Rarely Never 
 
3. Feel guilty 
 Always or Often Sometimes Rarely                      Never 
 
4. I’d be better off dead 
 Always or Often Sometimes Rarely Never  
 
5. Frustrated 
 Always or Often Sometimes Rarely Never 
 
6. Difficulty finding pleasure 
 Always or Often Sometimes Rarely    Never 
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Appendix 9. Generalised Anxiety Disorder Scale 7-Item (GAD-7) 
 
 GAD-7  
  
 
  
 
 
 
 
 
 
 
Over the last 2 weeks, how often have you 
been bothered by the following problems?   
 
 
 
 
1. Feeling nervous, anxious, or on edge   
 
 
2. Not being able to stop or control worrying   
 
 
3. Worrying too much about different things  
  
 
4. Trouble relaxing   
 
 
5. Being so restless that it's hard to sit still   
 
 
6. Becoming easily annoyed or irritable  
  
 
 
7.  Feeling afraid as if something awful might 
happen   
 
 
Not at  Several  Over half  Nearly  
    all  days   the days   every day 
 
 
   
 
0   1   2   3   
 
 
0   1   2   3   
 
 
0   1   2   3   
 
 
0   1   2   3   
 
 
0   1   2   3   
 
 
0   1   2   3   
 
 
 
0   1   2   3   
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Appendix 10. Smith Stress Symptom Inventory (SSSI) 
 
1. To what extent do the following statements fit how you feel RIGHT NOW at the PRESENT 
MOMENT? Please check all the items using this key. 
1   = Doesn’t fit me at all  2  = Fits me a little   3   = Fits me moderately well   4   = Fits me very well 
 
1	  	         2        3        4     1. I have a nervous stomach. 
1	  	         2        3        4     2. I am easily distracted. 
1	  	         2        3        4     3. I feel like I am losing my memory and forgetting things. 
1	  	         2        3        4     4. I feel like I am losing sleep. 
1	  	         2        3        4     5. I worry too much about things that do not really matter. 
1	  	         2        3        4     6. My breathing is hurried, shallow, or uneven. 
1	  	         2        3        4     7. I have conflicts with others. 
1	  	         2        3        4     8. I find myself thinking in narrow, rigid ways. 
1	  	         2        3        4     9. My heart is beating fast, hard, or irregularly. 
1	  	         2        3        4     10. I have difficulty controlling negative thoughts. 
1	  	         2        3        4     11. I feel distressed (discouraged or sad). 
1	  	         2        3        4     12. I have lost my appetite. 
1	  	         2        3        4     13. I am depressed. 
1	  	         2        3        4     14. I am anxious. 
1	  	         2        3        4     15. I feel distaste or disgust. 
1	  	         2        3        4     16. I feel cynical or hostile. 
1	  	         2        3        4     17. My shoulders, neck, or back are tense. 
1	  	         2        3        4     18. I have difficulty keeping troublesome thoughts out of my mind. 
1	  	         2        3        4     19. I feel confused. 
1	  	         2        3        4     20. My muscles feel tight, tense, or clenched up (furrowed brow, tightened     
       fist, clenched jaws). 
 
1	  	         2        3        4     21. I feel less sensitive or caring to others. 
1	  	         2        3        4     22. I feel fatigued. 
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1	  	         2        3        4     23. I have a backache.  
1	  	         2        3        4     24. I feel like I am losing concentration. 
1	  	         2        3        4      25. I am afraid. 
1	  	         2        3        4      26. My mouth feels dry. 
1	  	         2        3        4      27. I feel like I might make mistakes. 
1	  	         2        3        4      28. I perspire or feel too warm.  
1	  	         2        3        4      29. I feel disorganised. 
1	  	         2        3        4      30. I feel the need to go to the restroom unnecessarily. 
1	  	         2        3        4      31. I find myself thinking unimportant, bothersome thoughts. 
1	  	         2        3        4      32. I have a headache. 
1	  	         2        3        4      33. I feel less cooperative with others. 
1	  	         2        3        4      34. I feel restless and fidgety. 
1	  	         2        3        4      35. I feel irritated or angry. 
 
2. On a scale from 0 to 6, where 0 means not at all stressed and 6 means very stressed, how 
stressed do you feel RIGHT NOW? Please circle as appropriate. 
 
Not at all stressed        Very stressed 
 
 
 
 
 
 
 
 
 
 
0 1 2 3 4 5 6 
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Appendix 11. Adjusted National Hospital Seizure Severity Scale (NHS3) 
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Appendix 12. Normative salivary cortisol values before and after log-
transformation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Healthy controls salivary 
cortisol (N = 14) 
Morning (9am) 
Mean (SD) 
Evening (10pm) 
Mean (SD) 
Cortisol delta 
Mean (SD) 
Cortisol levels (nmol/L) 4.19 (1.55) 0.95 (0.46) 3.23 (1.58) 
Log-transformed cortisol 
levels (nmol/L) 0.59 (0.16) -0.05 (0.14) 0.47 (0.20) 
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Appendix 13. Time-point level correlations between morning and evening stress 
measures in patients with epilepsy and patients with PNES 
 
 
 Time-point level correlations between the morning self-reported stress (N = 63), salivary 
cortisol (N = 63) and HRV parameters (N = 42) measures in patients with epilepsy 
 1 2 3 4 5 6 
1 Self-reported stress       
2 LogCortisol  .027      
3 LogSDNN .127 -.349*     
4 LogRMSSD .145 -.255 .917**    
5 LogCVI .137 -.305 .986** .963**   
6 LogCSI -.052 -.080 -.196 -.570** -.336*  
Note. *Correlation is significant at .05 level. ** Correlation is significant at .01 level 
 
 
 
 
 
 
Time-point level correlations between the evening self-reported stress (N = 57), cortisol (N = 
60), and HRV parameters (N = 51) measures in patients with epilepsy 
 
 1 2 3 4 5 6 
1 Self-reported stress       
2 LogCortisol .063      
3 LogSDNN .197 -.054     
4 LogRMSSD .244 -.076 .940**    
5 LogCVI .244 -.055 .983** .971**   
6 LogCSI -.174 .091 -.453** -.729** -.562*  
Note. *Correlation is significant at .05 level. ** Correlation is significant at .01 level 
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Time-point level correlations between the morning self-reported stress (N = 50), cortisol (N 
= 47), and HRV parameters (N = 38) in patients with PNES 
 
 1 2 3 4 5 6 
1 Self-reported stress       
2 LogCortisol .000      
3 LogSDNN -.136 -.225     
4 LogRMSSD .184 -.228 .957**    
5 LogCVI .125 -.158 .978** .965**   
6 LogCSI .217 .154 -.385* -.636** -.468**  
Note. *Correlation is significant at .05 level. ** Correlation is significant at .01 level 
 
 
 
Time-point level correlations between the evening self-reported stress (N = 46), salivary 
cortisol (N = 46), and HRV parameters (N = 43) in patients with PNES 
 
 1 2 3 4 5 6 
1 Self-reported stress       
2 LogCortisol .111      
3 LogSDNN -.197 .147     
4 LogRMSSD -.224 .168 .947**    
5 LogCVI -.197 .153 .980** .969**   
6 LogCSI .177 -.127 -.382* -.657** -.487**  
Note. *Correlation is significant at .05 level. ** Correlation is significant at .01 level 
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Appendix 14. Kindness Self-Affirmation Intervention 
 
Personal	  Attributes	  Inventory	  
Please	  indicate	  whether	  you	  have	  ever	  performed	  each	  of	  the	  behaviours	  described	  below	  by	  
circling	  either	  ‘YES’	  or	  ‘NO’.	  If	  your	  answer	  is	  ‘yes’	  to	  any	  of	  the	  behaviours,	  please	  provide	  a	  
brief	  example	  of	  when	  you	  performed	  it.	  
	   	   	   	   	   	   	   	   	   	   	  
1. Have	  you	  ever	  forgiven	  another	  person	  when	  they	  have	  hurt	  you?	   YES	   	   NO	  
If	  yes,	  please	  provide	  an	  
example……………………………………………………………………………………………	  
………………………………………………………………………………………………………………………………………………	  
	  
2. Have	  you	  ever	  been	  considerate	  of	  another	  person’s	  feelings?	  	   YES	   	   NO	  
If	  yes,	  please	  provide	  an	  
example……………………………………………………………………………………………	  
………………………………………………………………………………………………………………………………………………	  
	  
3. Have	  you	  ever	  been	  concerned	  with	  the	  happiness	  of	  another	  person?	  	  
YES	   	   NO	  
If	  yes,	  please	  provide	  an	  
example……………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………	  
4. Have	  you	  ever	  looked	  out	  for	  another	  person’s	  interests	  before	  your	  own?	  	  
YES	   	   NO	  
If	  yes,	  please	  provide	  an	  
example……………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………	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5. Have	  you	  ever	  been	  generous	  and	  selfless	  to	  another	  person?	  	  
YES	   	   NO	  
If	  yes,	  please	  provide	  an	  
example……………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………	  
6. Have	  you	  ever	  attended	  to	  the	  needs	  of	  another	  person?	  	   	   YES	   	   NO	  
If	  yes,	  please	  provide	  an	  
example……………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………	  
	  
7. Have	  you	  ever	  tried	  to	  not	  hurt	  the	  feelings	  of	  another	  person?	   YES	   	   NO	  
If	  yes,	  please	  provide	  an	  
example……………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………	  
8. Have	  you	  ever	  felt	  satisfied	  when	  you’ve	  helped	  another	  person?	  	   YES	   	   NO	  
If	  yes,	  please	  provide	  an	  
example……………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………	  
9. Have	  you	  ever	  gone	  out	  of	  your	  way	  to	  help	  your	  friend	  even	  at	  the	  expense	  of	  your	  
own	  happiness?	  	   	   	   	   	   	   	   	   YES	   	   NO	  
If	  yes,	  please	  provide	  an	  
example……………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………	  
10. Have	  you	  ever	  found	  ways	  to	  help	  another	  person	  who	  is	  less	  fortunate	  than	  yourself?	  	  	  
YES	   	   NO	  
If	  yes,	  please	  provide	  an	  
example……………………………………………………………………………………………	  
…………………………………………………………………………………………………………………………………………	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Appendix 15. Telephone Feedback Questionnaire 
	  
Patient	  ID:	  ………………………………………………..	  
Date:	   	  	  	  	  ………………………………………………..	  First	  contact	  /	  Second	  Contact	  	  
1. Have	  you	  had	  a	  look	  at	  the	  self-­‐help	  booklet	  in	  the	  past	  week?	  
YES	  /	  NO	  
(If	  ‘YES’,	  skip	  to	  question	  2.)	  
1.1 What	  were	  the	  reasons	  for	  not	  reading	  the	  booklet?	  
A. I	  have	  not	  had	  time	  to	  do	  it.	  
B. I	  have	  forgotten	  about	  it.	  
C. I	  have	  lost	  the	  booklet.	  
D. The	  booklet	  was	  too	  long.	  	  
E. The	  booklet	  was	  too	  complicated.	  
F. I	  have	  lost	  interest	  in	  the	  study.	  
G. Other	  reason(s):	  	  
………………………………………………………………………...	  
1.2 Do	  you	  intend	  to	  read	  the	  booklet?	  Please	  tell	  me	  how	  much	  you	  intend	  to	  read	  the	  booklet	  on	  a	  
scale	  from	  1	  to	  5,	  where	  1	  means	  you	  definitely	  do	  not	  intend	  to	  read	  the	  booklet	  and	  5	  means	  
you	  definitely	  intend	  to	  read	  it.	  
	  
Definitely	  do	  not	  intend	  to	  	   	   	   	   	   Definitely	  intend	  to	  
1	   	   2	   	   3	   	   4	   	   5	  
	  
1.3 Will	  you	  be	  able	  to	  read	  the	  booklet	  in	  the	  next	  week?	  If	  so,	  can	  we	  contact	  you	  again	  in	  a	  week’s	  
time?	  When	  is	  the	  best	  time	  to	  contact	  you?	  
YES	  /	  NO	  
Best	  time	  to	  contact:………………………………………………….	  
	  
2. Overall,	  how	  helpful	  did	  you	  find	  the	  booklet	  on	  a	  scale	  from	  1	  to	  5,	  where	  1	  means	  not	  helpful	  at	  all	  
and	  5	  means	  very	  helpful?	  
	  
Not	  at	  all	  helpful	  	  	   	   	   	   	   	   	   Very	  helpful	  
1	   	   2	   	   3	   	   4	   	   5	  
	  
3. Now	  please	  think	  about	  the	  different	  parts	  of	  the	  booklet.	  For	  each	  part,	  please	  tell	  me	  whether	  you	  
have	  read	  it	  and	  how	  useful	  you	  found	  it,	  on	  a	  scale	  from	  1	  to	  5,	  where	  1	  means	  not	  useful	  at	  all	  and	  5	  
means	  very	  useful.	  
	  
	  
	  
	  
	  
	  
	  
	  
Booklet	  section	   Read	  the	  section	   Usefulness	  rating	  
‘Understanding	  Stress’	   YES/NO	   1	  	  	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  	  	  5	  
‘Spot	  the	  stressors	  in	  your	  life’	   YES/NO	   1	  	  	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  	  	  5	  
‘Clarify	  your	  values	  and	  priorities’	   YES/NO	   1	  	  	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  	  	  5	  
‘Ways	  of	  coping’	   YES/NO	   1	  	  	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  	  	  5	  
‘Coping	  with	  stressful	  thoughts’	   YES/NO	   1	  	  	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  	  	  5	  
‘Coping	  with	  stressful	  feelings’	   YES/NO	   1	  	  	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  	  	  5	  
‘Coping	  with	  a	  stressful	  lifestyle’	   YES/NO	   1	  	  	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  	  	  5	  
‘Take	  action’	  	   YES/NO	   1	  	  	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  	  	  5	  
‘Getting	  more	  help’	   YES/NO	   1	  	  	  	  	  	  	  	  	  2	  	  	  	  	  	  	  	  	  	  3	  	  	  	  	  	  	  	  	  4	  	  	  	  	  	  	  	  	  	  5	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4. What	  did	  you	  like	  the	  most	  about	  the	  booklet?	  
	  
………………………………………………………………………………………………………………………………………………….	  
	  
………………………………………………………………………………………………………………………………………………….	  
	  
5. What	  did	  you	  like	  the	  least	  about	  the	  booklet?	  
	  
………………………………………………………………………………………………………………………………………………….	  
	  
………………………………………………………………………………………………………………………………………………….	  
	  
6. Which	  particular	  coping	  technique	  did	  you	  like	  the	  most?	  
	  
………………………………………………………………………………………………………………………………………………….	  
	  
………………………………………………………………………………………………………………………………………………….	  
	  
	  
7. How	  likely	  are	  you	  to	  use	  at	  least	  one	  of	  the	  coping	  techniques	  from	  the	  booklet	  in	  the	  future	  on	  a	  
scale	  from	  1	  to	  5,	  where	  1	  means	  you	  are	  very	  unlikely	  to	  use	  any	  of	  the	  techniques	  and	  5	  means	  you	  
are	  very	  likely	  to	  use	  at	  least	  one	  of	  the	  techniques	  in	  the	  future?	  
	  
Very	  unlikely	   	   	   	   	   	   	   	   Very	  likely	  
1	   	   2	   	   3	   	   4	   	   5	  
	  
8. Would	  you	  recommend	  the	  booklet	  to	  other	  people	  with	  seizures?	  Please	  tell	  me	  how	  much	  you	  
would	  recommend	  it	  on	  a	  scale	  from	  1	  to	  5,	  where	  1	  means	  you	  would	  definitely	  not	  recommend	  the	  
booklet	  and	  5	  means	  you	  would	  definitely	  recommend	  it	  to	  other	  people	  with	  seizures.	  
	  
Definitely	  not	  recommend	  	   	   	   	   	   Definitely	  recommend	  
1	   	   2	   	   3	   	   4	   	   5	  
	  
	  
9. Do	  you	  have	  any	  other	  comments	  or	  feedback	  about	  the	  booklet?	  
	  
………………………………………………………………………………………………………………………………………………….	  
	  
………………………………………………………………………………………………………………………………………………….	  
	  
………………………………………………………………………………………………………………………………………………….	  
	  
………………………………………………………………………………………………………………………………………………….	  
	  
………………………………………………………………………………………………………………………………………………….	  
	  
………………………………………………………………………………………………………………………………………………….	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Appendix 16. European Quality of Life – 5 Dimensions Scale (EQ-5D) 
 
 
EQ – 5D 
 
Under each heading, please tick the ONE box that best describes your health TODAY  
 
MOBILITY 
I have no problems in walking about      q 
I have slight problems in walking about     q 
I have moderate problems in walking about     q 
I have severe problems in walking about     q 
I am unable to walk about       q 
 
SELF-CARE 
I have no problems washing or dressing myself    q 
I have slight problems washing or dressing myself    q 
I have moderate problems washing or dressing myself   q 
I have severe problems washing or dressing myself   q 
I am unable to wash or dress myself     q 
 
USUAL ACTIVITIES (e.g. work, study, housework,  
family or leisure activities) 
I have no problems doing my usual activities    q 
I have slight problems doing my usual activities    q 
I have moderate problems doing my usual activities   q 
I have severe problems doing my usual activities    q 
I am unable to do my usual activities     q 
 
PAIN / DISCOMFORT 
I have no pain or discomfort       q 
I have slight pain or discomfort      q 
I have moderate pain or discomfort      q 
I have severe pain or discomfort      q 
I have extreme pain or discomfort      q 
 
ANXIETY / DEPRESSION 
I am not anxious or depressed      q 
I am slightly anxious or depressed      q 
I am moderately anxious or depressed     q 
I am severely anxious or depressed      q 
I am extremely anxious or depressed     q 
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• We would like to know how good or bad your health is  
TODAY. 
• This scale is numbered from 0 to 100. 
• 100 means the best health you can imagine. 
0 means the worst health you can imagine. 
• Mark an X on the scale to indicate how your health is 
TODAY.  
• Now, please write the number you marked on the scale in 
the box below.  
                     
 
 
 
YOUR HEALTH TODAY  = 
 
 
 
 
 
 
 
 	  	  	   	  	  	  	  	  
10	  
0	  
20	  
30	  
40	  
50	  
60	  
80	  
70	  
90	  
100	  
5	  
15	  
25	  
35	  
45	  
55	  
75	  
65	  
85	  
95	  
The best health        
 you can imagine 	  
The worst health        
 you can imagine 
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Appendix 17. Seizure Diary 
	  
Seizure	  Diary	  
Instructions:	  Please	  complete	  the	  first	  line	  of	  this	  diary	  with	  the	  name	  of	  the	  month	  and	  year.	  Mark	  each	  seizure	  
you	  have	  with	  a	  cross	  on	  the	  appropriate	  date.	  (Example:	  write	  “January”	  and	  “2014”	  in	  the	  grey	  box	  at	  the	  top	  
of	  the	  table	  and	  make	  the	  mark	  “XX”	  in	  line	  5	  if	  you	  have	  had	  two	  seizures	  on	  January	  5th	  2014).	  
Please	  return	  this	  diary	  to	  us	  together	  with	  the	  next	  set	  of	  questionnaires,	  which	  will	  be	  sent	  to	  you	  by	  post	  in	  
one	  month’s	  time.	  	  
Month:	  	  
Year:	  	  	  	  	  
Month:	  
Year:	  
1	   1	  
2	   2	  
3	   3	  
4	   4	  
5	  	   5	  	  
6	   6	  
7	   7	  
8	   8	  
9	   9	  
10	   10	  
11	   11	  
12	   12	  
13	   13	  
14	   14	  
15	   15	  
16	   16	  
17	   17	  
18	   18	  
19	   19	  
20	   20	  
21	   21	  
22	   22	  
23	   23	  
24	   24	  
25	   25	  
26	   26	  
27	   27	  
28	   28	  
29	   29	  
30	   30	  
31	   31	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Appendix 18. Self-Help Intervention 
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